Sentence,class,file
"Therapeutic Advances in Gastroenterology 9(6) 782 http://tag.sagepub.com Hanauer, 2011; Steenholdt et  al.",Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
http://tag.sagepub.com 783 colleagues with some modifications [Baert et al.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
Therapeutic Advances in Gastroenterology 9(6) 784 http://tag.sagepub.com Evaluation of stratified ADA levels (four groups)  with exogenous IFX spiking using AHLC methodol-ogy.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
http://tag.sagepub.com 785 Mean differences (bias) confirmed the ICC evalu- ation.,OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
"Therapeutic Advances in Gastroenterology 9(6) 786 http://tag.sagepub.com three assays (82–85%), whereas KAPPA coeffi- cient shown a moderate agreement.",OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
"http://tag.sagepub.com 787 However, the group of samples that had a double- positive status for both IFX and ADAs were iden-tified almost exclusively by the in-house and Immundiagnostik assays.",OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
Therapeutic Advances in Gastroenterology 9(6) 788 http://tag.sagepub.com (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
http://tag.sagepub.com 789 the three assays under the interference of exoge- nous IFX.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
Therapeutic Advances in Gastroenterology 9(6) 790 http://tag.sagepub.com lower concentration (5 µg/ml) of exogenous IFX.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
"http://tag.sagepub.com 791 IgG4 ADAs In order to evaluate the influence of IgG4 ADAs, samples positive for ADAs were tested for the presence of IgG4.",OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
Therapeutic Advances in Gastroenterology 9(6) 792 http://tag.sagepub.com This suggests that using the limit of detection as  a cutoff may decrease the quality agreement between assays.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
http://tag.sagepub.com 793 healing [Casteele et al.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
"Therapeutic Advances in Gastroenterology 9(6) 794 http://tag.sagepub.com data analysis, interpretation and drafting of the  manuscript, and revised it critically for important intellectual content.",Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav http://tag.sagepub.com 853 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Gastric cancer (GC) is the fifth most commonly diagnosed malignant tumor and the second most common cause of cancer-related death world-wide.",Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
Therapeutic Advances in Gastroenterology 9(6) 854 http://tag.sagepub.com involved in immune evasion in GC patients.,Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
http://tag.sagepub.com 855 impaired function of CD8+ T cells [Takano et al.,OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
Therapeutic Advances in Gastroenterology 9(6) 856 http://tag.sagepub.com cell-mediated cytotoxicity (ADCC) or comple- ment-dependent cell-mediated cytotoxicity (CDC) due to the modified Fc structure.,Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
"http://tag.sagepub.com 857 preliminary clinical efficacy of durvalumab with  acceptable safety profile was achieved across a vari-ety of tumors, including GC [Segal et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
"Therapeutic Advances in Gastroenterology 9(6) 858 http://tag.sagepub.com carefully selected, based on their molecular phe- notypes, for example, expression profiles of PD-1 and PD-L1, so that more specific therapeutic tar-geting can be achieved.",Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
"http://tag.sagepub.com 859 Brahmer, J., Tykodi, S., Chow, L., Hwu, W.,  Topalian, S., Hwu, P. et al.",OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
"Therapeutic Advances in Gastroenterology 9(6) 860 http://tag.sagepub.com durable tumor remission, and long-term safety  in patients with advanced melanoma receiving nivolumab.",Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/0d/2d/10.1177_1756283X16658251.PMC5076768.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav http://tag.sagepub.com 823 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"Therapeutic Advances in Gastroenterology 9(6) 824 http://tag.sagepub.com Butterworth, 2003; Shawcross et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"http://tag.sagepub.com 825 hours; later orally, adjusted to 2–3 bowel move- ments/day).",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"Therapeutic Advances in Gastroenterology 9(6) 826 http://tag.sagepub.com A (methanol) and 60% solvent B (1% formic acid  in water), changing to 80% solvent A and 20% B from 0–2 minutes, back to 40% solvent A/60% B from 2–2.1 minutes, and equilibrating with these conditions from 2.1–3 minutes.",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
http://tag.sagepub.com 827 Primary outcome The primary outcome was not achieved.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
Therapeutic Advances in Gastroenterology 9(6) 828 http://tag.sagepub.com Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
http://tag.sagepub.com 829 group did not require endoscopic treatment.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
Therapeutic Advances in Gastroenterology 9(6) 830 http://tag.sagepub.com 24 hours in both groups.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"http://tag.sagepub.com 831 bronchial aspiration, secondary to the endoscopic  procedure).",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
Therapeutic Advances in Gastroenterology 9(6) 832 http://tag.sagepub.com Table 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"http://tag.sagepub.com 833 suggesting not only the relevance of sample pro- cessing, but the participation of genetic factors, such as the variability in the glutaminase gene [Romero-Gomez et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"Therapeutic Advances in Gastroenterology 9(6) 834 http://tag.sagepub.com ammonia levels in patients with HE, treated with  OP or placebo.",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
Available at: http://www.ravicti.com/,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"http://tag.sagepub.com 835 sites/default/files/ravicti-prescribing-information_june- 2015.pdf Jalan, R., Wright, G., Davies, N. and Hodges, S.  (2007) L-Ornithine phenylacetate (OP): a novel  treatment for hyperammonemia and hepatic  encephalopathy.",Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/e7/df/10.1177_1756283X16658252.PMC5076769.pdf
"836 http://tag.sagepub.com Ther Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
http://tag.sagepub.com 837 information of any symptomatic episode.,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
Therapeutic Advances in Gastroenterology 9(6) 838 http://tag.sagepub.com treatment.,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
http://tag.sagepub.com 839 caused by chronic effects of alkalization by ammo- nium.,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
Therapeutic Advances in Gastroenterology 9(6) 840 http://tag.sagepub.com superficial cells (production of HCO3− and  mucous) are also reduced by the gastritis and thus  predisposing for gastric peptic ulcer [Byrd et al.,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
http://tag.sagepub.com 841 not be detectable [Karnes et al.,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
"Therapeutic Advances in Gastroenterology 9(6) 842 http://tag.sagepub.com Fossmark, R., Sagatun, L., Nordrum, I., Sandvik,  A. and Waldum, H. (2015) Hypergastrinemia is associated with adenocarcinomas in the gastric   corpus and shorter patient survival.",Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
"http://tag.sagepub.com 843 Parsonnet, J., Friedman, G., Vandersteen, D.,  Chang, Y., Vogelman, J., Orentreich, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
"Therapeutic Advances in Gastroenterology 9(6) 844 http://tag.sagepub.com Weaver, L. (1995) Royal Society of Tropical Medicine  and Hygiene Meeting at Manson House, London, 16 February 1995.",Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/a0/22/10.1177_1756283X16663395.PMC5076771.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 913 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
"Therapeutic Advances in Gastroenterology 9(6) 914 http://tag.sagepub.com Roadrunner, Cook, Wilston-Salem, NC, United  States) was placed in the pancreatic duct.",Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
http://tag.sagepub.com 915 The second case was a 45-year-old man with a  main pancreatic duct-type IPMN localized at the pancreatic head who underwent pancreaticoduo-denectomy with modified Child’s reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
"Therapeutic Advances in Gastroenterology 9(6) 916 http://tag.sagepub.com A guidewire was placed through the anastomotic  site, and the site was dilated to 4 mm at 6 atm   with a 4 ×  20 mm balloon dilator in one-session,  followed by insertion of a 5 Fr pancreatic stent.",Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
http://tag.sagepub.com 917 Kikuyama et  al.,OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
"Therapeutic Advances in Gastroenterology 9(6) 918 http://tag.sagepub.com Conclusion We characterized endoscopic features of the anas-tomotic site, the understanding of which is essen-tial to identify the site, and investigated useful techniques to identify the site and perform can-nulation for pancreatography.",Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
"http://tag.sagepub.com 919 Gleeson, F., Pelaez, M., Petersen, B. and Levy, M.  (2007) Drainage of an inaccessible main pancreatic duct via EUS-guided transgastric stenting through the  minor papilla.",Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/1a/27/10.1177_1756283X16663877.PMC5076772.pdf
"Therapeutic Advances in Gastroenterology898 http://tag.sagepub.comTher Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"http://tag.sagepub.com 899 causing (benign) proliferation of hepatocytes and  in some HCA, malignant transformation [Pilati et al.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Therapeutic Advances in Gastroenterology 9(6) 900 http://tag.sagepub.com an atoll) that is enhanced late in the venous phase.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"http://tag.sagepub.com 901 hemorrhage generally arose in the larger lesions  (>5 cm), although smaller lesions could also bleed (Table 3), albeit at much lower rates.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Therapeutic Advances in Gastroenterology 9(6) 902 http://tag.sagepub.com hematoma into the abdominal cavity.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
http://tag.sagepub.com 903 embolization (TAE) for the treatment of HCAs  in pregnancy is often a matter of debate.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"Therapeutic Advances in Gastroenterology 9(6) 904 http://tag.sagepub.com stage, and the fetus is not yet so large as to  interfere with liver surgery [Parangi et al.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
http://tag.sagepub.com 905 subtypes.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Therapeutic Advances in Gastroenterology 9(6) 906 http://tag.sagepub.com influence the decision to remove the lesion.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
http://tag.sagepub.com 907 increased risk using a percutaneous approach.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Therapeutic Advances in Gastroenterology 9(6) 908 http://tag.sagepub.com contraindications for surgery exist.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"http://tag.sagepub.com 909 all patients; for some, a more customized approach  may be required.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"Therapeutic Advances in Gastroenterology 9(6) 910 http://tag.sagepub.com Bioulac-Sage, P., Cubel, G., Taouji, S., Scoazec,  J., Leteurtre, E., Paradis, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"http://tag.sagepub.com 911 Haage, P., Piroth, W., Staatz, G., Adam, G. and  Gunther, R. (1999) [CT-guided percutaneous biopsies for the classification of focal liver lesions: a  comparison between 14 g and 18 g puncture biopsy  needles].",Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Therapeutic Advances in Gastroenterology 9(6) 912 http://tag.sagepub.com the young: a case report.,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/69/89/10.1177_1756283X16663882.PMC5076773.pdf
"770 http://tag.sagepub.com Ther Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"http://tag.sagepub.com 771 agents, such as antacids, histamine-2 receptor  antagonists, or proton pump inhibitors (PPIs) for symptom relief and esophageal mucosal healing [Katz et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"Therapeutic Advances in Gastroenterology 9(6) 772 http://tag.sagepub.com This study compared the bioavailability, phar- macodynamics, and safety profiles after adminis-tration of two dexlansoprazole 30 mg ODTs and one dexlansoprazole 60 mg capsule.",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
http://tag.sagepub.com 773 ODT was swallowed.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"Therapeutic Advances in Gastroenterology 9(6) 774 http://tag.sagepub.com Statistical analysis All data analyses were generated using SAS (Statistical Analysis System) version 9.2 (SAS Institute, Cary, NC).",OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
http://tag.sagepub.com 775 similar between the two 30 mg ODTs and the 60  mg capsule (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
Therapeutic Advances in Gastroenterology 9(6) 776 http://tag.sagepub.com Table 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
http://tag.sagepub.com 777 (1.9%) participant included oropharyngeal pain  and flatulence with the two ODTs and nausea with the capsule.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"Therapeutic Advances in Gastroenterology 9(6) 778 http://tag.sagepub.com when dosed at 60 mg once daily [Takeda  Pharmaceuticals America, Inc., 2016].",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"http://tag.sagepub.com 779 Communications and was funded by Takeda  Pharmaceuticals USA, Inc.",Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
Available at: http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
Therapeutic Advances in Gastroenterology 9(6) 780 http://tag.sagepub.com controlled studies.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
Available at: http://general.takedapharm.com/content/file.aspx?filetypecode=DEXILANTPI&cacheRandomizer=0d596f3b-147f-4473-a695-c7ddb61e7ac3 (accessed April 2016).,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/4b/af/10.1177_1756283X16666800.PMC5076775.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 815 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Gastric outlet obstruction (GOO) can be caused by obstruction at the level of the distal stomach or duodenum, preventing normal gastric emptying.",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
"Therapeutic Advances in Gastroenterology 9(6) 816 http://tag.sagepub.com for obstructions in the esophagus, stomach, small  bowel, or colon.",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
http://tag.sagepub.com 817 fluoroscopic evaluations.,OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
"Therapeutic Advances in Gastroenterology 9(6) 818 http://tag.sagepub.com The location of GOO included: antrum (12%),  duodenal bulb (44%), second portion of duode-num (D2, 34%), and third or fourth portion of the duodenum (D3/D4, 10%).",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
http://tag.sagepub.com 819 stent placement to death compared with patients  who did not suffer a procedural complication.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
"Therapeutic Advances in Gastroenterology 9(6) 820 http://tag.sagepub.com with an increased risk of SEMS occlusion,  requiring reintervention.",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
http://tag.sagepub.com 821 occlusion.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
Therapeutic Advances in Gastroenterology 9(6) 822 http://tag.sagepub.com self-expanding metal stents: experience in 36 patients.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/10.1177_1756283X16667893.PMC5076776.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 795 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Crohn’s disease (CD) is a chronic relapsing and remitting inflammatory bowel disease with unknown etiology and its incidence is increasing in China [Zhao et  al.",Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"Therapeutic Advances in Gastroenterology 9(6) 796 http://tag.sagepub.com Spectral CT, a novel CT scanning mode, has  been recently introduced, which could improve lesion detection and enhance image quality.",Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
http://tag.sagepub.com 797 software and a standard reconstruction kernel.,OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"Therapeutic Advances in Gastroenterology 9(6) 798 http://tag.sagepub.com regression was used to find which parameter had  independent value to predict intestinal activity (both mild and severe lesions) and intestinal severity, respectively.",OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
http://tag.sagepub.com 799 lesions (7.18 ± 2.94 mm versus 4.62 ± 2.33 mm;  p < 0.001).,Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"Therapeutic Advances in Gastroenterology 9(6) 800 http://tag.sagepub.com independent predictors, both p < 0.001 (Table  3).",Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
http://tag.sagepub.com 801 enables the creation of monochromatic spectral  images at energy levels ranging from 40 to 140 keV.,Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
Therapeutic Advances in Gastroenterology 9(6) 802 http://tag.sagepub.com artifacts and averaging attenuation effects com- monly seen in the conventional CT scan [Pan et al.,Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"http://tag.sagepub.com 803 In our study, we classified bowel segments into  three categories, namely, endoscopically normal segment, mild lesions and severe lesions accord-ing to endoscopic examinations.",Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
Therapeutic Advances in Gastroenterology 9(6) 804 http://tag.sagepub.com Further clinical trials need to prove our results.,Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"http://tag.sagepub.com 805 Tong, J., Feng, Q., Shen, J., Qiao, Y., Zheng, Q., Gu,  Y. et al.",OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals 04_TAG668309.indd   805 08/10/2016   12:44:15 PM,Non-OADS,/arxiv_data1/oa_pdf/38/db/10.1177_1756283X16668309.PMC5076778.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 759 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder that affects up to 20% of adults in North America [Dent et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
"Therapeutic Advances in Gastroenterology 9(6) 760 http://tag.sagepub.com hydrogen–potassium adenosine triphosphatase  enzyme (proton pump) at the final step of acid production, suppressing the secretion of proton ions in the stomach and increasing intragastric pH [Shin and Kim, 2013].",Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
"http://tag.sagepub.com 761 Harmonisation of Technical Requirements for  Registration of Pharmaceuticals for Human Use, 2001; World Medical Association, 2013].",Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Therapeutic Advances in Gastroenterology 9(6) 762 http://tag.sagepub.com they received either the dexlansoprazole 30 mg  ODT or dexlansoprazole 30 mg capsule once daily for 5 days.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
"http://tag.sagepub.com 763 The time to reach Cmax (Tmax), terminal elimina- tion half-life (T1/2), apparent clearance after  extravascular administration (CL/F) and apparent  volume of distribution after extravascular admin-istration (Vz/F) were secondary pharmacokinetic endpoints; secondary pharmacodynamic end-points consisted of the mean pH and percentage of time with pH >  4 during the 6- to 24-hour  period following dose.",OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Therapeutic Advances in Gastroenterology 9(6) 764 http://tag.sagepub.com interval) was only used to quantify exposure on  day 5 of each treatment period.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
http://tag.sagepub.com 765 administrations of either the ODT or capsule.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
"Therapeutic Advances in Gastroenterology 9(6) 766 http://tag.sagepub.com 45.9% and 49.5% of the time, respectively,  during the > 6-hour to 24-hour postdose inter- val, which included overnight hours (90% CI for the difference: –7.4, 0.4) (Supplementary Table S1).",Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
http://tag.sagepub.com 767 because of elevated creatine kinase levels observed  prior to receiving the 30 mg capsule at check-in of treatment period 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Therapeutic Advances in Gastroenterology 9(6) 768 http://tag.sagepub.com Acknowledgments Medical writing assistance was provided by inVentiv Medical Communications and was funded by Takeda Pharmaceuticals U.S.A. Inc.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Available at: http://www.adarepharma.com/wp-content/uploads/2015/02/Nadines_PLG_ Paper_2013.pdf (accessed April 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Available at: http://general.takedapharm.com/content/file.aspx?filetypecode=DEXILANTPI& cacheRandomizer=0d596f3b-147f-4473-a695- c7ddb61e7ac3 (accessed April 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
http://tag.sagepub.com 769 US Food Drug Administration and Center for Drug  Evaluation and Research.,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Available at: http://www.fda.gov/ohrms/ dockets/ac/03/briefing/3995B1_07_GFI-BioAvail-BioEquiv.pdf (accessed April 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/NBK56308/ (accessed April 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_1756283X16670073.PMC5076779.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 355–359International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 355 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S117513Travel-related illness at a tertiary care hospital in  Osaka, Japan Y oshiro Hadano Michinori Shirano T etsushi Goto Center for Infectious Diseases, Osaka  City General Hospital, Osaka, Japan Abstract:  We analyzed the travel-related health problems in persons returning to Japan from  overseas.",Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"OCGH is in charge of pre-travel health-related consultation and post-travel Correspondence: Yoshiro Hadano  Center for Infectious Diseases, Osaka City General Hospital, 2–13-22, Miyakojima-hondori, Miyakojima-ku, Osaka, 5344–0021, JapanTel +81 6 6929 1221Fax +81 6 6929 0623Email hatayoshiyoshi@yahoo.co.jpJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Hadano et alRunning head recto: Travel-related illness at a tertiary care hospital in Osaka, JapanDOI: http://dx.doi.org/10.2147/IJGM.S117513",Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
Available from: http://www2.unwto.org/annualreport2014.,Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
Available from: http://www.jata-net.or.jp/.,Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
Available from: http://www.nih.go.jp/niid/ja/from-idsc.html.,OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 359 Travel-related illness at a tertiary care hospital in Osaka, Japan",Non-OADS,/arxiv_data1/oa_pdf/7a/6a/ijgm-9-355.PMC5076795.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/32/dddt-10-3407.PMC5076796.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3407–3413Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3407Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11801 5 Pathophysiology of visual disorders induced   by phosphodiesterase inhibitors in the treatment  of erectile dysfunction Marilita M Moschos eirini Nitoda 1st Department of Ophthalmology,   Medical School, National &  Kapodistrian University of Athens,   Athens, GreeceAim:  The aim of this review was to summarize the ocular action of the most common  phosphodiesterase (PDE) inhibitors used for the treatment of erectile dysfunction and the  subsequent visual disorders.",Non-OADS,/arxiv_data1/oa_pdf/8a/32/dddt-10-3407.PMC5076796.pdf
"It is rapidly absorbed, exhibiting an oral  bioavailability of ~40%–41%, and it reaches its maximal levels within 0.5–2 h after  oral ingestion.1,3,4 The volume of distribution is 1.5 L/kg of body weight; only 4%  of its total concentration is free, and the rest is protein-bound.3 The plasma clear - ance of sildenafil is around 10 mL/min/kg, it is predominately metabolized by liver  (cytochrome P4503A4 isoenzyme), and its mean terminal half-life is 3–5 h.1,3 Drugs  that are also metabolized by cytochrome P4503A4 isoenzyme, including erythromycin,  ketoconazole, and cimetidine, can potentiate the effect of sildenafil.5Correspondence: Marilita M Moschos  1st Department of Ophthalmology,  Medical School, National and  Kapodistrian University of Athens,  6 ikarias Street, ekali, 14578 Athens,  Greece Tel +30 69 4488 7319 Fax +30 21 0412 2319 email moschosmarilita@yahoo.f r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Moschos and Nitoda Running head recto: PDE inhibitors in the treatment of visual disorders DOI: http://dx.doi.org/10.2147/DDDT.S118015",Non-OADS,/arxiv_data1/oa_pdf/8a/32/dddt-10-3407.PMC5076796.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8a/32/dddt-10-3407.PMC5076796.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/32/dddt-10-3407.PMC5076796.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 163–176Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  163 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S64788Skin models for the testing of transdermal drugs Eman Abd1 Shereen A Y ousef1 Michael N Pastore2 Krishna T elaprolu1 Y ousuf H Mohammed1 Sarika Namjoshi1 Jeffrey E Grice1 Michael S Roberts1,2 1Translational Research Institute,   School of Medicine, University of  Queensland, Brisbane, 2School of  Pharmacy and Medical Sciences,  University of South Australia,  Adelaide, AustraliaAbstract: The assessment of percutaneous permeation of molecules is a key step in the evalua- tion of dermal or transdermal delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
"Alternative methods for evaluating product performance include a Correspondence: Michael S Roberts Level 5, Translational Research Institute, 37 Kent St, Woolloongabba, Queensland 4102, AustraliaEmail m.roberts@uq.edu.auJournal name: Clinical Pharmacology: Advances and Applications Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Abd et alRunning head recto: Skin models for transdermal drug testingDOI: http://dx.doi.org/10.2147/CPAA.S64788",Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
Available from: https://www.oecd.org/chemicalsafety/testing/48532204.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 176 Abd et al 114.,Non-OADS,/arxiv_data1/oa_pdf/bc/94/cpaa-8-163.PMC5076797.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/3f/copd-11-2573.PMC5076798.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2573–2583International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2573OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11506 1 Reduction of neutrophilic lung inflammation  by inhalation of the compatible solute ectoine:  a randomized trial with elderly individuals Klaus Unfried1,* Ursula Krämer1,* Ulrich sydlik1 andrea autengruber1 andreas Bilstein2 sabine stolz1 alessandra Marini1 Tamara schikowski1 stefanie Keymel3 Jean Krutmann1 1IUF leibniz research Institute of  environmental Medicine, 2bitop ag,   Witten, 3Department of Cardiology,   Pneumology and angiology, Medical  Faculty, heinrich-heine-University,   Düsseldorf, germany *These authors contributed equally  to this workBackground:  Compatible solutes are natural substances that are known to stabilize cellular  functions.",Non-OADS,/arxiv_data1/oa_pdf/56/3f/copd-11-2573.PMC5076798.pdf
"Chronic lung inflammation may contribute to the development of degenerative  end points like emphysema by accelerating the aging of the lung tissue.4,5 Neutrophils, Correspondence: Klaus Unfried IUF leibniz-Institut für  Umweltmedizinische Forschung, auf’m  hennekamp 50, Düsseldorf 40225,  germany Tel +49 211 3389 362 Fax +49 211 3389 331 email klaus.unfried@uni-duesseldorf.d eJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Unfried et al Running head recto: Inhalation of the compatible solute ectoine DOI: http://dx.doi.org/10.2147/COPD.S115061",Non-OADS,/arxiv_data1/oa_pdf/56/3f/copd-11-2573.PMC5076798.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/56/3f/copd-11-2573.PMC5076798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/3f/copd-11-2573.PMC5076798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/e0/dddt-10-3387.PMC5076799.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3387–3397Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3387Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11317 1 investigation of in vivo potential of scorpion venom  against skin tumorigenesis in mice via targeting  markers associated with cancer development abdulrahman K al asmari abdul Quaiyoom Khan research centre, Prince sultan  Military Medical city, riyadh,   saudi arabiaAbstract:  Cancer is the leading cause of morbidity and mortality all over the world in spite  of the advances made in its management.",Non-OADS,/arxiv_data1/oa_pdf/6d/e0/dddt-10-3387.PMC5076799.pdf
"Various studies show that  attention is being given to naturally derived products for the development of novel  and effective chemotherapeutic drugs.4,5 The therapeutic importance of biological  products in the mitigation of different chronic human diseases, including cancer, has  been well documented.5,6correspondence: abdulrahman K  al asmari research centre, Prince sultan Military  Medical city, PO Box 7897 (777-s),  riyadh 11159, saudi arabia Tel +966 11 477 7714 ext 25100 Fax +966 11 478 6601 email abdulrahman.alasmari@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Al Asmari and Khan Running head recto: Scorpion venom inhibits skin tumorigenesis in mice DOI: http://dx.doi.org/10.2147/DDDT.S113171",Non-OADS,/arxiv_data1/oa_pdf/6d/e0/dddt-10-3387.PMC5076799.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6d/e0/dddt-10-3387.PMC5076799.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/e0/dddt-10-3387.PMC5076799.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/dddt-10-3415.PMC5076800.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3415–3423Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3415Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11580 1 Preliminary in vitro and in vivo assessment of a new  targeted inhibitor for choroidal neovascularization  in age-related macular degeneration Wenbo li1,* lijie Dong1,* Minwang Ma2,* Bojie hu1 Zhenyu lu3 Xun liu1 Juping liu1 Xiaorong li1 1Tianjin Medical University eye  hospital, Tianjin, People’s republic of  china; 2affiliated hospital of Medical  college of chinese People’s armed  Police Forces (capF), Tianjin, People’s  republic of china; 3Tianjin Precision  cell Biotechnology co. ltd., Tianjin,   People’s republic of china *These authors contributed equally  to this workAbstract:  Choroidal neovascularization (CNV) in age-related macular degeneration usually  causes blindness.",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/dddt-10-3415.PMC5076800.pdf
"Therefore, sFlt 1 has  gained considerable attention because of its potential clinical application as an inhibi - tor of angiogenesis.8–11correspondence: Xiaorong li Tianjin Medical University eye hospital,  no 251 Fu Kang road, nankai  District, Tianjin 300384, People’s  republic of china Tel +86 22 5828 0725 Fax +86 22 2334 6434 email lixr10@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: In vitro and in vivo assessment of CR2-sFlt 1 for CNV in AMD DOI: http://dx.doi.org/10.2147/DDDT.S115801",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/dddt-10-3415.PMC5076800.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1c/d2/dddt-10-3415.PMC5076800.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/d2/dddt-10-3415.PMC5076800.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/8b/dddt-10-3425.PMC5076801.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3425–3434Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3425Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11533 9 n-acetylcysteine and meso-2,3-  dimercaptosuccinic acid alleviate oxidative stress  and hepatic dysfunction induced by sodium  arsenite in male rats ahmed M abu el-saad1,4 Mohammed a al-Kahtani2 ashraf M abdel-Moneim3,4 1Department of Biology, Faculty  of Medicine, Dammam University,   Dammam, saudi arabia; 2Department  of Biology, Faculty of science, King  Khalid University, abha, saudi arabia;   3Department of Biological sciences,   Faculty of science, King Faisal  University, al-ahsa, saudi arabia;   4Department of Zoology, Faculty  of science, alexandria University,   alexandria, egyptAbstract:  Environmental exposure to arsenic represents a serious challenge to humans and  other animals.",Non-OADS,/arxiv_data1/oa_pdf/19/8b/dddt-10-3425.PMC5076801.pdf
"This element is abundant in some rocks of earth’s crust, and the  excessive applications of agricultural insecticides and rodenticides increase arsenic  contamination in ground water.1,2 Exposure to arsenic results in cardiovascular abnor - malities, hepatic and renal diseases as well as neurological deficits.3 In fact, arsenic  has been implicated in the occurrence of various tumors and it is classified as a group I  carcinogen.4–6 Liver is one of the target organs of arsenic toxicity and carcinogenesis.7,8  Epidemiological studies have indicated that chronic arsenic exposure causes abnormal  liver function and hepatotoxicity.9 Previous studies have revealed that arsenic induces  hepatic oxidative injury and overproduction of reactive oxygen species (ROS), which correspondence: ashraf M abdel- Moneim Department of Biological sciences,  Faculty of science, King Faisal University,  al-ahsa 31982, saudi arabia Tel +966 013 589 7439 email aabdelmoneim@kfu.edu.s aJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Abu El-Saad et al Running head recto: Hepatoprotection of NAC and DMSA against sodium arsenite toxicity DOI: http://dx.doi.org/10.2147/DDDT.S115339",Non-OADS,/arxiv_data1/oa_pdf/19/8b/dddt-10-3425.PMC5076801.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/19/8b/dddt-10-3425.PMC5076801.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/8b/dddt-10-3425.PMC5076801.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 177–189Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  177 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S102191LRRK2 inhibitors and their potential in the  treatment of Parkinson’s disease: current  perspectives Farzaneh Atashrazm1 Nicolas Dzamko2 1Neuroscience Research Australia,   Randwick; 2School of Medical Sciences,   Faculty of Medicine, University of  New South Wales, Kensington, NSW,  AustraliaAbstract:  Major advances in understanding how genetics underlies Parkinson’ s disease (PD)  have provided new opportunities for understanding disease pathogenesis and potential new  targets for therapeutic intervention.",Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
"Chief among these are autophagy/lysosomal dysfunction, 1,2 Correspondence: Nicolas Dzamko Neuroscience Research Australia, Barker Street, Randwick, NSW, 2031, AustraliaTel +61 2 9399 1112Email n.dzamko@neura.edu.auJournal name: Clinical Pharmacology: Advances and Applications Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Atashrazm and DzamkoRunning head recto: LRRK2 drugs for treating Parkinson’ s diseaseDOI: http://dx.doi.org/10.2147/CPAA.S102191",Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 189 LRRK2 drugs for treating Parkinson’s disease  78.,Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinical-Pharmacology/UCM210798.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/e6/cpaa-8-177.PMC5076802.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2585–2596International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2585RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11403 4 A review of nebulized drug delivery in COPD Donald P Tashkin Department of Medicine, David  Geffen School of Medicine at UCLA,   Los Angeles, CA, USAAbstract:  Current guidelines recommend inhaled pharmacologic therapy as the preferred  route of administration for treating COPD.",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"A PubMed search (January 1, 1996 to March 15, 2016) was conducted using Correspondence: Donald P Tashkin Department of Medicine, David Geffen  School of Medicine at UCLA,   10833 Le Conte Avenue,   Los Angeles, CA 90095, USA Tel +1 310 825 3163 Fax +1 310 206 5088 email dtashkin@mednet.ucla.ed u Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Tashkin Running head recto: COPD and nebulizers DOI: http://dx.doi.org/10.2147/COPD.S114034",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"Available from: http://goo.gl/ItQL3 a.  Accessed May 4, 2016.",OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: http://www.lung.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"Available from: http://www.nhlbi.nih.gov/ resources/docs/cht-book.ht m. Accessed March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: http://www.cdc.gov/nchs/data/databriefs/db63_tables.,OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: http://www.mayoclinic.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"Available from: https://goo.gl/Vpsti J.  Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://dailymed.nlm.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2012/020950s037lbl.pd f. Accessed February 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT02347761?term =NLM identifier&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT02347774?term =NCT02347774&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02276222?ter m=NCT02276222&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://goo.gl/ab2VxL?term =NLM  identifier&rank =NCT0245908 0.,OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from:  https://goo.gl/fPyjfM?term =NLM identifier&rank =NCT0251251 0.,OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://goo.gl/83EjwX?term =NLM  identifier&rank =NCT0251813 9.,OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: http://www.brovana.com/brovana-approved-labeling- text.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"Available from: http://goo.gl/ItQL3 a. Accessed March 3, 2016.",OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: http://dailymed.nlm.nih.gov/dailymed/getFile.,OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
Available from: https://dailymed.nlm.nih.gov/dailymed/ archives/fdaDrugInfo.cfm?archiveid =2008 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/ea/copd-11-2585.PMC5076803.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/ec/dddt-10-3435.PMC5076804.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3435–3448Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3435Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11961 6 The clinical outcomes of triple antiplatelet  therapy versus dual antiplatelet therapy  for high-risk patients after coronary stent  implantation: a meta-analysis of 11 clinical trials  and 9,553 patients Zhong-guo Fan1,* guo-Bin Ding2,* Xiao-Bo li1,3 Xiao-Fei gao1,3 Ya-li gao1 nai-liang Tian1,3 1Department of cardiology, nanjing  First hospital, nanjing Medical  University, nanjing, 2Department of  cardiology, Taixing People’s hospital,   Yangzhou University, Taizhou,   3Department of cardiology, nanjing  heart center, nanjing, People’s  republic of china *These authors contributed equally  to this workBackground:  The optimal antiplatelet regimen after in-coronary intervention among patients  presenting with complex coronary artery lesions or acute coronary syndrome (ACS) has remained  unclear.",Non-OADS,/arxiv_data1/oa_pdf/9e/ec/dddt-10-3435.PMC5076804.pdf
"Keywords:  triple antiplatelet treatment, dual antiplatelet treatment, stent implantation, complex  lesions, acute coronary syndrome Introduction Since the application of the rapidly developed interventional techniques widely in the  clinic, improved clinical outcomes have been reported among patients with coronary  artery disease (CAD), especially those suffering from acute coronary syndrome (ACS)  or presenting with complex coronary artery lesions.1 Though successful stenting is  considered to strengthen these beneficial effects, the risk of stent thrombosis (ST) and  restenosis among these patients is still high, which are considered frequent causes of  death and recurrent myocardial infarction (MI) derived from the superimposition of  a platelet-rich thrombus.2 As a result, a routine dual antiplatelet treatment (DAPT)  consisting of aspirin and a P2Y12 receptor antagonist has been chosen as an adjuvant  therapy after percutaneous coronary intervention (PCI).3 However, ~10% of patients correspondence: nai-liang Tian Department of cardiology, nanjing First  hospital, nanjing Medical University,  no 68 changle road, nanjing 210006,  People’s republic of china Tel/fax +86 25 5220 8048 email tiannailiang@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Fan et al Running head recto: TAPT post-PCI for patients with complex coronary lesions or ACS DOI: http://dx.doi.org/10.2147/DDDT.S119616",Non-OADS,/arxiv_data1/oa_pdf/9e/ec/dddt-10-3435.PMC5076804.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9e/ec/dddt-10-3435.PMC5076804.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/ec/dddt-10-3435.PMC5076804.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/3c/dddt-10-3379.PMC5076850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3379–3386Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3379Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9795 6 Alemtuzumab in the treatment of multiple  sclerosis: patient selection and special  considerations Jan Dörr1,2 Karl Baum1 1Multiple Sclerosis Center, Neurology  Department, Klinik Hennigsdorf,   Hennigsdorf, 2NeuroCure Clinical  Research Center, Charité –  Universitätsmedizin Berlin,   Berlin, GermanyAbstract:  Multiple sclerosis (MS) is among the most common chronic inflammatory diseases  of the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/b8/3c/dddt-10-3379.PMC5076850.pdf
"However, modern drug treatment of MS is facing a dilemma: on the one hand, the  armamentarium of available drugs is constantly increasing, yet on the other, there is  an unmet need of evidence-based guidance on choosing the optimal treatment for the  individual patient.1 The lack of valid predictive biomarkers for both treatment response  and risk of side effects on the patient level is reinforced by the fact that potency and Correspondence: Jan Dörr NeuroCure Clinical Research Center,  Charité – Universitätsmedizin Berlin,  Charitéplatz 1, 10117 Berlin, Germany Tel +49 3302 545 4729 email jan-markus.doerr@charite.d e Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Dörr and Baum Running head recto: Patient selection for alemtuzumab in MS DOI: http://dx.doi.org/10.2147/DDDT.S97956",Non-OADS,/arxiv_data1/oa_pdf/b8/3c/dddt-10-3379.PMC5076850.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b8/3c/dddt-10-3379.PMC5076850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/3c/dddt-10-3379.PMC5076850.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/6f/dddt-10-3399.PMC5076851.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3399–3406Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11722 1 early intervention of long-acting nifedipine  giTs reduces brachial–ankle pulse wave velocity  and improves arterial stiffness in chinese patients  with mild hypertension: a 24-week, single-arm,  open-label, prospective study Jidong Zhang Yan Wang haijuan hu Xiaohong Yang Zejun Tian Demin liu guoqiang gu hongmei Zheng ruiqin Xie Wei cui Department of cardiology, The  second hospital of hebei Medical  University, shijiazhuang, hebei,   People’s republic of chinaBackground:  Nifedipine gastrointestinal therapeutic system (GITS) is used to treat angina  and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/5d/6f/dddt-10-3399.PMC5076851.pdf
"The 1991–2011 correspondence: Wei cui Department of cardiology, The second  hospital of hebei Medical University, 215 hepingxi road, shijiazhuang, hebei  050000, People’s republic of china Tel +86 311 6600 2115 Fax +86 311 6600 2115 email cuiwei@medmail.com.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: Early intervention of nifedipine GITS in PWV DOI: http://dx.doi.org/10.2147/DDDT.S117221",Non-OADS,/arxiv_data1/oa_pdf/5d/6f/dddt-10-3399.PMC5076851.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5d/6f/dddt-10-3399.PMC5076851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/6f/dddt-10-3399.PMC5076851.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/a4/dddt-10-3449.PMC5076852.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3449–3457Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3449Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10536 2α-aminoadipic acid protects against retinal  disruption through attenuating Müller cell gliosis  in a rat model of acute ocular hypertension Xiaolei Wang,1,2,* Jier su,2,3,*  Jingwen Ding,4 song han,2  Wei Ma,2,5 hong luo,2   guy hughes,6 Zhaoyang  Meng,1 Yi Yin,1 Yanling  Wang,1 Junfa li2 1Department of Ophthalmology,   Beijing Friendship hospital,   2Department of n eurobiology, Beijing  institute for Brain Disorders, capital  Medical University, Beijing, 3ningbo  college of health sciences, n ingbo,   4Department of Ophthalmology,   Beijing T ongren hospital, capital  Medical University, Beijing, 5Beijing  stomatological hospital, capital  Medical University, Beijing, People’s  republic of china; 6University of  california, irvine school of Medicine,   irvine, ca, Usa *These authors contributed equally  to this workObjective:  Ocular hypertension is an important risk factor for glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/08/a4/dddt-10-3449.PMC5076852.pdf
"Investigations indicate that Müller cells not only play an  important physiological role, but they are also involved in multiple pathological retinal  diseases such as glaucoma.6–8 It has been reported that reactive Müller cells can aggra - vate retinal damage by releasing cytokines such as tumor necrosis factor- α (TNF-α).9  Growing evidence supports that increased glial production of TNF- α contributes to  the neurodegeneration in glaucoma.10 TNF-α is a secreted inflammatory cytokine that correspondence: Junfa li Department of neurobiology, Beijing  institute for Brain Disorders, capital  Medical University, 10 Waixitoutiao,  Youanmen, Fengtai District, Beijing  100069, People’s republic of china Tel +86 10 8395 0061 email junfali@ccmu.edu.c n  Yanling Wang Department of Ophthalmology, Beijing  Friendship hospital, capital Medical  University, 95 Yong’an road, Xicheng  District, Beijing 100050, People’s  republic of china email wangyanling16105@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: AAA as a potential therapeutic target in glaucoma DOI: http://dx.doi.org/10.2147/DDDT.S105362",Non-OADS,/arxiv_data1/oa_pdf/08/a4/dddt-10-3449.PMC5076852.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/08/a4/dddt-10-3449.PMC5076852.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/a4/dddt-10-3449.PMC5076852.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"1, e1241363 (6 pages)http://dx.doi.org/10.1080/21675511.2016.1241363",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"ORCID Elizabeth M. Turner http://orcid.org/0000-0002-4914-9477 Christian Schlieker http://orcid.org/0000-0002-1237-4267 References [1] Olins AL, Rhodes G, Welch DB, Zwerger M, Olins DE.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
Nucleus 2010; 1:53-70; PMID:21327105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"JCell Biol 1990; 111:1535-42; PMID:2170422; http://dx.doi.org/10.1083/jcb.111.4.1535 [3] Worman HJ, Yuan J, Blobel G, Georgatos SD.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Geno-mics 1998; 54:469-76; PMID:9878250; http://dx.doi.org/10.1006/geno.1998.5615 [7] Silve S, Dupuy PH, Ferrara P, Loison G. Human lamin B receptor exhibits sterol C14-reductase activity in Saccha- romyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Biochim Biophys Acta 1998;1392:233-44; http://dx.doi.org/10.1016/S0005-2760(98)00041-1 [8] Bennati AM, Castelli M, Della Fazia MA, Beccari T, Car- uso D, Servillo G, Roberti R. Sterol dependent regulationof human TM7SF2 gene expression: Role of the encoded3b-hydroxysterol D14-reductase in human cholesterol biosynthesis.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Biochim Biophys Acta 2006; 1761:677-85; http://dx.doi.org/10.1016/j.bbalip.2006.05.004 [9] Brown MS, Goldstein JL.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Cell 1997; 89:331-40; PMID:9150132;http://dx.doi.org/10.1016/S0092-8674(00)80213-5 [10] Sharpe LJ, Brown AJ.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"J Biol Chem 2013; 288:18707-15; PMID:23696639; http://dx.doi.org/10.1074/jbc.R113.479808 [11] Tsai PL, Zhao C, Turner E, Schlieker CD.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Annu Rev Genomics Hum Genet 2006; 7:369-405; PMID:16824021; http://dx.doi.org/10.1146/annurev.genom.7.080505.115732 [13] Somech R, Shaklai S, Amariglio N, Rechavi G, Simon AJ.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Pediatr Res 2005; 57:8R-15R; PMID:15817509; http://dx.doi.org/10.1203/01.PDR.0000159566.54287.6C [14] Worman HJ, Bonne G. “Laminopathies: ”aw i d es p e c - trum of human diseases.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Cold Spring Harb Perspect Biol 2010; 2:a000760; PMID:20182615; http://dx.doi.org/10.1101/cshperspect.a000760 [16] Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, L u c k eB ,K a r lH ,K a p sR ,M €uller D, Vay /C19a A, et al.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Hum Mol Genet 2003;12:61-9; PMID:12490533; http://dx.doi.org/10.1093/ hmg/ddg003 [18] Konstantinidou A, Karadimas C, Waterham HR, Superti-Furga A, Kaminopetros P, Grigoriadou M,Kokotas H, Agrogiannis G, Giannoulia-Karantana A,Patsouris E, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Prenat Diagn 2008; 28:309-12; PMID: 18382993; http://dx.doi.org/10.1002/pd.1976 [19] Best S, Salvati F, Kallo J, Garner C, Height S, Thein SL, Rees DC.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Br J Haematol 2003; 123:542-4; PMID:14617022; http://dx.doi.org/10.1046/j.1365-2141.2003.04621.x [20] Subramanian G, Chaudhury P, Malu K, Fowler S, Manmode R ,G o t u rD ,Z w e r g e rM ,R y a nD ,R o b e r t iR ,G a i n e sP .L a m i n B Receptor Regulates the Growth and Maturation of Myeloid Progenitors via its Sterol Reductase Domain: Implicationsfor Cholesterol Biosynthesis in Regulating Myelopoiesis.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"JImmunol 2012; 188:85-102; PMID:22140257; http://dx.doi.org/10.4049/jimmunol.1003804 [21] Oosterwijk JC, Mansour S, van Noort G, Waterham HR, Hall CM, Hennekam RCM.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"J Med Genet 2003; 40:937-41;PMID:14684694; http://dx.doi.org/10.1136/jmg.40.12.937 [22] Waterham HR, Koster J, Mooyer P, Noort Gv, Kelley RI, Wilcox WR, Wanders RJ, Hennekam RC, Oosterwijk JC.Autosomal Recessive HEM/Greenberg skeletal dysplasiaIs Caused by 3 b-Hydroxysterol D14-Reductase De ﬁ- ciency Due to Mutations in the Lamin B Receptor Gene.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Am J Hum Genet 2003; 72:1013-7; PMID:12618959; http://dx.doi.org/10.1086/373938 [23] Chitayat D, Gruber H, Mullen BJ, Pauzner D, Costa T, Lach- man R, Rimoin DL.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Am J Med Genet 1993; 47:272-7; PMID:8213919; http://dx.doi.org/10.1002/ajmg.1320470226 [24] Horn LC, Faber R, Meiner A, Piskazeck U, Spranger J. Greenberg dysplasia: ﬁrst reported case with additional non/C0skeletal malformations and without consanguinity.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Prenat Diagn 2000; 20:1008-11; PMID:11113916; http://dx.doi.org/10.1002/1097-0223(200012)20:12%3c1008::AID-PD954%3e3.0.CO;2-S [25] Greenberg CR, Rimoin DL, Gruber HE, DeSa D, Reed M, Lachman RS.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Am J Med Genet 1988; 29:623-32; PMID:3377005; http://dx.doi.org/10.1002/ajmg.1320290321 [26] Clayton P, Fischer B, Mann A, Mansour S, Rossier E, Veen M, Lang C, Baasanjav S, Kieslich M, Brossuleit K,et al.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
Nucleus 2010; 1:354-66; PMID:21327084; http://dx.doi.org/10.4161/ nucl.1.4.12435RARE DISEASES e1241363-5,Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Hum Mol Genet 2007; 16:1176-87; PMID:17403717; http://dx.doi.org/10.1093/hmg/ddm065 [28] Turner EM, Brown RS, Laudermilch E, Tsai PL, Schlieker C. The Torsin Activator LULL1 Is Required for Ef ﬁcient Growth of Herpes Simplex Virus 1.",Non-OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"J Virol 2015;89:8444-52; PMID:26041288; http://dx.doi.org/10.1128/JVI.01143-15 [29] Li X, Roberti R, Blobel G. Structure of an integral mem- brane sterol reductase from Methylomicrobium alcaliphi-lum.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Nature 2015; 517:104-7; PMID:25307054; http://dx.doi.org/10.1038/nature13797 [30] Vembar SS, Brodsky JL.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Nat Rev Mol Cell Biol2008; 9:944-57; PMID:19002207; http://dx.doi.org/10.1038/nrm2546 [31] Zattas D, Hochstrasser M. Ubiquitin-dependent pro- tein degradation at the yeast endoplasmic reticulumand nuclear envelope.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Crit Rev Biochem Mol Biol2015; 50:1-17; PMID:25231236; http://dx.doi.org/ 10.3109/10409238.2014.959889 [32] Dauer WT, Worman HJ.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Dev Cell 2009;17:626-38; PMID:19922868; http://dx.doi.org/10.1016/j.devcel.2009.10.016[33] Burke B, Stewart CL.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Curr TopicsDev Biol 2014; 109:1-52; PMID:24947235; http://dx.doi.org/10.1016/B978-0-12-397920-9.00006-8 [34] Gruenbaum Y, Foisner R. Lamins: nuclear intermediate ﬁlament proteins with fundamental functions in nuclear mechanics and genome regulation.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Annu Rev Biochem 2015; 84:131-64; PMID:25747401; http://dx.doi.org/ 10.1146/annurev-biochem-060614-034115 [35] Rose A, Schlieker C. Alternative nuclear transport for cellular protein quality control.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Trends Cell Biol 2012; 22:509-14;PMID:22858153; http://dx.doi.org/10.1016/j.tcb.2012.07.003 [36] Labbadia J, Morimoto RI.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Huntington ’s disease: underly- ing molecular mechanisms and emerging concepts.Trends Biochem Sci 2013; 38:378-85; PMID:23768628; http://dx.doi.org/10.1016/j.tibs.2013.05.003 [37] Balchin D, Hayer-Hartl M, Hartl FU.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Science 2016; 353:aac4354;PMID:27365453; http://dx.doi.org/10.1126/science.aac4354 [38] Khmelinskii A, Blaszczak E, Pantazopoulou M, Fischer B, Omnus DJ, Le Dez G, Brossard A, Gunnarsson A, BarryJD, Meurer M, et al.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
"Nature 2014; 516:410-3; PMID:25519137; http://dx.doi.org/10.1038/nature14096 [39] Foresti O, Rodriguez-Vaello V, Funaya C, Carvalho P. Qual- ity control of inner nuclear membrane proteins by the Asicomplex.",OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
Science 2014; 346:751-5; PMID:25236469; http://dx.doi.org/10.11 26/science.1255638e1241363-6 E. M. TURNER AND C. SCHLIEKER,OADS,/arxiv_data1/oa_pdf/cd/23/krad-04-01-1241363.PMC5077067.pdf
http://apps.who.int/iris/bit-stream/10665/204176/1/9789241510066_eng.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/cc/a8/10.1177_2333794X16674561.PMC5077069.pdf
http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/a8/10.1177_2333794X16674561.PMC5077069.pdf
http://apps.who.int/iris/bit- stream/10665/149021/2/WHO_NMH_NHD_14.6_eng.pdf.,OADS,/arxiv_data1/oa_pdf/cc/a8/10.1177_2333794X16674561.PMC5077069.pdf
http://www.who.int/dietphysicalac-tivity/factsheet_inactivity/en/.,Non-OADS,/arxiv_data1/oa_pdf/cc/a8/10.1177_2333794X16674561.PMC5077069.pdf
http://www.who.int/dietphysicalactivity/factsheet_young_people/en/.,Non-OADS,/arxiv_data1/oa_pdf/cc/a8/10.1177_2333794X16674561.PMC5077069.pdf
DOI: http://dx.doi.org/10.1093/pm/pnw051  12.,Non-OADS,/arxiv_data1/oa_pdf/a1/32/10.1177_2050313X16675258.PMC5077070.pdf
"Geneva: World Health Organization, 2011, http://apps.who.int/iris/bit- stream/10665/80135/1/9789241501507_eng.pdf (accessed 15  May 2016).",Non-OADS,/arxiv_data1/oa_pdf/52/71/10.1177_2050312116675098.PMC5077071.pdf
"Your 5 moments for hand  hygiene, http://who.int/gpsc/tools/5momentsHandHygiene_A3.pdf?ua=1 (accessed 15 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/52/71/10.1177_2050312116675098.PMC5077071.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 321–324International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 321 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S117664Case report of atypical Still’s disease: a diagnosis  of exclusion Sandeep Yerra1  Letlhogonolo Tlhabano2  T ejaswini Vasamsetty3 1Department of Anesthesiology,   University of Virginia, Charlottesville,   VA, 2Internal Medicine, Wake Forest  Baptist Health, Winston-Salem,   3Internal Medicine, East Carolina  University, Greenville, NC, USAIntroduction: We present an unusual presentation of a 39-year-old man with myalgias and  shortness of breath.",Non-OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
"Upon further history, he reported decreased oral fluid  Correspondence: Sandeep Yerra 237 Yellowstone Drive, Apt 108, Charlottesville, VA, USA Email drsandeepyerra@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Y erra et alRunning head recto: Case report of atypical Still’ s diseaseDOI: http://dx.doi.org/10.2147/IMCRJ.S117664",Non-OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 324 Yerra et al  complication of ASD and falls within the spectrum of HLH.,Non-OADS,/arxiv_data1/oa_pdf/d8/ad/imcrj-9-321.PMC5077124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 571–580International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  571OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11299 6 Utilization of services provided by village based  ethnic minority midwives in mountainous villages  of Vietnam Duong Thi Thuy Doan1 Ha Thi Thu Bui1 Thi Minh le1 Duc Minh Duong1 Hong Thi luu2 T uan anh Dinh2 T olib Mirzoev3 1Department of reproductive  Health, Hanoi school of Public  Health, 2Department of Maternal  and child Health, Ministry of  Health, Hanoi, Vietnam; 3nuffield  centre for International Health  and Development, leeds Institute  of Health sciences, University  of leeds, leeds, UKIntroduction:  Since 2011, the Vietnam’s Ministry of Health implemented the ethnic minority  midwives (EMMs) scheme in order to increase the utilization of maternal health services by  women from ethnic minorities and those living in hard-to-reach mountainous areas.",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
"Keywords:  safe motherhood services, midwifery training, ethnic minority Introduction Maternal mortality has been reducing from 140 in 1990 to 49 in 2013 in Vietnam.1  Although national-level health indicators have improved, nowadays the distribution of  four or more antenatal care (ANC) visits and skilled birth attendance rate remain highly  inequitable.2 Disparities between ethnic minority groups who mostly inhabit rural, moun - tainous areas, and Kinh/Hoa (majority ethnicity) are substantial and are likely to increase  over time.2–5 For example, in 2006 the risk of not giving birth in a health facility between  women from ethnic minority groups in rural areas was nearly five times higher than that  of women of majority ethnicity, and in 2010–2011 such risk rose to ~20 times higher.6correspondence: Duong Thi Thuy Doan Department of reproductive Health,  Hanoi school of Public Health,  138 giang Vo, Ba Dinh, Hanoi, Vietnam  Tel +84 6266 2320 email dttd@hsph.edu.v n Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Doan et al Running head recto: Utilization of services provided by Village based ethnic minority midwife DOI: http://dx.doi.org/10.2147/IJWH.S112996",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
Available from: http://www.who.int/reproductivehealth/ publications/monitoring/maternal-mortality-2013/en/.,Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
Available from: http://vietnam.unfpa.,Non-OADS,/arxiv_data1/oa_pdf/8f/c4/ijwh-8-571.PMC5077125.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/34/ijn-11-5429.PMC5077128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5429–5442International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5429OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11503 7 Daunorubicin and gambogic acid coloaded  cysteamine-cdT e quantum dots minimizing the  multidrug resistance of lymphoma in vitro and  in vivo Yi Zhou1,2 ruju Wang1 Bing chen1 Dan sun3 Y ong hu2 Peipei Xu1 1Department of hematology, Drum  T ower hospital, school of Medicine,   2Institute of Materials engineering  and collaborative Innovation center  of chemistry for life sciences,   college of engineering and applied  sciences, Nanjing University, Nanjing  People’s republic of china; 3school  of Mechanical engineering, Queen’s  University Belfast, Belfast, UKAbstract:  To minimize the side effects and the multidrug resistance (MDR) arising from  daunorubicin (DNR) treatment of malignant lymphoma, a chemotherapy formulation of  cysteamine-modified cadmium tellurium (Cys-CdTe) quantum dots coloaded with DNR and  gambogic acid (GA) nanoparticles (DNR-GA-Cys-CdTe NPs) was developed.",Non-OADS,/arxiv_data1/oa_pdf/be/34/ijn-11-5429.PMC5077128.pdf
"Daunorubicin (DNR), an anthracycline antibiotic, has been used as a first-line  chemotherapy component in the treatment of NHL.4,5 Despite its side effects, including  cardiac toxicity and bone marrow suppression,6 the modest lipophicity and net posi - tive charge at physiological pH made DNR an efficient substrate for P-glycoprotein  (P-gp).7,8 P-gp is known to actively pump substrates out of tumor cells through an  adenosine triphosphate, resulting in multidrug resistance (MDR) and hampering the correspondence: Peipei Xu Department of hematology, Drum  Tower hospital, school of Medicine,  Nanjing University, Nanjing, 210093, The  People’s republic of china Tel +86 025 8310 5211 Fax +86 025 8310 5211 email xu_peipei0618@163.co m  Yong hu Institute of Materials engineering and  collaborative Innovation center of  chemistry for life sciences, college of  engineering and applied sciences, Nanjing  University, Nanjing, Jiangsu 210093,  People’s republic of china Tel +86 025 8359 4668 Fax +86 025 8359 4668 email hvyong@nju.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhou et al Running head recto: DNR and GA coloaded QDs overcoming MDR DOI: http://dx.doi.org/10.2147/IJN.S115037",Non-OADS,/arxiv_data1/oa_pdf/be/34/ijn-11-5429.PMC5077128.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/be/34/ijn-11-5429.PMC5077128.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/34/ijn-11-5429.PMC5077128.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/1d/ijn-11-5443.PMC5077129.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5443–5455International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5443OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11370 6 core–shell magnetic nanoparticles display  synergistic antibacterial effects against  Pseudomonas aeruginosa  and Staphylococcus   aureus  when combined with cathelicidin ll-37  or selected ceragenins Katarzyna Niemirowicz1  ewelina Piktel,1 agnieszka  Z Wilczewska,2 Karolina  h Markiewicz,2 Bonita  Durnaś,3 Marzena Wątek,4  Irena Puszkarz,3 Marta  Wróblewska,5,6 Wiesława  Niklińska,7 Paul B savage,8  robert Bucki1,3 1Department of Microbiological and  Nanobiomedical engineering, Medical  University of Białystok, 2Institute of  Chemistry, University of Białystok,   Białystok, 3Department of Physiology,   Pathophysiology and Immunology  of Infections, The Faculty of health  sciences of the Jan Kochanowski  University in Kielce, 4holy cross  Oncology center of Kielce, Kielce,   5Department of Dental Microbiology,   Medical University of Warsaw,   6Department of Microbiology,   central clinical hospital in  Warsaw, Warsaw, 7Department of  histology and embryology, Medical  University of Bialystok, Białystok,   Poland; 8Department of chemistry  and Biochemistry, Brigham Young  University, Provo, UT, UsaAbstract:  Core–shell magnetic nanoparticles (MNPs) are promising candidates in the  development of new treatment methods against infections, including those caused by antibiotic- resistant pathogens.",Non-OADS,/arxiv_data1/oa_pdf/81/1d/ijn-11-5443.PMC5077129.pdf
"For most MRSA  strains, antibiotics from the glycopeptide family are the only therapeutic option.5–7 correspondence: robert Bucki Department of Microbiological and  Nanobiomedical engineering, Medical  University of Białystok, Mickiewicza 2 C,  15-222 Białystok, Poland Tel +48 85 748 5483 Fax +48 85 748 5492 email buckirobert@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Niemirowicz et al Running head recto: Antibacterial effects of core–shell MNPs against P. aeruginosa  and S. aureus DOI: http://dx.doi.org/10.2147/IJN.S113706",Non-OADS,/arxiv_data1/oa_pdf/81/1d/ijn-11-5443.PMC5077129.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/81/1d/ijn-11-5443.PMC5077129.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/1d/ijn-11-5443.PMC5077129.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/69/ijn-11-5415.PMC5077130.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5415–5427International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5415OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11195 0 Decoration of ph-sensitive copolymer micelles  with tumor-specific peptide for enhanced cellular  uptake of doxorubicin Qing chen1,* Miaomiao long2,* lipeng Qiu3 Mengqin Zhu3 Zhen li1 Mingxi Qiao1 haiyang hu1 Xiuli Zhao1 Dawei chen1 1Department of Pharmaceutics, school  of Pharmacy, shenyang Pharmaceutical  University, shenyang, 2Department of  research and Development, Nanjing  chia Tai Tianqing Pharmaceutical  group co. ltd, Nanjing, 3Department  of Pharmaceutics, school of  Pharmaceutical sciences, Jiangnan  University, Wuxi, People’s republic  of china *These authors contributed equally  to this workAbstract:  To improve the targeting efficacy of hyaluronic acid (HA)-based micelles,  pH-sensitive mixed micelles based on HA-g-poly(L-histidine) (PHis) and d- α-tocopheryl poly - ethylene glycol 2000 copolymers were prepared and decorated with human epidermal growth  factor receptor 2 (Her2) peptide, a tumor cell-specific peptide ligand, on their surface.",Non-OADS,/arxiv_data1/oa_pdf/f6/69/ijn-11-5415.PMC5077130.pdf
"To  achieve receptor-mediated targeting, various targeting moieties including peptides, correspondence: lipeng Qiu Department of Pharmaceutics, school  of Pharmaceutical sciences, Jiangnan  University, 1800 lihu avenue, Wuxi  214122, People’s republic of china Tel +86 510 8519 7769 Fax +86 510 8519 7769 email flyqlp@163.co m Dawei chen Department of Pharmaceutics, school  of Pharmacy, shenyang Pharmaceutical  University, 103 Wenhua road, shenyang  110016, People’s republic of china Tel +86 512 6588 4729 Fax +86 512 6588 4729 email chendawei@syphu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: Decoration of pH-sensitive copolymer micelles DOI: http://dx.doi.org/10.2147/IJN.S111950",Non-OADS,/arxiv_data1/oa_pdf/f6/69/ijn-11-5415.PMC5077130.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f6/69/ijn-11-5415.PMC5077130.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/69/ijn-11-5415.PMC5077130.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/93/ijn-11-5485.PMC5077131.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5485–5496International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5485OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11536 7 Efficient delivery of Notch1 siRNA to SKOV3  cells by cationic cholesterol derivative-based  liposome Yun-Chun Zhao1 Li Zhang2 Shi-Sen Feng3 Lu Hong3 Hai-Li Zheng3 Li-Li Chen4 Xiao-Ling Zheng1 Yi-Qing Ye1 Meng-Dan Zhao1 Wen-Xi Wang3 Cai-Hong Zheng1 1Pharmacy Department, Women’s  Hospital, 2Pharmacy Department,   The Second Affiliated Hospital,   School of Medicine, Zhejiang  University, Hangzhou, People’s  Republic of China; 3Department of  Pharmaceutic Preparation, College  of Pharmaceutical Science, Zhejiang  University of T echnology, Hangzhou,   4Department of Gynecologic  Oncology, Women’s Hospital, School  of Medicine, Zhejiang University,   Hangzhou, People’s Republic of ChinaAbstract:  A novel cationic cholesterol derivative-based small interfering RNA (siRNA)  interference strategy was suggested to inhibit Notch1 activation in SKOV3 cells for the gene  therapy of ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/c8/93/ijn-11-5485.PMC5077131.pdf
"It acts as a tumor inhibitor in murine skin tumors11 and non-small-cell Correspondence: Cai-Hong Zheng Women’s Hospital, School of Medicine,  Zhejiang University, 1 Xueshi Road,  Hangzhou 310006, People’s Republic  of China Tel +86 571 8999 1730 Fax +86 571 8999 1730 email chzheng@zju.edu.c n  Wen-Xi Wang College of Pharmaceutical  Science, Zhejiang University of  Technology,18 Chaowang Road,  Hangzhou 310014, People’s Republic  of China Tel +86 571 8832 0320 Fax +86 571 8832 0320 email yjw@zjut.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhao et al Running head recto: Cholesterol derivative liposome for siRNA DOI: http://dx.doi.org/10.2147/IJN.S115367",Non-OADS,/arxiv_data1/oa_pdf/c8/93/ijn-11-5485.PMC5077131.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c8/93/ijn-11-5485.PMC5077131.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/93/ijn-11-5485.PMC5077131.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5457–5472International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5457OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11634 7 lx2-32c–loaded polymeric micelles with small  size for intravenous drug delivery and their  inhibitory effect on tumor growth and metastasis  in clinically associated 4T1 murine breast cancer li-qing chen Wei huang Zhong-gao gao Wei-shuo Fang Ming-ji Jin state Key laboratory of Bioactive  substance and Function of Natural  Medicines, Institute of Materia Medica,   chinese academy of Medical sciences  and Peking Union Medical college,   Beijing, People’s republic of chinaAbstract:  Lx2-32c is a novel taxane derivative with a strong antitumor activity.",Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
"Lx2-32c (Figure 1) is a semisynthetic taxane derivative which was obtained from  the structural modification of cephalomannine by Prof Weishuo Fang in our institute; it  exhibits strong antitumor activity.3 The antitumor mechanisms of Lx2-32c include pro - moting microtubule polymerization, reducing the Tau-protein expression, and decreasing  the pump efflux of P-glycoprotein, thus maintaining high intracellular drug concentration correspondence: Wei huang;  Zhong-gao gao state Key laboratory of Bioactive  substance and Function of Natural  Medicines, Institute of Materia  Medica, chinese academy of Medical  sciences and Peking Union Medical  college, 1 Xian Nong Tan street,  Beijing 100050, People’s republic of china email huangwei@imm.ac.c n;   zggao@imm.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: Lx2-32c-loaded polymeric micelles for breast cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S116347",Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
Available from: http://www.who.int/gho/ ncd/mortality_morbidity/en /.,Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
Available from:  http://www.who.int/cancer/publications/ mammography_screening /en/.,Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/04/ijn-11-5457.PMC5077132.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/b7/ijn-11-5381.PMC5077137.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5381–5414International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5381RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S11721 0 Getting into the brain: liposome-based strategies  for effective drug delivery across the   blood–brain barrier Débora B vieira1 Lionel F Gamarra1,2 1Hospital Israelita Albert einstein, São  Paulo, Brazil; 2Faculdade de Ciências  Médicas da Santa Casa de São Paulo,   São Paulo, BrazilAbstract:  This review summarizes articles that have been reported in literature on  liposome-based strategies for effective drug delivery across the blood–brain barrier.",Non-OADS,/arxiv_data1/oa_pdf/c0/b7/ijn-11-5381.PMC5077137.pdf
"However,  in 1898, Max Lewandowsky was the first to postulate the existence of a specialized  barrier at the level of cerebral vessels: the blood–brain barrier (BBB), after he and his  colleagues had carried out some experiments to demonstrate that some drugs were  neurotoxic when injected directly into the brain and not into the vascular system.3   It was just in the late 1960s that Reese and Karnovsky visualized the fact that the bar - rier was localized to the endothelium by electron-microscopy studies.4 The BBB is composed of polarized endothelial cells connected by tight junctions of  the cerebral capillary endothelium and a variety of transporters (Figure 1), which are  responsible for its extremely low permeability, limiting the delivery of drugs to the cen - tral nervous system (CNS).5,6 BBB functionality is dynamically regulated by an ensem - ble of different cell types, such as astrocytes, pericytes, and neurons (Figure 1A).7–9  Correspondence: Lionel F Gamarra Hospital Israelita Albert einstein, Avenida  Albert einstein, Number 627, Morumbi,  São Paulo, SP 05651–901, Brazil Tel +55 11 2151 3727 email lgamarra@einstein.b rJournal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Vieira and Gamarra Running head recto: Liposomal strategies for effective drug delivery across the BBB DOI: http://dx.doi.org/10.2147/IJN.S117210",Non-OADS,/arxiv_data1/oa_pdf/c0/b7/ijn-11-5381.PMC5077137.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c0/b7/ijn-11-5381.PMC5077137.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/b7/ijn-11-5381.PMC5077137.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/b4/ijn-11-5473.PMC5077140.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5473–5484International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5473OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11546 8 graphene/single-walled carbon nanotube  hybrids promoting osteogenic differentiation  of mesenchymal stem cells by activating p38  signaling pathway Xinxin Yan1,2 Wen Yang3 Zengwu shao1 shuhua Yang1 Xianzhe liu1 1Department of Orthopaedic surgery,   Union hospital, Tongji Medical  college, huazhong University of  science and T echnology, 2Department  of Orthopaedic surgery, Wuhan  Third hospital, 3Department of  anesthesiology, Union hospital, Tongji  Medical college, huazhong University  of science and T echnology, Wuhan,   People’s republic of chinaAbstract:  Carbon nanomaterials are becoming increasingly significant in biomedical fields since  they exhibit exceptional physicochemical and biocompatible properties.",Non-OADS,/arxiv_data1/oa_pdf/36/b4/ijn-11-5473.PMC5077140.pdf
"Moreover, MSCs are less likely to be rejected by correspondence: Xianzhe liu Department of Orthopaedic surgery,  Union hospital, Tongji Medical college,  huazhong University of science and  Technology, 1277 Jiefang road, Wuhan  430022, People’s republic of china Tel +86 27 8535 1627 Fax +86 27 8535 1627 email liuxianzhe@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y an et al Running head recto: G/SWCNT hybrids promoted osteogenic differentiation of MSCs DOI: http://dx.doi.org/10.2147/IJN.S115468",Non-OADS,/arxiv_data1/oa_pdf/36/b4/ijn-11-5473.PMC5077140.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/36/b4/ijn-11-5473.PMC5077140.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/b4/ijn-11-5473.PMC5077140.pdf
"Improved vaccine candidates will be advanced as  needed until the following requirements have been met: long-term protection against natural  transmission, excellent safety and tolerability, and operational feasibility for population-wide  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fa/b7/nihms821274.PMC5077156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/68/nihms821247.PMC5077158.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 329–331International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 329 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S119899Bleb incarceration following Ahmed valve surgery Fredric J Gross Giovanni DiSandro Department of Ophthalmology,   Eastern Virginia Medical School,  Norfolk, VA, USAAbstract: Globe luxation is a painful and potentially vision-threatening condition in which the globe  becomes trapped behind the eyelids requiring physician intervention in the emergency department or  eye clinic.",Non-OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
"Computed tomography scan of the orbits (Figure 2) showed shallow orbits with no intraorbital masses, rectus muscle  Correspondence: Fredric J Gross Department of Ophthalmology, Eastern Virginia Medical School, 7338 Millbrook Road, Norfolk, VA 23505, USAFax +1 757 388 0355Email heye5@aol.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Gross and DiSandroRunning head recto: Bleb incarceration following Ahmed valve surgeryDOI: http://dx.doi.org/10.2147/IMCRJ.S119899",Non-OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 331 Bleb incarceration following Ahmed valve surgery Discussion Globe luxation is a relatively uncommon occurrence in  which the eyelids become trapped behind the globe result-ing in a painful emergency that can be vision threatening.,Non-OADS,/arxiv_data1/oa_pdf/1e/44/imcrj-9-329.PMC5077236.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 129–134Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 129 ORIGINAL RESEARCH    open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S113020A comparison of functional outcomes in patients  undergoing revision arthroscopic repair of  massive rotator cuff tears with and without  arthroscopic suprascapular nerve release Felix H Savoie III1 Mark Zunkiewicz2 Larry D Field2 William H Replogle3 Michael J O’Brien1  1T ulane Institute of Sports Medicine,   T ulane University School of  Medicine, New Orleans, LA, USA;   2Mississippi Sports Medicine and  Orthopaedic Center, Jackson, MS,  USA;  3Department of Family Medicine,   University of Mississippi Medical Center, Jackson, MS, USAPurpose: This study was designed to compare functional outcomes in patients undergoing revi- sion repair of massive rotator cuff tears (retracted medial to the glenoid) with Goutallier Grade  4 atrophy and concomitant release of the suprascapular nerve to a similar group of patients with  Grade 3 atrophy undergoing revision rotator cuff repair (RTCR) without nerve release.",Non-OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
"Since the first reported case of an isolated suprascapular nerve lesion in 1886 by Dörrien, 3 significant progress has been made in  understanding the variety of pathologies affecting the suprascapular nerve as well as Correspondence: Felix H Savoie III Department of Orthopaedics, Tulane University School of Medicine, 1430 Tulane Avenue, 8632 New Orleans, LA 70112, USATel +1 504 988 5770Fax +1 504 988 3517Email fsavoie@tulane.eduJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCH  Y ear: 2016V olume: 7Running head verso: Savoie III et alRunning head recto: Arthroscopic suprascapular nerve releaseDOI: http://dx.doi.org/10.2147/OAJSM.S113020",Non-OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/4c/oajsm-7-129.PMC5077237.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c4/3f/jbm-7-233.PMC5077238.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c4/3f/jbm-7-233.PMC5077238.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine Journal of Blood Medicine 2016:7 233Dovepress submit your manuscript | www.dovepress.com Dovepress  Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/jbm-7-233.PMC5077238.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 233 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S120071Reducing the iron burden and improving survival in transfusion-dependent  thalassemia patients: current perspectives [Corrigendum] Bayanzay K, Alzoebie L. J Blood Med.",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/jbm-7-233.PMC5077238.pdf
"On page 159, Keywords section, the keyword “deferiserox”  should have read “deferasirox”.Journal name: Journal of Blood Medicine Article Designation: CORRIGENDUMY ear: 2016V olume: 7Running head verso: Bayanzay and AlzoebieRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/JBM.S120071",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/jbm-7-233.PMC5077238.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2677–2687Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2677OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11859 3 self-stigma and quality of life in patients with  depressive disorder: a cross-sectional study Michaela holubova1,2 Jan Prasko1 Marie Ociskova1 Marketa Marackova1 ales grambal1 Milos slepecky3 1Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University Olomouc, University  hospital Olomouc, Olomouc,   2Department of Psychiatry, hospital  liberec, liberec, czech republic;   3Department of Psychology sciences,   Faculty of social science and health  care, constantine the Philosopher  University, Nitra, slovak republicBackground:  Self-stigma is a maladaptive psychosocial phenomenon that can affect many areas  of patients’ lives and have a negative impact on their quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
"Self-stigma might also lead to suicide.6,7 Self-stigma may also have a  deleterious impact on the treatment efficacy in mental disorders.8–13correspondence: Jan Prasko Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University Olomouc, University hospital  Olomouc, iP Pavlova 6, 775 20 Olomouc,  czech republic email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Holubova et al Running head recto: Self-stigma and quality of life in patients with depressive disorder DOI: http://dx.doi.org/10.2147/NDT.S118593",Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
"Available from: http://www.ema.europa.eu/pdfs/human/ ich/013595en.pd f. Accessed March 20, 2009.",Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
Available from: https://archive.org/ details/ecdeuassessmentm1933guyw.,Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/07/ndt-12-2677.PMC5077239.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/ef/ndt-12-2689.PMC5077240.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2689–2705Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2689Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11012 6 Hyperbaric oxygen therapy as a potential  treatment for post-traumatic stress disorder  associated with traumatic brain injury David J eve1 Martin R Steele2 Paul R Sanberg1 Cesar v Borlongan1 1Department of Neurosurgery and  Brain Repair, Center of excellence  for Aging and Brain Repair, Morsani  College of Medicine, 2veterans  Reintegration Steering Committee,   veterans Research, University of  South Florida, Tampa, FL, USAAbstract:  Traumatic brain injury (TBI) describes the presence of physical damage to the brain  as a consequence of an insult and frequently possesses psychological and neurological symptoms  depending on the severity of the injury.",Non-OADS,/arxiv_data1/oa_pdf/46/ef/ndt-12-2689.PMC5077240.pdf
"A transient loss of consciousness is also a hallmark of TBI, although  there is a debate as to whether this is a necessary component of its definition, which  can lead to it being described as a postconcussion syndrome (PCS) in a quarter of Correspondence: Cesar v Borlongan Department of Neurosurgery and Brain  Repair, Center of excellence for Aging  and Brain Repair, Morsani College of  Medicine, University of South Florida,  12901 Bruce B Downs Blvd, MDC-78,  Tampa, FL, USA Tel +1 813 974 3154 Fax +1 813 974 3078 email cborlong@health.usf.ed uJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Eve et al Running head recto: HBOT for TBI & PTSD DOI: http://dx.doi.org/10.2147/NDT.S110126",Non-OADS,/arxiv_data1/oa_pdf/46/ef/ndt-12-2689.PMC5077240.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/46/ef/ndt-12-2689.PMC5077240.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/ef/ndt-12-2689.PMC5077240.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 325–328International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 325 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S116331Serum total IgG and IgG4 levels in thyroid  eye disease Aileen Sy Rona Z Silkiss Department of Ophthalmology,   California Pacific Medical Center,  San Francisco, CA, USAPurpose: To investigate the relationship between immunoglobulin G (IgG)4-related disease  (IgG4-RD) and thyroid eye disease (TED) with respect to IgG levels.",Non-OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
"6,7 No biopsies for histopathological Correspondence: Aileen Sy and  Rona Z SilkissDepartment of Ophthalmology, California Pacific Medical Center, 711 Van Ness Avenue, San Francisco, CA 94102, USATel +1 510 763 0881Fax +1 510 763 0907Email aileensy@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE SERIESY ear: 2016V olume: 9Running head verso: Sy and SilkissRunning head recto: Total IgG and IgG4 levels in thyroid eye diseaseDOI: http://dx.doi.org/10.2147/IMCRJ.S116331",Non-OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 328 Sy and Silkiss was not available.,Non-OADS,/arxiv_data1/oa_pdf/7d/58/imcrj-9-325.PMC5077241.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 859–863Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  859 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S116035Percutaneous cementoplasty for painful osteolytic  distal femur metastases: a case report Mingxing Lei1 Yaosheng Liu1 Shaoxing Yang2 Weigang Jiang1 Yuncen Cao1 Shubin Liu1 1Department of Orthopedic  Surgery, 2Department of Pulmonary  Neoplasms Internal Medicine, The  Affiliated Hospital of Academy of Military Medical Sciences, Beijing,  People’s Republic of ChinaAbstract:  Percutaneous cementoplasty has been shown to immediately restore the mechanical  stability of affected bones, prevent further risk of bone fractures, and allow immediate weight  bearing.",Non-OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
"8, Fengtaidongda Rd, Beijing 100071, People’s Republic of ChinaTel +86 010 6694 7317Fax +86 010 6694 7317Email 632763246@qq.com; lsb9126@126.comJournal name: Journal of Pain Research  Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Lei et alRunning head recto: Percutaneous cementoplasty for distal femur metastasesDOI: http://dx.doi.org/10.2147/JPR.S116035",Non-OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 863 Percutaneous cementoplasty for distal femur metastases Acknowledgment The work was supported by the Beijing Municipal Science  and Technology Commission (No Z131107002213052 and No Z161100000516101), and Capital Health Research and Development Special Fund (No 2011-5006-03).",Non-OADS,/arxiv_data1/oa_pdf/76/58/jpr-9-859.PMC5077242.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 547–555Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 547 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S116462Psychosocial factors are strongly associated  with insomnia in users and nonusers of  prescribed sleep medication: evidence  from the HUNT3 study Randi Andenæs   Sølvi Helseth   Nina Misvær   Milada C Småstuen   Lis Ribu Faculty of Health Sciences,   Department of Nursing and Health Promotion, Oslo and Akershus University College of Applied Sciences, Oslo, NorwayObjective: The aim of this study was to examine how neuroticism, stressful life events, self- rated health, life satisfaction, and selected lifestyle factors were related to insomnia both by sex  and among users and nonusers of prescribed sleep medication (PSM).",Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
"2,3 Insomnia is more commonly reported in females than in males.4 Throughout history, people have sought to alleviate sleep problems with various  medications and therapies.5 In the US, prescriptions of sleep medication from 1993 to Correspondence: Randi Andenæs   Faculty of Health Sciences, Department  of Nursing and Health Promotion, Oslo and Akershus University College of Applied Sciences, Post Box 4, St Olavs plass, N-0130 Oslo, Norway   Tel +47 6723 6232 Email randi.andenas@hioa.noJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Andenæs et alRunning head recto: Insomnia and prescribed sleep medicationDOI: http://dx.doi.org/10.2147/JMDH.S116462",Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
Available from: https://www.fhi.no/en/hn/health-registries/norpd/.,Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
Available from: http://www.whocc.no/.,Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
Available from: http://www.whocc.no/atc_ddd_index/.,OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 555 Insomnia and prescribed sleep medication  23.,Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
Available from: https://helsedirektoratet.no/Retningslinjer/Vanedannende%20legemidler.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/cc/jmdh-9-547.PMC5077243.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/9c/ott-9-6461.PMC5077260.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6461–6466OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6461Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10732 1 Dephosphorylated cofilin expression is associated  with poor prognosis in cases of human breast  cancer: a tissue microarray analysis Yusufu Maimaiti1,2,* Zeming liu1,* Jie Tan1 Kelimu abudureyimu2 Bangxing huang3 chunping liu1 Yawen guo1 changwen Wang1 Xiu nie3 Jing Zhou1 Tao huang1 1Department of Breast and Thyroid  surgery, Union hospital, Tongji  Medical college, huazhong University  of science and T echnology, Wuhan,   2Department of general surgery,   research institute of Minimally  invasive, People’s hospital of Xinjiang  Uygur autonomous region, Urumqi,   3Department of Pathology, Union  hospital, T ongji Medical college,   huazhong University of science and  Technology, Wuhan, People’s republic  of china *These authors contributed equally  to this workBackground:  Proteins in the cofilin pathway regulate actin dynamics and may be involved in  cancer cell migration and invasion.",Non-OADS,/arxiv_data1/oa_pdf/c5/9c/ott-9-6461.PMC5077260.pdf
"The increased motility of cancer cells helps  drive migration and invasion and is an essential step in breast cancer metastasis.5,6 correspondence: Tao huang; Jing Zhou Department of Breast and Thyroid  surgery, Union hospital, Tongji Medical  college, huazhong University of  science and Technology, 1277 JieFang  avenue, Wuhan 430022, People’s  republic of china email huangtaowh@163.co m;   drtinazhou@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Maimaiti et al Running head recto: Dephosphorylated cofilin and prognosis in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S107321",Non-OADS,/arxiv_data1/oa_pdf/c5/9c/ott-9-6461.PMC5077260.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/9c/ott-9-6461.PMC5077260.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/9c/ott-9-6461.PMC5077260.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/1d/ott-9-6379.PMC5077261.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/1d/ott-9-6379.PMC5077261.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/1d/ott-9-6379.PMC5077261.pdf
"9;198:2014.Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2016 Volume: 9 Running head verso: Dove Medical Press Running head recto: miR-32 functions as a tumor suppressor and directly targets  DOI: http://dx.doi.org/10.2147/OTT.S124096 Accordingly, we retract Zhu D, Chen H, Y ang X, Chen W,  Wang L, Xu J, Yu L. miR-32 functions as a tumor suppres - sor and directly targets SOX9 in human non–small cell lung  cancer.",Non-OADS,/arxiv_data1/oa_pdf/29/1d/ott-9-6379.PMC5077261.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/ba/tcrm-12-1573.PMC5077262.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1573–1578Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1573ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11749 1 The potential role for use of mitochondrial  Dna copy number as predictive biomarker  in presbycusis Masoumeh Falah1,2 Massoud houshmand3 Mohammad najafi2 Maryam Balali1 saeid Mahmoudian1 alimohamad asghari4 hessamaldin emamdjomeh1 Mohammad Farhadi1 1enT and head & neck Research  Center and Department, iran  University of Medical sciences, T ehran,   iran; 2Cellular and Molecular Research  Center, Biochemistry Department,   iran University of Medical sciences,   T ehran, iran; 3Department of  Medical genetics, national institute  for genetic engineering and  Biotechnology, T ehran, iran; 4skull base  research center, iran University of  Medical sciences, T ehran, iranObjectives:  Age-related hearing impairment, or presbycusis, is the most common communication  disorder and neurodegenerative disease in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/32/ba/tcrm-12-1573.PMC5077262.pdf
"Thus, the condition greatly impacts the quality  of human life and general health.1,3 Panza et al demonstrated that presbycusis is a  risk factor for dementia and cognitive decline.4 There is, as yet, no treatment for Correspondence: Mohammad Farhadi enT and head & neck Research Center  and Department, iran University of  Medical sciences, hazrat Rasool akram  hospital, niayesh street, sattarkhan  street, Tehran, iran Tel +98 21 6655 2828 Fax +98 21 6652 5329 email mfa.ent@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Falah et al Running head recto: mtDNA copy number as biomarker in presbycusis DOI: http://dx.doi.org/10.2147/TCRM.S117491",Non-OADS,/arxiv_data1/oa_pdf/32/ba/tcrm-12-1573.PMC5077262.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/32/ba/tcrm-12-1573.PMC5077262.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/ba/tcrm-12-1573.PMC5077262.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/84/tcrm-12-1563.PMC5077263.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1563–1571Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1563ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11588 4 high-frequency oscillatory ventilation is an effective  treatment for severe pediatric acute respiratory  distress syndrome with refractory hypoxemia Yu-Xiong guo1,* Zhao-n i Wang2,* Ya-Ting li2 li Pan2 li-Fen Yang2 Yan hu1 Yue-Yu sun1 liang-Ming Cai2 Zhuang-gui Chen2 1Pediatric intensive Care Unit,   Department of Pediatrics,   guangdong  general hospital,   guangdong academy of Medical  sciences, 2Pediatric intensive Care  Unit, Department of Pediatrics,   The Third affiliated hospital of  sun Yat-sen University, guangzhou,   People’s Republic of China *These authors contributed equally  to this workBackground and purpose:  Early or primary application of high-frequency oscillatory  ventilation (HFOV) has been recently suggested not to offer benefit to patients with acute  respiratory distress syndrome (ARDS).",Non-OADS,/arxiv_data1/oa_pdf/7a/84/tcrm-12-1563.PMC5077263.pdf
"Mechanical ventilation is Correspondence: Zhuang-gui Chen Pediatric intensive Care Unit,  Department of Pediatrics, The  Third Affiliated Hospital of Sun  Yat-sen University, 600 Tianhe  Road, guangzhou 510630,  People’s Republic of China Tel +86 020 8525 3380  email chenzhuanggui@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Guo et al Running head recto: HFOV is an effective treatment for PARDS DOI: http://dx.doi.org/10.2147/TCRM.S115884",Non-OADS,/arxiv_data1/oa_pdf/7a/84/tcrm-12-1563.PMC5077263.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7a/84/tcrm-12-1563.PMC5077263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/84/tcrm-12-1563.PMC5077263.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/de/ott-9-6445.PMC5077264.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6445–6459OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6445Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10925 3 inhibitory effect of quercetin on epithelial to  mesenchymal transition in sK-Mel-28 human  melanoma cells defined by in vitro analysis on  3D collagen gels Dhairya h Patel* neeti sharma* symbiosis school of Biomedical  sciences, symbiosis international  University, gram – lavale,   Taluka – Mulshi, Pune, india *These authors contributed equally  to this workAbstract:  Considering the emerging concept of complementary and alternative medicine under  the paucity of effective treatment for melanoma, we aimed to understand the effect of quercetin  (Qu) on collagen I-induced epithelial–mesenchymal transition (EMT) in melanoma cells.",Non-OADS,/arxiv_data1/oa_pdf/43/de/ott-9-6445.PMC5077264.pdf
"However, a recent study correspondence: neeti sharma symbiosis school of Biomedical sciences,  symbiosis international University,  gram – lavale; Taluka – Mulshi,  Pune 412115, india Tel +91 97 6443 5566 email neeti.sharma@ssbs.edu.i n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Patel and Sharma Running head recto: Quercetin reverses collagen I-induced EMT in SK-MEL-28 melanoma cells DOI: http://dx.doi.org/10.2147/OTT.S109253",Non-OADS,/arxiv_data1/oa_pdf/43/de/ott-9-6445.PMC5077264.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/43/de/ott-9-6445.PMC5077264.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/de/ott-9-6445.PMC5077264.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/62/opth-10-2079.PMC5077265.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2079–2083Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2079Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11610 3 infantile esotropia: risk factors associated with   reoperation adriano Magli1 luca rombetto2 Francesco Matarazzo2 roberta Carelli1 1Department of Ophthalmology,   Orthoptics and Pediatric  Ophthalmology, University of  salerno, salerno, 2Department of  Ophthalmology, Federico ii University,   naples, italyAbstract:  The aim of this study was to identify clinical and demographic factors associated  with misalignment after first surgery performed on children affected by infantile esotropia to  evaluate the reoperation rate.",Non-OADS,/arxiv_data1/oa_pdf/30/62/opth-10-2079.PMC5077265.pdf
"Materials and methods A retrospective study was carried out analyzing data from 863 patients, examined  and operated between 1980 and 2014 by the same surgeon (AM) in the Department  of Ophthalmology of “Federico II” University of Naples, in the Department of  Ophthalmology, Orthoptics and Pediatric Ophthalmology of University of Salerno,  and in two other private centers.Correspondence: adriano Magli Department of Ophthalmology,  Orthoptics and Pediatric Ophthalmology,  University of salerno, Via giovanni  Paolo ii, 132, 84084 Fisciano,  salerno, italy Tel +39 89 08 1761 2609 Fax +39 89 08 166 4373 email amagli@unisa.i t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Magli et al Running head recto: Risk factors for reoperation in infantile esotropia DOI: http://dx.doi.org/10.2147/OPTH.S116103",Non-OADS,/arxiv_data1/oa_pdf/30/62/opth-10-2079.PMC5077265.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/30/62/opth-10-2079.PMC5077265.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/62/opth-10-2079.PMC5077265.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/b8/opth-10-2069.PMC5077266.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2069–2078Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2069Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11548 3 Comparative analysis of the performance of two  different platforms for femtosecond laser-assisted  cataract surgery robert P rivera† Phillip C hoopes Jr steven h linn Phillip C hoopes hoopes Vision, Draper, UT, Usa †Dr rivera passed away on  april 1, 2015Purpose:  To analyze and compare the intraoperative and postoperative outcomes of cataract  surgery performed with two different femtosecond laser platforms.",Non-OADS,/arxiv_data1/oa_pdf/c6/b8/opth-10-2069.PMC5077266.pdf
"In this context, one of the most  relevant advances is the development of femtosecond laser systems to perform anterior  capsulotomy, lens segmentation, and corneal incisions during cataract surgery.3–5 This  new technology provides several advantages to the surgeon over the conventional Correspondence: Phillip C hoopes Jr hoopes Vision, Draper, UT 84020, Usa Tel +1 801 568 0200 email pchj@hoopesvision.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rivera et al Running head recto: Comparison of two femtosecond laser-assisted cataract surgery platforms DOI: http://dx.doi.org/10.2147/OPTH.S115483",Non-OADS,/arxiv_data1/oa_pdf/c6/b8/opth-10-2069.PMC5077266.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c6/b8/opth-10-2069.PMC5077266.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/b8/opth-10-2069.PMC5077266.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/89/ott-9-6435.PMC5077267.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6435–6444OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6435Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11203 8 Differences in esophageal cancer characteristics  and survival between chinese and caucasian  patients in the seer database Min-Qiang lin,1,* Yue-Ping  li,2,* san-gang Wu,3 Jia-Yuan  sun,4 huan-Xin lin,4 shi- Yang Zhang,5 Zhen-Yu he4 1Department of scientific Management,   The First affiliated hospital of Xiamen  University, Xiamen, 2Public health  school of Fujian Medical University,   Fuzhou, 3Department of radiation  Oncology, The First affiliated  hospital of Xiamen University,   Xiamen,  4Department of radiation  Oncology, state Key laboratory  of Oncology in south china,   collaborative innovation center  of cancer Medicine, sun Yat-sen  University cancer center, guangzhou,   5Department of hospital infection  Management, The First affiliated  hospital of Xiamen University,   Xiamen, People’s republic of china *These authors contributed equally  to this workBackground:  To compare the clinicopathologic characteristics and survival of Chinese and  Caucasian esophageal cancer (EC) patients residing in the US, using a population-based national  registry (Surveillance Epidemiology and End Results [SEER]) database.",Non-OADS,/arxiv_data1/oa_pdf/74/89/ott-9-6435.PMC5077267.pdf
"Indeed, about half of all EC-related  deaths were found in People’s Republic of China and nearly all are due to ESCC.4  In recent years, the incidence of esophageal adenocarcinoma (EAC) has increased  rapidly in Western countries, such as the US, and EAC is now the most common  histologic subtype in these countries.5–8 The epidemiology and survival of patients with  ESCC and EAC have diverse characteristics, which are closely correlated with genetic  profile, society, lifestyle, economy, culture, environment, and dietary habits.9,10  Along with the progress of international exchange, an increasing number of  Chinese migrate to the US, accounting for a majority of Asian immigrants.11 Due to  geographic migration, Chinese immigrants tend to have similar lifestyles and dietary correspondence: shi-Yang Zhang Department of hospital infection  Management, The First Affiliated Hospital  of Xiamen University, 55 Zhenhai road,  Xiamen 361003, People’s republic of  china Tel +86 592 213 9369 Fax +86 592 213 7229 email 18859938889@163.co m  Zhen-Yu he Department of radiation Oncology,  state Key laboratory of Oncology in  south china, collaborative innovation  center of cancer Medicine, sun Yat-sen  University cancer center, 651 Dongfeng  road east, guangzhou 510060, People’s  republic of china Tel +86 20 8734 3543 Fax +86 20 8734 3392 email hezhy@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lin et al Running head recto: Characteristics of Chinese and Caucasian EC DOI: http://dx.doi.org/10.2147/OTT.S112038",Non-OADS,/arxiv_data1/oa_pdf/74/89/ott-9-6435.PMC5077267.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/74/89/ott-9-6435.PMC5077267.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/89/ott-9-6435.PMC5077267.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/cc/opth-10-2055.PMC5077268.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2055–2059Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2055Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11769 1 Orbital exenteration in immunodeficiency  virus-infected patients Kagmeni giles1,2 Yannick Bilong1,2 nomo arlette1,2 nanfack Chantal1,3 Bella assumpta lucienne1,3 1eye Department, University of  Yaoundé i, 2Yaounde T eaching hospital,   3gyneco-Obstetric and Pediatric  hospital, Yaoundé, CameroonBackground:  Orbital exenteration (OE) is a disfiguring procedure most commonly performed  for locally advanced and potentially life-threatening periorbital malignancies.",Non-OADS,/arxiv_data1/oa_pdf/c0/cc/opth-10-2055.PMC5077268.pdf
"The Correspondence: Kagmeni giles Yaounde Teaching hospital, BP 04  Yaounde, Cameroon Tel +237 699 51 4473 email dr.kagmeni@gmx.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Giles et al Running head recto: Orbital exenteration in immunodeficiency virus-infected patients DOI: http://dx.doi.org/10.2147/OPTH.S117691",Non-OADS,/arxiv_data1/oa_pdf/c0/cc/opth-10-2055.PMC5077268.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c0/cc/opth-10-2055.PMC5077268.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/cc/opth-10-2055.PMC5077268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/ea/opth-10-2061.PMC5077269.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2061–2068Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2061Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11780 3 steady-state pattern electroretinogram and  frequency doubling technology in anisometropic  amblyopia Costantino schiavi Filippo Tassi alessandro Finzi ernesto strobbe Mauro Cellini Department of experimental,   Diagnostic, and specialty Medicine,   Ophthalmology service, University  of Bologna, Bologna, italyBackground:  Steady-state pattern electroretinogram (PERG) and frequency doubling  technology (FDT) perimetry can be used to selectively investigate the activity of the M-Y  ganglion cells in adult anisometropic amblyopes.",Non-OADS,/arxiv_data1/oa_pdf/d5/ea/opth-10-2061.PMC5077269.pdf
"Strabismic and anisometropic amblyopia  may be combined, and it is not yet clearly established whether anisometropia is the  cause of the nonalternating strabismic deviation, or whether a uniocular deviation Correspondence: Mauro Cellini Policlinico sant’Orsola-Malpighi,  Ophthalmology service, University  of Bologna, Via Pelagio Palagi 9,  Bologna 40138, italy Tel +39 051 6362 835 Fax +39 051 6362 835 email mauro.cellini@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Schiavi et al Running head recto: PERG and FDT in anisometropic amblyopia DOI: http://dx.doi.org/10.2147/OPTH.S117803",Non-OADS,/arxiv_data1/oa_pdf/d5/ea/opth-10-2061.PMC5077269.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d5/ea/opth-10-2061.PMC5077269.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/ea/opth-10-2061.PMC5077269.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6399–6406OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11639 2 Biomarker and competing endogenous rna  potential of tumor-specific long noncoding RNA  in chromophobe renal cell carcinoma hai-Tao he1,2,* Mu Xu1,* Ye Kuang1 Xiao-Yun han1 Ming-Qi Wang1 Qing Yang1 1Department of Pathogenobiology,   2Department of cell Biology,   college of Basic Medical sciences,   Jilin University, changchun, People’s  republic of china *These authors contributed equally  to this workBackground:  Accumulating evidence suggests long noncoding RNAs (lncRNAs) play  important roles in the initiation and progression of cancers.",Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"They pointed out correspondence: Qing Yang Department of Pathogenobiology,  college of Basic Medical sciences,  Jilin University, 126 Xinmin street,  changchun 130021, Jilin Province,  People’s republic of china Tel +86 431 8561 9439 Fax +86 431 8561 9401 email yangq@jlu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: Long noncoding RNA and chromophobe renal cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S116392",Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"Their corresponding RNA expression  data (level 3) were downloaded from TCGA data portal  (http://cancergenome.nih.go v, up to Jan 20, 2016).",OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
The  authors downloaded all the data from the TCGA database  and performed this study in line with the TCGA publication guidelines ( http://cancergenome.nih.gov/publications/ publicationguideline s).,OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"Furthermore, among these 143 differentially expressed  Table 1  clinical characteristics of patients with chromophobe  renal cell carcinoma Category Cohort M Cohort T P-value (n=23) (%) (n=59) (%) age, mean ± sD 52.6±13.3 51.0±14.2 0.647 gender, n (%) 0.623 Female 12 (52.2) 26 (44.1) Male 11 (47.8) 33 (55.9) aJcc stages, n (%) 0.594 stage i 9 (39.2) 17 (28.9) stage ii 8 (34.8) 23 (39.0) stage iii 3 (13.0) 14 (23.7) stage iV 3 (13.0) 5 (8.4) Tumor size, n (%) 0.790 T1 9 (39.1) 17 (28.8) T2 8 (34.8) 23 (39.0) T3 5 (21.7) 14 (23.7) T4 1 (4.4) 5 (8.5) lymph node, n (%) 0.382 n0 11 (47.8) 38 (64.4) n1+n2 2 (8.7) 4 (6.8) nX 10 (43.5) 17 (28.8) Metastasis status, n (%) 0.947 M0 18 (78.3) 48 (81.4) M1 1 (4.4) 2 (3.4) MX 4 (17.3) 9 (15.2) Tumor status, n (%) 0.783 Tumor free 19 (82.6) 50 (84.7) With tumor 3 (13.0) 8 (13.6) na 1 (4.4) 1 (1.7) Abbreviations:  aJcc, american Joint committee on cancer; na, not applicable;  sD, standard deviation.Table 2  Forty-three cancer specific lncRNAs in ceRNA network  construction LncRNA Entrez ID Chromosome Expression   change (T vs N) linc00588 26138 chr8 Upregulation slc26a4-as1 286002 chr7 Upregulation Baalc-as2 157556 chr8 Upregulation linc00265 349114 chr7 Upregulation UcKl1-as1 100113386 chr20 Upregulation linc00239 145200 chr14 Upregulation ParT1 25859 chr5 Upregulation Pacrg-as1 285796 chr6 Upregulation KrTaP5-as1 338651 chr11 Upregulation cDKn2B-as1 100048912 chr9 Upregulation linc00889 158696 chrX Upregulation linc00669 647946 chr18 Upregulation linc00930 100144604 chr15 Upregulation linc00598 646982 chr13 Upregulation nr2F1-as1 441094 chr5 Downregulation linc00882 100302640 chr3 Downregulation linc00242 401288 chr6 Downregulation linc01554 202299 chr5 Downregulation casc2 255082 chr10 Downregulation linc00312 29931 chr3 Downregulation Tincr 257000 chr19 Downregulation linc00092 100188953 chr9 Downregulation hcg4 54435 chr6 Downregulation hnF1a-as1 283460 chr12 Downregulation lOc145837 145837 chr15 Downregulation Meg3 55384 chr14 Downregulation linc00839 84856 chr10 Downregulation lOc285768 285768 chr6 Downregulation aDOra2a-as1 646023 chr22 Downregulation gaTa3-as1 399717 chr10 Downregulation linc00924 145820 chr15 Downregulation Bre-as1 100302650 chr2 Downregulation Uca1 652995 chr19 Downregulation egOT 100126791 chr3 Downregulation linc00908 284276 chr18 Downregulation linc00671 388387 chr17 Downregulation linc00271 100131814 chr6 Downregulation cOl18a1-as1 378832 chr21 Downregulation linc01550 388011 chr14 Downregulation WT1-as 51352 chr11 Downregulation linc01139 339535 chr1 Downregulation linc00473 90632 chr6 Downregulation lhFPl3-as2 723809 chr7 Downregulation Notes:  The names, entrez iDs and chromosomal locations of theses lncrnas were  obtained from the entrez gene database http://www.ncbi.nlm.nih.gov/gen e.38 Abbreviations:  cerna, competing endogenous rna; lncrna, long noncoding  rna; n, normal; T, tumor.",Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/52/ott-9-6399.PMC5077270.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2117–2125Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2117OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11812 1 Factors affecting medication adherence in  elderly people hyekyung Jin1 Yeonhee Kim2 sandy Jeong rhie1,3 1college of Pharmacy, 2center for  excellence in T eaching & learning,   3Division of life and Pharmaceutical  sciences, ewha Womans University,   seoul, republic of KoreaBackground:  Little is known about the functional health literacy (FHL) associated with  medication adherence in elderly patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
"Although appropriate drug therapy can contribute to alleviating symptoms and  reduction of morbidity and mortality rates, the use of medications can also be a burden on  health care costs, risk of side effects, and noncompliance in the elderly patients.3,4correspondence: sandy Jeong rhie college of Pharmacy, ewha Womans  University, 52 ewhayeodae-gil,  seodaemun-gu, seoul 03760,  republic of Korea Tel +82 2 3277 3023 Fax +82 2 3277 2851 email sandy.rhie@ewha.ac.k r Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jin et al Running head recto: Medication adherence in the elderly DOI: http://dx.doi.org/10.2147/PPA.S118121",Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
Available from:   http://kostat.go.kr/portal/korea/kor_nw/2/1/index.board?bmode =  read&aSeq =348565 /.,OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
Avail - able from: http://www.mohw.go.kr/front_new/jb/sjb030301vw.jsp?,Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
Available from: http://nces.ed.gov/pubs2006/2006483.pdf /.,Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ppa-10-2117.PMC5077271.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2107–2116Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2107OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11988 6 reaching women in the Peruvian Andes through  cervical cancer screening campaigns: assessing  attitudes of stakeholders and patients John s luque1 Jonathan n Maupin2 Daron g Ferris3,4 Wendy s guevara  condorhuaman4 1Department of Public health  sciences, hollings cancer center,   Medical University of south carolina,   charleston, sc, 2school of human  evolution and social change,   Arizona state University, T empe,   AZ, 3Department of Obstetrics and  gynecology, Augusta University,   Augusta, gA, UsA; 4cervicusco,   cusco, PeruBackground:  Peru is characterized by high cervical cancer incidence and mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
"Cervical cancer is the second most common cancer among  women worldwide; however, it can be prevented when premalignant changes of the correspondence: John s luque Department of Public health sciences,  Medical University of south carolina,  135 cannon street, suite 303, Msc 835,  charleston, sc 29425, UsA Tel +1 843 876 2248 email luquej@musc.ed uJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Luque et al Running head recto: Cervical cancer screening campaigns in Peru DOI: http://dx.doi.org/10.2147/PPA.S119886",Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
Available from: http://www.hpvcentre.,Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
Available from: http://hints.cancer.gov /.,Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
"Available from:  https://www.newglobalcitizen.com/global-pro-bono/team-ibm-bd- volunteers-helping-local-clinic-save-lives-perus-andes-mountain s.  Accessed September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f3/9f/ppa-10-2107.PMC5077272.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/a4/ott-9-6377.PMC5077273.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/89/a4/ott-9-6377.PMC5077273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/a4/ott-9-6377.PMC5077273.pdf
2014;7:1583–1591.Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2016 Volume: 9 Running head verso: Dove Medical Press Running head recto: MiR-206 functions as a tumor suppressor DOI: http://dx.doi.org/10.2147/OTT.S124095,Non-OADS,/arxiv_data1/oa_pdf/89/a4/ott-9-6377.PMC5077273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/ee/ott-9-6417.PMC5077274.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6417–6423OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6417Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11250 1 Prognostic nutritional index serves as a predictive  marker of survival and associates with systemic  inflammatory response in metastatic intrahepatic  cholangiocarcinoma chenyue Zhang1,2 haiyong Wang1,3 Zhouyu ning1,2 litao Xu1,2 liping Zhuang1,2 Peng Wang1,2 Zhiqiang Meng1,2 1Department of integrative Oncology,   Fudan University shanghai cancer  center, 2Department of Oncology,   shanghai Medical college, Fudan  University, shanghai, 3Department of  radiation Oncology, shandong cancer  hospital and institute, Jinan, People’s  republic of chinaObjective:  The significance of the prognostic nutritional index (PNI) has been widely reported  and confirmed in many types of cancers.",Non-OADS,/arxiv_data1/oa_pdf/d1/ee/ott-9-6417.PMC5077274.pdf
"Despite being a rare malignancy, the incidence and mortality of ICC  are increasing at an unprecedented rate.3–6 Unlike other tumors originating from the  liver and gastrointestinal tract, the pathogenesis of ICC remains complex and obscure,  thus making the disease more intractable and challenging.7 Moreover, patients with correspondence: Zhiqiang Meng;  Peng Wang Department of integrative Oncology,  Fudan University shanghai cancer  center, 270 Dong an road, shanghai  200032, People’s republic of china Tel +86 21 6417 5590 Fax +86 21 6443 7657 email mengzhq@yeah.ne t;  wangp413@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Prognostic nutritional index as a predictive marker of survival DOI: http://dx.doi.org/10.2147/OTT.S112501",Non-OADS,/arxiv_data1/oa_pdf/d1/ee/ott-9-6417.PMC5077274.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d1/ee/ott-9-6417.PMC5077274.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/ee/ott-9-6417.PMC5077274.pdf
Website http://www.geneious.com [accessed 15 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/5e/a6/apps.1600048.PMC5077280.pdf
"With the MISA tool (Thiel et al., 2003; http://pgrc.ipk-gatersleben.de/misa), 11,100 SSRs were detected in 9456 con-tigs.",OADS,/arxiv_data1/oa_pdf/52/49/apps.1600064.PMC5077281.pdf
Website http://www.iucnredlist.org [accessed 12  September 2016].,Non-OADS,/arxiv_data1/oa_pdf/52/49/apps.1600064.PMC5077281.pdf
"The transcriptomic data generated here are publicly available in the National Center   for Biotechnology Information (NCBI) Sequence Read Archive for submission SPR074674 and the Trinity assemblies in the NCBI Transcriptome Shotgun Assembly Sequence Archive (Table 1; http://www.ncbi.nlm.nih.gov/sra/SRP074674).Several studies focusing on Veronica in both hemispheres have  used standard DNA sequencing and amplified fragment length polymorphism (AFLP) fingerprinting techniques to elucidate patterns of relationship from phylogeography (Meudt and Bayly, 2008) to phylogeny of the genus as a whole (Wagstaff et al., 2002; Albach and Meudt, 2010; Meudt et al., 2015) or of par-ticular polyploid complexes (e.g., Albach, 2007), and used these to infer the evolution of chromosome number, genome size, breeding systems, and habit (Albach and Greilhuber, 2004;   Albach et al., 2008; Meudt et al., 2015).",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
a Sequence Read Archive (SRA) accession numbers for SRA submission SPR074674 (http://www.ncbi.nlm.nih.gov/sra/SRP074674).,OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"Functional annotation of contigs from the different assemblies was conducted using BLAT (Kent, 2002) with default settings against the TAIR database (version 10 represented gene model from 2011-01-03; Lamesch et al., 2012) and MapMan hierarchical categories (Ath_AGI_LOCUS_TAIR10_Aug2012; http://mapman.gabipd.org/web/guest/   mapmanstore).",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"To demonstrate the quality and utility of the transcriptomic resources developed here, we compared the transcriptome sequences of our eight sampled individuals relative to   each other and to two outgroups, Picrorhiza kurrooa (http://scbb.ihbt.res.in/   Picro_information/; SRR392742; Gahlan et al., 2012) and Plantago ovata   (SRR629688; Kotwal et al., 2016).",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"To do this, we mined the data from these 10 individuals for SNPs using Site Identification from Short Read Sequences (SISRS) version 1.0 (Schwartz et al., 2015; https://github.com/rachelss/SISRS/releases).",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"For each LCN locus, resulting sequences were trimmed with BBMap tools (https://sourceforge.net/projects/bbmap/), de novo assembled with CAP3 (99%  Fig.",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"There are nearly 4000 plant transcriptomes in the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra/) and 1000 Plants (1KP) project (www.onekp.com; Matasci et al., 2014) online resources (Hodel et al., 2016).",OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
Website http://sweetgum.nybg.org/   science/ih/ [accessed 14 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/43/a4/apps.1600091.PMC5077287.pdf
"Keywords surveillance; occupational injuries; sharps injuries; hospital incident reporting; underreporting This manuscript is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ Corresponding Author:  Leslie I. Boden, PhD; Boston University School of Public Health, 715 Albany Street, T-444W, Boston, MA  02118.",Non-OADS,/arxiv_data1/oa_pdf/0d/19/nihms819408.PMC5077298.pdf
"Introduction Chronic diseases like diabetes, hypertension, and heart disease account for most U.S. deaths  each year [ 1], and unlike acute illnesses they are primarily managed not by clinicians but by  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
This paper makes two main contributions: (1) we extend causal inference methods to better  handle uncertainty in observational data; (2) we present a novel set of free-living data from  people with diabetes that is available for research use ( https://idash.ucsd.edu ).,Non-OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
Data  are available through iDASH ( https://idash.ucsd.edu ).,OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
2010; 8(1):29. http://dx.doi.org/ 10.1186/1478-7954-8-29 .,Non-OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
2015; 58:198– 207. http://dx.doi.org/10.1016/j.jbi.2015.10.004 .,OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
2008 < http://www.cs.duke.edu/amink/software/banjo/ >.,Non-OADS,/arxiv_data1/oa_pdf/7f/2f/nihms816437.PMC5077631.pdf
"9, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.201 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:201-206",Non-OADS,/arxiv_data1/oa_pdf/4d/4e/trd-79-201.PMC5077723.pdf
"TB transmission and TB infection control http://dx.doi.org/10.4046/trd.2016.79.4.201  203 www.e-trd.org Although TB susceptibility varies among different human  races and individuals, it is estimated to be nearly the same as  in the animal experiments.",Non-OADS,/arxiv_data1/oa_pdf/4d/4e/trd-79-201.PMC5077723.pdf
TB transmission and TB infection control http://dx.doi.org/10.4046/trd.2016.79.4.201  205 www.e-trd.org phages kill the TB bacilli.,Non-OADS,/arxiv_data1/oa_pdf/4d/4e/trd-79-201.PMC5077723.pdf
Available from:  http://www.nice.org.uk/CG117.,Non-OADS,/arxiv_data1/oa_pdf/4d/4e/trd-79-201.PMC5077723.pdf
"26, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.207 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:207-213",Non-OADS,/arxiv_data1/oa_pdf/9a/a2/trd-79-207.PMC5077724.pdf
"Mitochondrial perspective of COPD pathogenesis http://dx.doi.org/10.4046/trd.2016.79.4.207  209 www.e-trd.org might activate mitochondrial intrinsic pathway of apoptosis,  which was demonstrated by immunohistochemistry in COPD  lungs20.",Non-OADS,/arxiv_data1/oa_pdf/9a/a2/trd-79-207.PMC5077724.pdf
"Mitochondrial perspective of COPD pathogenesis http://dx.doi.org/10.4046/trd.2016.79.4.207  211 www.e-trd.org suppression showed strong correlation with the degree of  airflow limitation, a hallmark of COPD44.",Non-OADS,/arxiv_data1/oa_pdf/9a/a2/trd-79-207.PMC5077724.pdf
Mitochondrial perspective of COPD pathogenesis http://dx.doi.org/10.4046/trd.2016.79.4.207  213 www.e-trd.org 34.,Non-OADS,/arxiv_data1/oa_pdf/9a/a2/trd-79-207.PMC5077724.pdf
"27 , 2016, Accepted:  Aug. 16, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.214 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:214-233",Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
"Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  215 www.e-trd.org Introduction Since the first description of acute respiratory distress syn - drome (ARDS) as a series of 12 patients in 1967 by Ashbaugh  et al.1, it still remains a major public health problem that incurs  high health care costs and causes major mortality in the in - tensive care unit (ICU) despite improvements in outcomes in  the last two decades.",Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
ksccm.org or http://www.lungkorea.org).,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
"Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  217 www.e-trd.org tion syndromes (MODS) rather than respiratory failure12, and  the mortality rate was reported to be significantly higher when  another organ failure in addition to respiratory insufficiency,  was involved13.",Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
"Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  219 www.e-trd.org 0.39; 95% CI, 0.25–0.63; p<0.001) and 90-day mortality (23.6%  prone group vs. 41.0% supine group: HR, 0.44; 95% CI, 0.29– 0.67; p<0.001) compared to the group with the supine posi - tion, despite the mechanical ventilation for 12 or 24 hours49.",Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  221 www.e-trd.org was used75.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
"Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  223 www.e-trd.org liver functions prefer pancuronium, and the ones with renal  or liver function disorders prefer atracurium or cisatracurium.",Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  225 www.e-trd.org patients who cannot directly express their pain because of  endotracheal intubation or unconsciousness should evaluate  the pain through behavioral pain scale156.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  227 www.e-trd.org It is required to have a proper prevention for the occurrence  of delirium caused by the absence of appropriate analgesia  and sedation or other physical diseases.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  229 www.e-trd.org distress syndrome.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  231 www.e-trd.org 102.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
Guideline of mechanically ventilated patients and ARDS http://dx.doi.org/10.4046/trd.2016.79.4.214  233 www.e-trd.org 154.,Non-OADS,/arxiv_data1/oa_pdf/df/e6/trd-79-214.PMC5077725.pdf
"20, 2016 Accepted:  Aug. 9, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.234 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:234-240",Non-OADS,/arxiv_data1/oa_pdf/6f/f3/trd-79-234.PMC5077726.pdf
Tuberculosis infection control in health-care facilities http://dx.doi.org/10.4046/trd.2016.79.4.234  235 www.e-trd.org Environmental Control Environmental control is the second level of the TB control  hierarchy.,Non-OADS,/arxiv_data1/oa_pdf/6f/f3/trd-79-234.PMC5077726.pdf
"Tuberculosis infection control in health-care facilities http://dx.doi.org/10.4046/trd.2016.79.4.234  237 www.e-trd.org minimum negative pressure differential should be ≥2.5 Pa  (0.01″ water gauge), maintaining the size of value as follows;  bathroom≥isolation room≥anteroom>corridors.",Non-OADS,/arxiv_data1/oa_pdf/6f/f3/trd-79-234.PMC5077726.pdf
Tuberculosis infection control in health-care facilities http://dx.doi.org/10.4046/trd.2016.79.4.234  239 www.e-trd.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/f3/trd-79-234.PMC5077726.pdf
Available from:  http://www.law.go.kr/flDownload.do?flSeq=9689277.,Non-OADS,/arxiv_data1/oa_pdf/6f/f3/trd-79-234.PMC5077726.pdf
"Address for correspondence: Kai M. Beeh, M.D., Ph.D. Insaf Respiratory Research Institute GmbH, Biebricher Allee 34, D-65187  Wiesbaden, Germany Phone:  49-611-9854347, Fax: 49-611-9854348 E-mail:  k.beeh@insaf-wi.de Received:  Aug. 9, 2016 Revised:  Aug. 19 , 2016 Accepted:  Aug. 30, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.241 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:241-247",Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Bronchodilators and COPD exacerbations http://dx.doi.org/10.4046/trd.2016.79.4.241  243 www.e-trd.org versus placebo17.,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Bronchodilators and COPD exacerbations http://dx.doi.org/10.4046/trd.2016.79.4.241  245 www.e-trd.org label TIO (p=0.09).,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
"1. choice Alternative choice Other possible treatment A SAMA or SABA LAMA or LABA or SABA+SAMA Theophyllin B LAMA or LABA LAMA+LABA SABA and/or SAMA, theophyllin C Inhaled corticosteroid+LABA or  LAMALAMA+LABA or LAMA+PDE-4-inhibitor or  LABA+PDE-4-inhibitorSABA and/or SAMA, theophyllin D Inhaled corticosteroid+LABA and/or  LAMAInhaled corticosteroid+LAMA+LABA or inhaled  corticosteroid+LABA+PDE-4-inhibitor or  LAMA+LABA or LAMA+PDE-4-inhibitorCarbocysterin, N-acetylcysteine, SABA  and/or SAMA, theophyllin Adopted from Global Initiative for Chronic Obstructive Lung Disease (2016)1, http://www.goldcopd.org.",Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Bronchodilators and COPD exacerbations http://dx.doi.org/10.4046/trd.2016.79.4.241  247 www.e-trd.org et al.,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Available from: http://www.g-ba.de/down - loads/92-975-1206/2016-01-15_Nutzenbewertung-IQWiG_ Aclidiniumbromid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
Available from: http://www.g-ba.de/down - loads/92-975-767/2015-05-04_Nutzenbewertung-IQWiG_ A15-06_Aclidiniumbromid-Formoterol.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/08/trd-79-241.PMC5077727.pdf
"27, 2016 Revised:  Aug. 8, 2016 Accepted:  Aug. 25, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.4.248 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:248-256",Non-OADS,/arxiv_data1/oa_pdf/9e/36/trd-79-248.PMC5077728.pdf
"Resistance to EGFR-TKIs in lung adenocarcinoma http://dx.doi.org/10.4046/trd.2016.79.4.248  249 www.e-trd.org (TKD) lead to the persistent activation of its downstream sig - naling pathways, which results in uncontrolled cell prolifera - tion8.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/trd-79-248.PMC5077728.pdf
Resistance to EGFR-TKIs in lung adenocarcinoma http://dx.doi.org/10.4046/trd.2016.79.4.248  251 www.e-trd.org either E19del or L858R had a less favorable outcome com - pared with patients who have a single typical mutation.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/trd-79-248.PMC5077728.pdf
Resistance to EGFR-TKIs in lung adenocarcinoma http://dx.doi.org/10.4046/trd.2016.79.4.248  253 www.e-trd.org resistance after EGFR-TKI treatment.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/trd-79-248.PMC5077728.pdf
Resistance to EGFR-TKIs in lung adenocarcinoma http://dx.doi.org/10.4046/trd.2016.79.4.248  255 www.e-trd.org J Clin Oncol 2009;27:1394-400.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/trd-79-248.PMC5077728.pdf
"26, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.257 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:257-266",Non-OADS,/arxiv_data1/oa_pdf/ae/f4/trd-79-257.PMC5077729.pdf
Protective effects of NQO1 activation in bleomycin-induced lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.257  259 www.e-trd.org 3.,Non-OADS,/arxiv_data1/oa_pdf/ae/f4/trd-79-257.PMC5077729.pdf
Protective effects of NQO1 activation in bleomycin-induced lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.257  261 www.e-trd.org characteristics of the lung tissue treated with β-Lap alone were  similar to those of the control tissue.,Non-OADS,/arxiv_data1/oa_pdf/ae/f4/trd-79-257.PMC5077729.pdf
Protective effects of NQO1 activation in bleomycin-induced lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.257  263 www.e-trd.org not shown).,Non-OADS,/arxiv_data1/oa_pdf/ae/f4/trd-79-257.PMC5077729.pdf
"Protective effects of NQO1 activation in bleomycin-induced lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.257  265 www.e-trd.org reverses the TGF- β1–induced expression of collagen I, which  is one of the well-known ECM proteins, and inhibits EMT and  the morphological changes in A549 cells (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/ae/f4/trd-79-257.PMC5077729.pdf
"5, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.267 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:267-273",Non-OADS,/arxiv_data1/oa_pdf/2a/25/trd-79-267.PMC5077730.pdf
Gender difference in patients with cystic fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.267  269 www.e-trd.org tic regression model and the Mann-Whitney U test that have  been represented in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/25/trd-79-267.PMC5077730.pdf
Gender difference in patients with cystic fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.267  271 www.e-trd.org able difference in the age at diagnosis with respiratory symp - toms over the lifespan and males presented their illness with  delayed periods than females.,Non-OADS,/arxiv_data1/oa_pdf/2a/25/trd-79-267.PMC5077730.pdf
Gender difference in patients with cystic fibrosis http://dx.doi.org/10.4046/trd.2016.79.4.267  273 www.e-trd.org 2:S67-74.,Non-OADS,/arxiv_data1/oa_pdf/2a/25/trd-79-267.PMC5077730.pdf
"22, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.274 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:274-281",Non-OADS,/arxiv_data1/oa_pdf/1e/7d/trd-79-274.PMC5077731.pdf
Prognostic factors in limited disease small cell lung cancer http://dx.doi.org/10.4046/trd.2016.79.4.274  275 www.e-trd.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/7d/trd-79-274.PMC5077731.pdf
Prognostic factors in limited disease small cell lung cancer http://dx.doi.org/10.4046/trd.2016.79.4.274  277 www.e-trd.org system.,Non-OADS,/arxiv_data1/oa_pdf/1e/7d/trd-79-274.PMC5077731.pdf
Prognostic factors in limited disease small cell lung cancer http://dx.doi.org/10.4046/trd.2016.79.4.274  279 www.e-trd.org showed that younger patients were significantly more likely  to receive EP than EC as first-line chemotherapy and were  significantly more likely to undergo prophylactic cranial irra - diation (PCI).,Non-OADS,/arxiv_data1/oa_pdf/1e/7d/trd-79-274.PMC5077731.pdf
"Prognostic factors in limited disease small cell lung cancer http://dx.doi.org/10.4046/trd.2016.79.4.274  281 www.e-trd.org ment of limited-stage small cell lung cancer in the elderly,  chemotherapy vs. sequential chemoradiotherapy vs. concur - rent chemoradiotherapy: that’s the question.",Non-OADS,/arxiv_data1/oa_pdf/1e/7d/trd-79-274.PMC5077731.pdf
"2, 2016, Accepted:  Aug. 19, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.282 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:282-288",Non-OADS,/arxiv_data1/oa_pdf/78/09/trd-79-282.PMC5077732.pdf
"DST in a high burden of drug-resistant TB cases http://dx.doi.org/10.4046/trd.2016.79.4.282  283 www.e-trd.org Introduction Tuberculosis (TB) is a major public health problem, with 8.6  million new cases and 1.3 million deaths per year1.",Non-OADS,/arxiv_data1/oa_pdf/78/09/trd-79-282.PMC5077732.pdf
DST in a high burden of drug-resistant TB cases http://dx.doi.org/10.4046/trd.2016.79.4.282  285 www.e-trd.org without statistical significance (p=0.377).,Non-OADS,/arxiv_data1/oa_pdf/78/09/trd-79-282.PMC5077732.pdf
"DST in a high burden of drug-resistant TB cases http://dx.doi.org/10.4046/trd.2016.79.4.282  287 www.e-trd.org reduce the culture period of Mtb, liquid culture systems have  been adopted and show superior performance in reducing  the culture period compared with solid medium.",Non-OADS,/arxiv_data1/oa_pdf/78/09/trd-79-282.PMC5077732.pdf
"Address for correspondence: Kwangha Lee, M.D., Ph.D. Division of Pulmonary, Allergy and Critical Care Medicine, Department  of Internal Medicine, Pusan National University School of Medicine, 179  Gudeok-ro, Seo-gu, Busan 49241, Korea Phone:  82-51-240-7743, Fax: 82-52-245-3127 E-mail:  jubilate@pusan.ac.kr Received:  Dec. 14, 2015 Revised:  Feb. 4, 2016 Accepted:  Aug. 10, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.289 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:289-294",Non-OADS,/arxiv_data1/oa_pdf/ad/79/trd-79-289.PMC5077733.pdf
"Charlson’s comorbidity index in patients with prolonged acute mechanical ventilation http://dx.doi.org/10.4046/trd.2016.79.4.289  291 www.e-trd.org NY, USA) program.",Non-OADS,/arxiv_data1/oa_pdf/ad/79/trd-79-289.PMC5077733.pdf
"Charlson’s comorbidity index in patients with prolonged acute mechanical ventilation http://dx.doi.org/10.4046/trd.2016.79.4.289  293 www.e-trd.org Discussion The previous studies have shown that comorbid conditions  before admission appear to predict mortality in ICU patients,  and as such, comorbidity indices should be used as an impor - tant tool for predicting patient outcomes11,19-21.",Non-OADS,/arxiv_data1/oa_pdf/ad/79/trd-79-289.PMC5077733.pdf
"23, 2016 Accepted:  Aug. 9, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.4.295 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:295-301",Non-OADS,/arxiv_data1/oa_pdf/c9/7d/trd-79-295.PMC5077734.pdf
Association of sIgE to SEB with AHR http://dx.doi.org/10.4046/trd.2016.79.4.295  297 www.e-trd.org 5.,Non-OADS,/arxiv_data1/oa_pdf/c9/7d/trd-79-295.PMC5077734.pdf
"Association of sIgE to SEB with AHR http://dx.doi.org/10.4046/trd.2016.79.4.295  299 www.e-trd.org SE in patients without allergic rhinitis was 30.0%, and that in  patients with allergic rhinitis was 42.6% without statistically  significant difference (p=0.431).",OADS,/arxiv_data1/oa_pdf/c9/7d/trd-79-295.PMC5077734.pdf
"Association of sIgE to SEB with AHR http://dx.doi.org/10.4046/trd.2016.79.4.295  301 www.e-trd.org berge P , Johansson SG.",OADS,/arxiv_data1/oa_pdf/c9/7d/trd-79-295.PMC5077734.pdf
"Department of Internal Medicine, Inje University Ilsan Paik Hospital, 170  Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea Phone:  82-31-910-7992, Fax: 82-31-910-7219 E-mail:  gusrud9@paik.ac.kr Received:  Aug. 5, 2015 Revised:  Oct. 7, 2015 Accepted:  Aug. 10, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).CASE REPORThttp://dx.doi.org/10.4046/trd.2016.79.4.302 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:302-306",Non-OADS,/arxiv_data1/oa_pdf/b2/1f/trd-79-302.PMC5077735.pdf
"Pulmonary leukocytoclastic vasculitis in MDS patient http://dx.doi.org/10.4046/trd.2016.79.4.302  303 www.e-trd.org lungs, and pitting edema was observed in both legs.",Non-OADS,/arxiv_data1/oa_pdf/b2/1f/trd-79-302.PMC5077735.pdf
"Pulmonary leukocytoclastic vasculitis in MDS patient http://dx.doi.org/10.4046/trd.2016.79.4.302  305 www.e-trd.org more, karyotype was 46 XY,+1,der(1;7)(q10;q10) that can be  seen in treatment related MDS/acute myeloid leukemia.",Non-OADS,/arxiv_data1/oa_pdf/b2/1f/trd-79-302.PMC5077735.pdf
"31, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).CASE REPORThttp://dx.doi.org/10.4046/trd.2016.79.4.307 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:307-311",Non-OADS,/arxiv_data1/oa_pdf/6a/9e/trd-79-307.PMC5077736.pdf
Pulmonary strongyloidiasis in a COPD patient http://dx.doi.org/10.4046/trd.2016.79.4.307  309 www.e-trd.org tinued for 14 days.,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/trd-79-307.PMC5077736.pdf
Supplementary Material Supplementary material can be found in the journal  homepage (http://www.e-trd.org).,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/trd-79-307.PMC5077736.pdf
Pulmonary strongyloidiasis in a COPD patient http://dx.doi.org/10.4046/trd.2016.79.4.307  311 www.e-trd.org 8.,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/trd-79-307.PMC5077736.pdf
"[3] rejected theResearch Article Mycobiology 2016 September, 44(3): 121-130 http://dx.doi.org/10.5941/MYCO.2016.44.3.121 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: David.Triest@wiv-isp.be Received  March 29, 2016 Revised  June 7, 2016 Accepted  July 12, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/ee/mb-44-121.PMC5078124.pdf
Available from: http://tree.bio.ed.ac.uk/software/tracer/.,OADS,/arxiv_data1/oa_pdf/38/ee/mb-44-121.PMC5078124.pdf
"Five G. subnudus  specimensResearch Article Mycobiology 2016 September, 44(3): 131-136 http://dx.doi.org/10.5941/MYCO.2016.44.3.131 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jae-jinkim@korea.ac.kr Received  July 14, 2016 Revised  August 16, 2016 Accepted  September 5, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/bb/mb-44-131.PMC5078125.pdf
Available from: http://www.nybg.org/bsci/res/col/vestiped.,Non-OADS,/arxiv_data1/oa_pdf/21/bb/mb-44-131.PMC5078125.pdf
"To this aim, the National Institute of Biological Resources(NIBR) of Korea and the Korea National Arboretum (KNA)Research Article Mycobiology 2016 September, 44(3): 137-145 http://dx.doi.org/10.5941/MYCO.2016.44.3.137 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: ywlim@snu.ac.kr Received  August 30, 2016 Revised  September 17, 2016 Accepted  September 21, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/86/mb-44-137.PMC5078126.pdf
"An investigation of the phylogeneticResearch Article Mycobiology 2016 September, 44(3): 146-154 http://dx.doi.org/10.5941/MYCO.2016.44.3.146 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: ywlim@snu.ac.kr Received  September 6, 2016 Revised  September 17, 2016 Accepted  September 21, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/fe/mb-44-146.PMC5078127.pdf
"A recent project surveying and excavating Koreanindigenous fungi has been organized by the National Instituteof Biological Resources (NIBR, http://www.nibr.go.kr).Through this project, we discovered five new records ofwood rot fungi from Korea.",Non-OADS,/arxiv_data1/oa_pdf/d1/fe/mb-44-146.PMC5078127.pdf
This suggests that thec li m a t e  o f  J e j u  I s la n d  m a y  be  c h a n gin g  fr o m w a rm  t e m pe r a t eto subtropic (http://www.kma.go.kr/weather/) [44].,Non-OADS,/arxiv_data1/oa_pdf/d1/fe/mb-44-146.PMC5078127.pdf
Available from: http://www.kma.go.kr/ weather/climate/average_regional05.jsp.,Non-OADS,/arxiv_data1/oa_pdf/d1/fe/mb-44-146.PMC5078127.pdf
"These enzymes break down complexcarbohydrates and proteins to generate sugars and smallerpeptides that are utilized by yeasts for fermentation [4-6].Research Article Mycobiology 2016 September, 44(3): 155-161 http://dx.doi.org/10.5941/MYCO.2016.44.3.155 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: dhkim@jbnu.ac.kr Received  September 9, 2016 Revised  September 14, 2016 Accepted  September 21, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/ff/mb-44-155.PMC5078128.pdf
"After PCR, the products were purified, sequenced, and used in BLASTn searches(http://www.ncbi.nlm.nih.gov ) to confirm preliminary identification.",OADS,/arxiv_data1/oa_pdf/41/ff/mb-44-155.PMC5078128.pdf
Both ITS and CF sequences of all of the isolates upon alignment and BLASTn search(http://www.ncbi.nlm.nih.gov) revealed 99% sequencesimilarity to A. oryzae /flavus .,OADS,/arxiv_data1/oa_pdf/41/ff/mb-44-155.PMC5078128.pdf
"Moreover, adequate detectionResearch Article Mycobiology 2016 September, 44(3): 162-170 http://dx.doi.org/10.5941/MYCO.2016.44.3.162 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: Samantha.leexiii@gmail.com Received  June 7, 2016 Revised  July 6, 2016 Accepted  July 6, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/83/mb-44-162.PMC5078129.pdf
"This introduces the advantage ofResearch Article Mycobiology 2016 September, 44(3): 171-179 http://dx.doi.org/10.5941/MYCO.2016.44.3.171 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: ahmed_bondkly@yahoo.com Received  June 11, 2016 Revised  June 17, 2016 Accepted  June 25, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/1b/mb-44-171.PMC5078130.pdf
"Pruning, the use of healthy plant material, and the propagation of resistant cacao clones are so far the knownResearch Article Mycobiology 2016 September, 44(3): 180-186 http://dx.doi.org/10.5941/MYCO.2016.44.3.180 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: aderosmana65@gmail.com Received  May 4, 2016 Revised  June 7, 2016 Accepted  July 7, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/mb-44-180.PMC5078131.pdf
"The colony diameters were recorded 5 days after inoculation.Research Note Mycobiology 2016 September, 44(3): 187-190 http://dx.doi.org/10.5941/MYCO.2016.44.3.187 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: thchang@knu.ac.kr §These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/7d/48/mb-44-187.PMC5078132.pdf
"The sequences were edited with the help ofthe SeqMan program within the LASERGENE softwarepackage (DNASTAR, Madison, WI, USA) and comparedAlternaria tenuissima  sequences previously deposited in GenBank (http://www.blast.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/7d/48/mb-44-187.PMC5078132.pdf
Available from: http://nt.ars-grin.gov/fungaldatabases/.4 .,OADS,/arxiv_data1/oa_pdf/7d/48/mb-44-187.PMC5078132.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ce/11/40800_2016_Article_37.PMC5078134.pdf
http://ispub.com/ IJPM/6/2/11191 .,Non-OADS,/arxiv_data1/oa_pdf/ce/11/40800_2016_Article_37.PMC5078134.pdf
"3, 179~185, September , 201 6  <Review>   http://dx.doi.org/10.12717/DR.201 6.20.3.179  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received June 29, 2016, Received in revised form July 19, 2016, Accepted August  30, 2016   † Corresponding Author : Hyuk Song, Dept .",Non-OADS,/arxiv_data1/oa_pdf/c3/10/DR-20-179.PMC5078143.pdf
"3, 187~196, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.187  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 01, 2016, Received in revised form July 20, 2016, Accepted September  05, 2016   † Corresponding Author : Hea Ja Baek, Dept.",Non-OADS,/arxiv_data1/oa_pdf/8f/36/DR-20-187.PMC5078144.pdf
"3, 197~205, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.197  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 04, 2016, Received in revised form July 28, 2016, Accepted September  13, 2016   † Corresponding Author : Sung -Ho Lee, Dept.",Non-OADS,/arxiv_data1/oa_pdf/7f/fd/DR-20-197.PMC5078145.pdf
"3, 207~217, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.207  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 11, 2016, Received in revised form August  05, 2016, Accepted September  17, 2016   † Corresponding Author : Young -Don Lee, Marine Science Institute, Jeju National University, Jeju 63333, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c3/72/DR-20-207.PMC5078146.pdf
"3, 219~225, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.219  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 18, 2016, Received in revised form August  12, 2016, Accepted September  19, 2016   † Corresponding Author : Jeong-Ho Cha, Agaon Fertility Clinic , Seoul 08391, Korea.",Non-OADS,/arxiv_data1/oa_pdf/da/2e/DR-20-219.PMC5078147.pdf
"3, 227~235, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.227  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 22, 2016, Received in revised form August  16, 2016, Accepted September  19, 2016   † Corresponding Author : Sung Han Kim, Faculty of Applied Bioscience, Kunsan National University, Gunsan 54150, Korea .",Non-OADS,/arxiv_data1/oa_pdf/6b/15/DR-20-227.PMC5078148.pdf
"3, 237~245, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.237  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received July 25, 2016, Received in revised form August  16, 2016, Accepted September  20, 2016   † Corresponding Author : Ki-Ho Lee, Dept .",Non-OADS,/arxiv_data1/oa_pdf/0e/a4/DR-20-237.PMC5078149.pdf
"3, 255~266, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.255  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received August  03, 2016, Received in revised form August  19, 2016, Accepted September  20, 2016   † Corresponding Author : Dong Soo Kim , Institute of Marine Living Modified Organism (iMLMO), Pukyung National University, Busan 608 -737, Korea .",Non-OADS,/arxiv_data1/oa_pdf/d2/91/DR-20-255.PMC5078151.pdf
"3, 267~274, September , 201 6  <Research paper >  http://dx.doi.org/10.12717/DR.201 6.20.3.267  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received August  19, 2016, Received in revised form September  02, 2016, Accepted September  22, 2016   † Corresponding Author : Young Chang Sohn , Dept .",Non-OADS,/arxiv_data1/oa_pdf/d0/96/DR-20-267.PMC5078152.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://linkinghub.elsevier.com/retrieve/pii/S0022395615000655 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://content.wkhealth.com/linkback/ openurl?sid=WKPTLP:landingpage&an=00001574-900000000- 99440 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://content.wkhealth.com/ linkback/openurl?sid=WKPTLP:landingpage&an=00075197-201511000-00005 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Avail-able from: http://www.ncbi.nlm.nih.gov/pubmed/24849343 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/16219387 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.jneuroinﬂammation.com/content/9/1/74 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/ S0028390815301672 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/25128567 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3638389&tool= pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 23303207 .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.journals.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2521 9857 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
2015;114(04):586–95.Available from: http://www.journals.cambridge.org/abstract_ S0007114515001889 .1036 E. Sherwin et al.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcent ral.nih.gov/articler ender.fcgi?artid= 1728209&tool=pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid =4315778&tool=pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
nlm.nih.gov/pubmed/25251188 http://onlinelibrary.wiley.com/store/10.1111/nmo.12427/asset/nmo12427.pdf?v=1&t=i421p93 c&s=a1dd31adf78c572ed1b10e1428e70666629969d7 .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15849817 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/S0306452214 006277 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Avail- able from: http://linkinghub.elsevier.com/retrieve/pii/S0889 159115000896 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://www.ncbi.nlm.nih.gov/pubmed/21889518 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://www.ncbi.nlm.nih.gov/pubmed/22853653 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Mosby Inc. 2011;150(4):736–43.Available from: http://www.ncbi.nlm.nih.gov/pubmed/22000 186.,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Availablefrom: http://linkinghub.elsevier.com/retrieve/pii/S00165085100 10061 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
2015;(September).Available from: http://linkinghub.elsevier.com/retrieve/pii/ S0306452215008520 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/ S1044743115000470 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22875882 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25043484 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2814855&tool=pmcentrez&rendertype= abstract .1038 E. Sherwin et al.,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20406 665.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Avail-able from: http://linkinghub.elsevier.com/retrieve/pii/S088915 9115002342 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/ S0306453015009348 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/S08891591150 00884 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/1933 8686 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://www.ncbi.nlm.nih.gov/pubmed/25625578 .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2892549&tool=pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2012- 0900N .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Availablefrom: http://linkinghub.elsevier.com/retrieve/pii/S088915911 3005904 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/S0889159113005898 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.pubmedcentral.nih.,OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867413 014736 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from:http://linkinghub.elsevier.com/retrieve/pii/S0166432814006305 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/26031685 .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
Available from: http://linkinghub.elsevier.com/retrieve/pii/ S027273580900004X .,Non-OADS,/arxiv_data1/oa_pdf/b3/20/40263_2016_Article_370.PMC5078156.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2013/04/WC500142358.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
http://www.ema.europa.eu/docs/en_ GB/document_library/Regulatory_and_procedural_guideline/2016/04/WC500204187.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
2003. http://www.gmp-compliance.org/ guidemgr/ﬁles/EXPOSURE.PDF .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2009/09/WC500002926.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
http://www.ema.europa.eu/docs/en_ GB/document_library/Other/2010/05/WC500090218.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
J Pediatr Pharmacol Ther 2016;21:98. http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
2015. https://www.banzel.com/pdfs/BanzelPI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
2000. https://clinicaltrials.gov/ct2/show/NCT01713946 .,Non-OADS,/arxiv_data1/oa_pdf/1d/11/40263_2016_Article_383.PMC5078157.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/80/fd/40263_2016_Article_384.PMC5078162.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.006,Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
Sus- ceptibility to antibiotics was interpreted following recom- mended criteria by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for coryneform organisms (http://www.eucast.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 3–97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
aAccording to European Committee on Antimicrobial Susceptibility Testing (EUCAST) susceptibility breakpoints ( http://www.eucast.org/ ).NMNI Fernández-Natal et al.,Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 3–97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
"Using the Etest method and applying the EUCAST recom- mendations for antimicrobial susceptibility of coryneform or- ganisms ( http://www.eucast.org/ ), the two C. kroppenstedtii strains were found to be uniformly sensitive to penicillin, van- comycin, linezolid, gentamicin and rifampin.",Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 3–97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 3–97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1e/01/main.PMC5078570.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BiomarkersMass spectrometryMetabolomics Traumatic brain injury 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/6a/main.PMC5078571.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0152352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/b3/6a/main.PMC5078571.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/6a/main.PMC5078571.pdf
"Inclusion criteria were: age ≥18 years ( ≥16 years in United King- dom), clinical diagnosis of TBI and indications for acute head computed tomography according to National Institute for Health and Care Excel- lence (NICE) criteria ( http://www.nice.org.uk/guidance/cg176 ).",Non-OADS,/arxiv_data1/oa_pdf/b3/6a/main.PMC5078571.pdf
A http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b3/6a/main.PMC5078571.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/be/main.PMC5078572.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.10.001 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/be/main.PMC5078572.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gulf War Illness (GWI) MagnetoencephalographyVeteransCerebellumBrain areas 1.,Non-OADS,/arxiv_data1/oa_pdf/62/e3/main.PMC5078573.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.030 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/62/e3/main.PMC5078573.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/e3/main.PMC5078573.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/62/e3/main.PMC5078573.pdf
Res.http://dx.doi.org/10.1016/j.trsl.2016.01.007 (epub ahead of print).132 B.E.,OADS,/arxiv_data1/oa_pdf/62/e3/main.PMC5078573.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Prion Prion-seeding activitySD50Non-neural tissueCreutzfeldt-Jakob disease 1.,Non-OADS,/arxiv_data1/oa_pdf/44/de/main.PMC5078574.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.033 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/de/main.PMC5078574.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/de/main.PMC5078574.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.008,Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
FAMEs were prepared as described by Sasser ( http://www.midi- inc.com/pdf/MIS_Technote_101.pdf ).,OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8 5–92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/81/main.PMC5078575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Androgen receptorHepatocellular carcinoma Metastasis miR-367-3p 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/07/main.PMC5078576.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0132352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/7c/07/main.PMC5078576.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/07/main.PMC5078576.pdf
"4 (3), e73 (Mar 20).EBioMedicine 12 (2016) 28 –29 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.042 .",OADS,/arxiv_data1/oa_pdf/3a/dd/main.PMC5078577.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.048 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/3a/dd/main.PMC5078577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/dd/main.PMC5078577.pdf
http://dx.doi.org/10.1093/cid/cis892 .,OADS,/arxiv_data1/oa_pdf/3a/dd/main.PMC5078577.pdf
A subsequent step would be to develop a support-vectorEBioMedicine 12 (2016) 6 –7 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.036 .,Non-OADS,/arxiv_data1/oa_pdf/40/34/main.PMC5078578.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.041 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/40/34/main.PMC5078578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/34/main.PMC5078578.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/34/main.PMC5078578.pdf
Lancet http://dx.doi.org/10.1016/S0140- 6736(16)30512-8 .,OADS,/arxiv_data1/oa_pdf/40/34/main.PMC5078578.pdf
"Once this was established then the next step may be to assess whether preoperative interventions, such as physiotherapy, exercise programs, and/or medical optimisation, could improve the outcomes of the “at risk ”patient.EBioMedicine 12 (2016) 30 –31 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.039 .",Non-OADS,/arxiv_data1/oa_pdf/fe/3e/main.PMC5078580.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.002 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/main.PMC5078580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/main.PMC5078580.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Accidental fallsOutcome assessmentPatient-reported outcomes Preoperative period Postoperative periodElective surgical procedures 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0392352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
(Available: https://clinicaltrials.gov/ct2/show/NCT02032030 ) ([cited 2016 Feb 10]).,Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
"Agency for Healthcare Research and Quality (US), Rockville (MD) (Available: https://www.effectivehealthcare.ahrq.gov/ehc/products/480/1846/ preoperative-testing-report-140130.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
(Available: http://www.cdc.gov/brfss/annual_data/annual_2012.html ).,OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
Anesthe-siology http://dx.doi.org/10.1097/ALN.0000000000001217 .,Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
"The Joint Commission, United States (Available: http://www.jointcommission.org/assets/1/6/2015_NPSG_OME.",Non-OADS,/arxiv_data1/oa_pdf/ba/c4/main.PMC5078581.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Hepatocellular carcinomaNested case-controlled study Predictor TGF-β1 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/61/main.PMC5078582.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.001 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/61/main.PMC5078582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/61/main.PMC5078582.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Plasma proteinsBiobankCovariateStorage timeSampling monthProximity extension assay 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
"In order to investigate the effect of storage time in freezer, chronologicEBioMedicine 12 (2016) 309 –314 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.10.005 .",Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.038 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
Samples were analyzed for the complete ProseekMultiplex In ﬂammation panel I and 20 proteins each from the Proseek Multiplex CVD I panel and Proseek Multiplex Oncology II panels(http://www.olink.com/proseek-multiplex/ ).,OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
http://dx.doi.org/10.3109/1354750X.2015.1093546 .,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
http://dx.doi.org/10.1002/pmic.201500204 Epub 2016 Jun 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
"(Available) http://www.smhi.se 2016 Vostalova, J., Rajnochova Svobodova, A., Galandakova, A., Sianska, J., Dolezal, D., Ulrichova, J., 2013.",Non-OADS,/arxiv_data1/oa_pdf/6d/c3/main.PMC5078583.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cascade of careHepatitis CLinkage with careTestingEngagement with care Prevalence Treatment 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.035 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://www.health.gov.bc.ca/data/ .,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://www.health.gov.bc.ca/data/ .,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://www.health.gov.bc.ca/data/ .,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://www.bcstats.gov.bc.ca/StatisticsBySubject/ Demography/PopulationEstimates.aspx2015 .,Non-OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
http://apps.who.int/iris/ bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1 .195 N.Z.,OADS,/arxiv_data1/oa_pdf/7d/17/main.PMC5078584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Islet transplantationXenotransplantation Encapsulation Type 1 diabetesPERVPorcine islet 1.,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5078586.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.034 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5078586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5078586.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: GlioblastomaNew methods for integrative data analysisMesenchymal transformationPartial correlation based networksBrain tumor stem cells Annexin A2 Master regulators of cancer cell phenotypesEpigenetic regulationData integrationSpare inverse covariance selection 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0502352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
"All datasets except somatic mutations were downloaded as Level 3 (gene level) data from TCGA (The Cancer Ge-nome Atlas, http://cancergenome.nih.gov ) database.",OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
"νij=pis used for interactions 1) between miRNAs with their pre- dicted mRNA targets, as de ﬁn e db ym i R a n d a( John et al., 2004 )p r e - diction (MicroCosm Targets Version 5 ( Grifﬁths-Jones et al., 2008 ), http://www.ebi.ac.uk/enright- srv/microcosm/htdocs/targets/v5/), 2) between cislocalized methylations probes with their correspond- ing mRNA, as de ﬁned by associations between genes and methyla- tion probes provided in the TCGA level 3 data, and 3) between all interactions involving a point mutation.",Non-OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
Microarray data were analyzed using the GSEA software ( http://www.broadinstitute.org/ gsea).,OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
"All data manipulations were performed in R ( https://www.r-project.org/ ) and MATLAB (The MathWorks, Inc., Natick, MA, United States).2.14.",OADS,/arxiv_data1/oa_pdf/eb/79/main.PMC5078587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: SepsisHost response Genome-wide association study MortalityExome 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0432352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
"Next, we searched the NHGRI-EBIGWAS catalog ( https://www.ebi.ac.uk/gwas/ assessed at 07/25/2016; Welter et al., 2014 ) for all notable genes whereas pathways ( Table 4 ) were checked using http://www.genecards.org /assessed at (07/25/ 2016).",OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
chttp://www.genecards.org/ .,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
Available from: http://www.fda.gov/ Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm277143.htm .,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5078589.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Vaccine con ﬁdence Vaccine safetyAttitudesGlobal immunization Hierarchical regression 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.042 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
We require that our surveys be credited fully as Gallup Interna- tional (not Gallup or Gallup Poll).For further details see website: www.Gallup- international.com .iiwww.vaccinecon ﬁdence.org iiihttp://www.wingia.com/web/ ﬁles/richeditor/ ﬁlemanager/Methosheet_Global.pdf296 H.J.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/S0140- 6736(13)60764 –3.,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://www.cdc.gov/ media/releases/2013/t0912_measles-outbreaks-data.html (Accessed on 4 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.vaccine.,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
8 (Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4801332/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.vaccine.,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.vaccine.2014.09.007 .,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.ypmed.2009.12.001 .,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.vaccine.2010.07.043 .,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
"Outbreaks http://dx.doi.org/10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4 .Larson, H.J., Cooper, L.Z., Eskola, J., Katz, S.L., Ratzan, S., 2011.",Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
Vaccine http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/ 10.4161/21645515.2014.969618 .,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1126/science.281.5377.630 .,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1016/j.socscimed.2016.01.024 (January 2015).,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
18 (44) ( http://www.eurosurveillance.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
"http://www.hhs.gov/ sites/default/ ﬁles/nvpo/nvac/reports/nvac-vaccine-con ﬁdence-public-health-report- 2015.pdf (accessed June 23, 2016).",Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
"112, 1 –11.http://dx.doi.org/10.1016/j.socscimed.2014.04.",OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
http://dx.doi.org/10.1371/journal.pone.0146741 .,Non-OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
WHO (Retrieved from http://www.who.int/immunization/ sage/meetings/2013/april/4_survey_questionsRevised.pdf ).301 H.J.,OADS,/arxiv_data1/oa_pdf/4d/be/main.PMC5078590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/62/main.PMC5078591.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.045 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/62/main.PMC5078591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/62/main.PMC5078591.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bladder cancer Biomarker 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.036 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
Mutational data were downloaded from the Cancer Genome Atlas portal ( https://tcga-data.nci.nih.gov/tcga/ ).,OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
MutSigCV (version 1.4; https://www.broadinstitute.org/cancer/cga/ mu tsig) and used to identify genes that were mutated more often than expected by chance given the background mutation processes107 V. Dadhania et al.,Non-OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
RPPA data of 126 samples comprising of 190 pro- teins from the TCGA cohort were processed using R package in Bioconductor ( http://www.bioconductor.org ) and ANOVA analysis was used to identify proteins with the expression levels associated with molecular subtypes of bladder cancer.,OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC5078592.pdf
[http://dx.doi.org/10.1002/cncr.11105 ] [PMID: 12569593 ] [2] Kulke MH.,OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
[http://dx.doi.org/10.1016/j.hoc.2007.04.004 ] [PMID: 17548033 ] [3] Detterbeck FC.,OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1016/S0046-8177(82)80029-4 ] [PMID: 6176523 ] [5] Fan JT, Buettner H, Bartley GB, Bolling JP.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1016/S0002-9394(14)73875-9 ] [PMID: 7832228 ] [6] Harbour JW, De Potter P, Shields CL, Shields JA.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1016/S0161-6420(94)38030-4 ] [PMID: 8008351 ] [7] Perri P, Bandello F, Police G, et al.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"Bilateral Choroidal Metastases from Endobronchial Carcinoid The Open Ophthalmology Journal, 2016, Volume 10    165 [http://dx.doi.org/10.1097/00006982-199807000-00020 ] [PMID: 9730189 ] [8] Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1634/theoncologist.2008-0207 ] [PMID: 19091780 ] [9] Kabasakal L, Demirci E, Ocak M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1007/s00259-012-2123-y ] [PMID: 22526963 ] [10] Pavel M, Kidd M, Modlin I.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
[http://dx.doi.org/10.1053/j.seminoncol.2012.11.003 ] [PMID: 23391116 ] [11] Harbour JW.,OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1016/j.ajo.2004.01.009 ] [PMID: 15183811 ] [12] Kawakami S, Wakabayashi Y, Goto H. A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.2147/OPTH.S51196 ] [PMID: 24143066 ] [13] Martin AI, Horgan N. Radiolabelled somatostatin analogue treatment in a case of carcinoid tumour with choroidal metastases.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1038/eye.2012.198 ] [PMID: 23037907 ] [14] Tunc M, Wendel R, Char DH.",OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
[http://dx.doi.org/10.1016/S0002-9394(98)00053-1 ] [PMID: 9645730 ] © De Bruyn et al.,OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/TOOPHTJ-10-160.PMC5078593.pdf
"[http://dx.doi.org/10.1579/0044-7447-34.1.11 ] [PMID: 15789513 ] [3] Saarikoski S, Sillanpaa MK, Saarnio KM, Hillamo RE, Pennanen AS, Salonen RO.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1007/s11270-008-9623-1 ] [4] Wu CF, Larson TV, Wu SY, Williamson J, Westberg HH, Liu LJ.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.scitotenv.2007.07.042 ] [PMID: 17716709 ] [5] Yttri KE, Dye C, Braathen OA, Simpson D, Steinnes E. Carbonaceous aerosols in Norwegian urban areas.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.5194/acp-9-2007-2009 ] [6] Orru H, Kimmel V, Kikas U, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.scitotenv.2009.12.006 ] [PMID: 20106505 ] [7] Pettersson E, Boman C, Westerholm R, Bostrom D, Nordin A. Stove Performance and Emission Characteristics in Residential Wood Log and Pellet Combustion, Part 2: Wood Stove.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1021/ef1007787 ] [8] Kocbach Bølling A, Pagels J, Yttri KE, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1186/1743-8977-6-29 ] [PMID: 19891791 ] [9] Bølling AK, Totlandsdal AI, Sallsten G, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1186/1743-8977-9-45 ] [PMID: 23176191 ] [10] Johansson C, Norman M, Gidhagen L. Spatial & temporal variations of PM10 and particle number concentrations in urban air.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1007/s10661-006-9296-4 ] [PMID: 16983585 ] [11] Brunekreef B, Beelen R, Hoek G, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
[http://dx.doi.org/10.3846/1822-427X.2008.3.206-212 ] [13] Dockery DW.,Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/10473289.2006.10464485 ] [14] Rückerl R, Schneider A, Breitner S, Cyrys J, Peters A.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.3109/08958378.2011.593587 ] [PMID: 21864219 ] [15] Brook RD, Rajagopalan S, Pope CA III, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1161/CIR.0b013e3181dbece1 ] [PMID: 20458016 ] [16] Schwarze PE, Ovrevik J, Låg M, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1177/096032706072520 ] [PMID: 17165623 ] [17] Meister K, Johansson C, Forsberg B.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1289/ehp.1103995 ] [PMID: 22182596 ] [18] Brunekreef B, Forsberg B. Epidemiological evidence of effects of coarse airborne particles on health.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
[http://dx.doi.org/10.1183/09031936.05.00001805 ] [PMID: 16055881 ],Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1097/01.ede.0000181630.15826.7d ] [PMID: 16222161 ] [20] Krewski D, Jerrett M, Burnett RT, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/10937404.2012.632359 ] [PMID: 22202227 ] [23] Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/10590500802494538 ] [PMID: 19034792 ] [24] Pindus M, Orru H, Modig L. Close proximity to busy roads increases the prevalence and onset of cardiac disease--Results from RHINE Tartu.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.puhe.2015.07.029 ] [PMID: 26298587 ] [25] Ostro B, Tobias A, Querol X, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1289/ehp.1103618 ] [PMID: 21846610 ] [26] Laden F, Neas LM, Dockery DW, Schwartz J.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1289/ehp.00108941 ] [PMID: 11049813 ] [27] Mar TF, Ito K, Koenig JQ, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1038/sj.jea.7500465 ] [PMID: 16288316 ] [28] Ito K, Christensen WF, Eatough DJ, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1038/sj.jea.7500464 ] [PMID: 16304602 ] [29] Boman BC, Forsberg AB, Järvholm BG.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.5271/sjweh.729 ] [PMID: 12934718 ] [30] Naeher LP, Brauer M, Lipsett M, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/08958370600985875 ] [PMID: 17127644 ] [31] Tainio M, Tuomisto JT, Pekkanen J, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.atmosenv.2010.02.036 ] [32] Pierse N, Rushton L, Harris RS, Kuehni CE, Silverman M, Grigg J.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1136/thx.2004.036418 ] [PMID: 16396948 ] [33] Orru H, Maasikmets M, Lai T, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1007/s11869-010-0075-6 ] [34] Teinemaa E, Maasikmets M, Vainumäe K, Heinsoo A, Arumäe T, Lehes L. Fulfilling the requirements of Convention on Long-Range Transboundary Air Pollution (Geneva) Convention.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"Available from: http://envir.ee/sites/ default/files/genfi_aruanne_final.pdf [35] Kaasik M, Orru H, Tekkel E, Vals P. Situation and tendencies in air quality in a north European medium-sized town.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"Available from: http://www.eea.europa.eu/ publications/EMEPCORINAIR5 [37] Ng NL, Herndon SC, Trimborn A, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/02786826.2011.560211 ] [38] Canonaco F, Crippa M, Slowik JG, Baltensperger U, Prévôt AS.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
[http://dx.doi.org/10.5194/amt-6-3649-2013 ],Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1021/es048568l ] [PMID: 16053095 ] [40] Hoek G, Krishnan RM, Beelen R, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1186/1476-069X-12-43 ] [PMID: 23714370 ] [41] Willers  SM,  Eriksson  C,  Gidhagen  L,  Nilsson  ME,  Pershagen  G,  Bellander  T.  Fine  and  coarse  particulate  air  pollution  in  relation  to respiratory health in Sweden.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1183/09031936.00088212 ] [PMID: 23314898 ] [42] Laumbach RJ, Kipen HM.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.jaci.2011.11.021 ] [PMID: 22196520 ] [43] Delfino RJ, Brummel S, Wu J, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1136/oem.2008.041376 ] [PMID: 19017694 ] [44] Kunii O, Kanagawa S, Yajima I, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/00039890209602912 ] [PMID: 12071356 ] [45] Andersson M, Modig L, Hedman L, Forsberg B, Rönmark E. Heavy vehicle traffic is related to wheeze among schoolchildren: a population- based study in an area with low traffic flows.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1186/1476-069X-10-91 ] [PMID: 21995638 ] [46] von Mutius E, Illi S, Nicolai T, Martinez FD.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1111/j.1440-1843.2010.01758.x ] [PMID: 20456673 ] [49] McGowan JA, Hider RN, Chacko E, Town GI.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1111/j.1467-842X.2002.tb00266.x ] [PMID: 11895020 ] [50] Bølling AK, Pagels J, Yttri KE, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1186/1743-8977-6-29 ] [51] Barregard L, Sällsten G, Gustafson P, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/08958370600685798 ] [PMID: 16864402 ] [52] Swiston  JR,  Davidson  W,  Attridge  S,  Li  GT,  Brauer  M,  van  Eeden  SF.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1183/09031936.00097707 ] [PMID: 18256060 ] [53] Tan WC, Qiu D, Liam BL, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1164/ajrccm.161.4.9904084 ] [PMID: 10764314 ] [54] Kocbach A, Herseth JI, Låg M, Refsnes M, Schwarze PE.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.taap.2008.07.002 ] [PMID: 18674554 ] [55] Löndahl J, Pagels J, Boman C, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1080/08958370802087124 ] [PMID: 18668412 ] [56] Gustafsson M, Forsberg B, Orru H, Åström S, Tekie H, Sjöberg K. Quantification of population exposure to NO2, PM25 and PM10 and estimated health impacts in Sweden 2010.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1016/j.scitotenv.2014.12.003 ] [PMID: 25497678 ] [58] Park SK, O’Neill MS, Stunder BJ, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1038/sj.jes.7500552 ] [PMID: 17299527 ] [59] Hopke PK, Ito K, Mar T, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1038/sj.jea.7500458 ] [PMID: 16249798 ] [60] Harrison RM, Yin J.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1039/c000329h ] [PMID: 20401363 ] [61] Strak M, Hoek G, Godri KJ, et al.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1371/journal.pone.0058944 ] [PMID: 23516583 ] [62] Lough GC, Schauer JJ, Park JS, Shafer MM, Deminter JT, Weinstein JP.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1021/es048715f ] [PMID: 15757346 ] [63] Lee S, Russell AG, Baumann K. Source apportionment of fine particulate matter in the southeastern United States.",OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
[http://dx.doi.org/10.3155/1047-3289.57.9.1123 ] [PMID: 17912931 ] © Pindus et al.,OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/cc/TORMJ-10-58.PMC5078594.pdf
"[http://dx.doi.org/10.1007/s00264-008-0563-6] [PMID: 18437379] [2] Ranawat CS, Rodriguez JA.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/S0883-5403(97)90190-X] [PMID: 9195310] [3] Sathappan SS, Ginat D, Patel V, Walsh M, Jaffe WL, Di Cesare PE.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2007.01.022] [PMID: 18280413] [4] Tanaka R, Shigematsu M, Motooka T, Mawatari M, Hotokebuchi T. Factors influencing the improvement of gait ability after total hip arthroplasty.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2009.06.009] [PMID: 19646844] [5] Robb C, Harris R, O’Dwyer K, Aslam N. Radiographic assessment of biomechanical parameters following hip resurfacing and cemented total hip arthroplasty.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1007/s002640050006] [PMID: 10774857] [8] Mihalko WM, Phillips MJ, Krackow KA.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1302/0301-620X.87B11.16736] [PMID: 16260659] [10] Mason WT, Burgess B. M., Villar, R.N.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.1054/arth.2002.30775] [12] Ranawat CS.,OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2007.05.003] [PMID: 17823005] [15] Crowe JF, Sculco TP, Kahn B.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1097/01.blo.0000072469.32680.b6] [PMID: 12897608] [16] Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1302/0301-620X.94B5.27073] [PMID: 22529080] [17] Desai AS, Dramis A, Board TN.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.1007/s12178-013-9180-0] [PMID: 23900834] [18] Kurtz WB.,Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2011.02.003] [PMID: 21435822] [19] Sarin VK, Pratt WR, Bradley GW.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2004.07.001] [PMID: 16230240] [20] Mezger U, Jendrewski C, Bartels M. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.1007/s00423-013-1059-4] [21] Goradia VK.,Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1097/JSA.0000000000000047] [PMID: 25370874] [22] Mavrogenis AF, Savvidou OD, Mimidis G, et al.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.3928/01477447-20130724-10] [PMID: 23937743] [23] Manzotti A, Cerveri P, De Momi E, Pullen C, Confalonieri N. Does computer-assisted surgery benefit leg length restoration in total hip replacement?",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1007/s00264-009-0903-1] [PMID: 19904533] [24] Loughead JM, McCalden RW.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.4055/cios.2011.3.4.259] [PMID: 22162787] [26] Dong H, Buxton M. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1017/S0266462306051014] [PMID: 16571195] [27] Desai AS, Dramis A, Kendoff D, Board TN.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1007/s12178-011-9071-1] [PMID: 21475560] [28] Slover JD, Tosteson AN, Bozic KJ, Rubash HE, Malchau H. Impact of hospital volume on the economic value of computer navigation for total knee replacement.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.2106/JBJS.G.00888] [PMID: 18594098] [29] Novak EJ, Silverstein MD, Bozic KJ.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.2106/JBJS.F.01109] [PMID: 17974880] [30] Jassim SS, Benjamin-Laing H, Douglas SL, Haddad FS.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.4055/cios.2014.6.4.462] [PMID: 25436072] [31] Hampstead H. National Joint Registry; c2008-2014.,OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"Available from: http://www.njrcentre.org.uk [32] Meermans G, Malik A, Witt J, Haddad F. Preoperative radiographic assessment of limb-length discrepancy in total hip arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"Smart tool for THA The Open Orthopaedics Journal, 2016, Volume 10   499 [http://dx.doi.org/10.1007/s11999-010-1588-x] [PMID: 20878559] [33] Landis JR, Koch GG.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.2307/2529310] [PMID: 843571] [34] Altman DG, Bland J. M. Meaurement in medicine: the analysis of method comparison studies.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.2307/2987937] [35] Bland JM, Altman DG.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.1016/S0140-6736(86)90837-8] [PMID: 2868172] [36] Giavarina D. Understanding bland altman analysis.,OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.11613/BM.2015.015] [PMID: 26110027] [37] Ogawa K, Kabata T, Maeda T, Kajino Y, Tsuchiya H. Accurate leg length measurement in total hip arthroplasty: a comparison of computer navigation and a simple manual measurement device.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.4055/cios.2014.6.2.153] [PMID: 24900895] [38] Tsai TY, Li JS, Dimitriou D, Kwon YM.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.clinbiomech.2015.06.010] [PMID: 26117163] [39] Sykes A, Hill J, Orr J, et al.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1080/17453670610046280] [PMID: 16819674] [41] Maloney WJ, Keeney JA.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2004.02.018] [PMID: 15190563] [42] Woolson ST, Hartford JM, Sawyer A.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/S0883-5403(99)90119-5] [PMID: 10065720] [43] Della Valle CJ, Di Cesare PE.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.08.020] [PMID: 24290738] [45] Kalteis T, Handel M, Bäthis H, Perlick L, Tingart M, Grifka J. Imageless navigation for insertion of the acetabular component in total hip arthroplasty: is it as accurate as CT-based navigation?",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1302/0301-620X.88B2.17163] [PMID: 16434517] [46] Parratte S, Argenson JN.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.2106/JBJS.F.00529] [PMID: 17332097] [47] Parratte  S,  Argenson  JN,  Flecher  X,  Aubaniac  JM.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1016/S0035-1040(07)90245-7] [48] Sendtner E, Schuster T, Wörner M, Kalteis T, Grifka J, Renkawitz T. Accuracy of acetabular cup placement in computer-assisted, minimally- invasive THR in a lateral decubitus position.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1007/s00264-010-1042-4] [PMID: 20495801] [49] Kjellberg M, Al-Amiry B, Englund E, Sjödén GO, Sayed-Noor AS.",OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"[http://dx.doi.org/10.1007/s00256-011-1166-7] [PMID: 21491155] [50] Nam D, Sculco PK, Abdel MP, Alexiades MM, Figgie MP, Mayman DJ.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
[http://dx.doi.org/10.3928/01477447-20130327-11] [PMID: 23590775] © Grosso et al.,Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/6e/TOORTHJ-10-490.PMC5078595.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ZikaDrug discovery Replicon Flavivirus 1.,Non-OADS,/arxiv_data1/oa_pdf/84/cc/main.PMC5078599.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.013 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/cc/main.PMC5078599.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/cc/main.PMC5078599.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sjogren's syndromeXerostomiaHyposalivation Autoimmune disorders Salivary gland dysfunction 1.,Non-OADS,/arxiv_data1/oa_pdf/72/fb/main.PMC5078600.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.005 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/72/fb/main.PMC5078600.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/fb/main.PMC5078600.pdf
"The increasedEBioMedicine 12 (2016) 20 –21 DOIs of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.043 ,http:// dx.doi.org/10.1016/j.ebiom.2016.08.037 .",OADS,/arxiv_data1/oa_pdf/49/3d/main.PMC5078601.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.014 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/49/3d/main.PMC5078601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/3d/main.PMC5078601.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mesenchymal precursor cellsDiabetic nephropathyStem cellInﬂammation Glomerular ﬁltration rate 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC5078602.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.011 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC5078602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC5078602.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizophrenia MiR-137EFNB2SNPRegulation 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.012 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
"Bioinformatic Analyses TargetScan (TargetScan 6.2, http://www.targetscan.org )a n dM i r a n - da (http://www.microrna.org ) were used to predicate miR-137 and EFNB2 interaction according to the presence of binding sites in the seed region, the ef ﬁcacy of targeting and the probability of conserved targeting ( Lewis et al., 2005 ).",OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
"The human hsa-miR-137 sequences were obtained from miRBase (miRBase, http://www.mirbase.org ).",OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
"EFNB2 mRNA 3 ′-UTR sequences, the location of the single nucleotide polymorphism (SNP) rs550067317 in EFNB2 and allele frequencies were obtained from the UCSC genome browser ( http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
edu/cgi-bin/hgTracks ) and NCBI database ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
"RNA folding structures between miRNAs and targeting sequences and the minimum folding energy (MFE) were predicted by RNAhybrid ( http://bibiserv.techfak.uni-bielefeld.de/rnahybrid ) (Kruger and Rehmsmeier, 2006; Rehmsmeier et al., 2004 ).",OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
"The minor allele C is only existin Northern Han Chinese population (Beijing, CHB) and the frequency is 0.97% according to the present data base ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/e9/f2/main.PMC5078603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HIV-1Envelope glycoproteinsCD4Non-neutralizing antibodies ADCC CD4-mimetics 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/main.PMC5078604.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.004 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/main.PMC5078604.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/73/main.PMC5078604.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Helicobacter pyloriHigh-fat diet Insulin resistance Gut microbiota 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/57/main.PMC5078605.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.010 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/cd/57/main.PMC5078605.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/57/main.PMC5078605.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Aneurysm Vascular biologyTGF-βsignaling pathway EchocardiographyMouse model 1.,Non-OADS,/arxiv_data1/oa_pdf/27/cf/main.PMC5078606.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.0062352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/cf/main.PMC5078606.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/cf/main.PMC5078606.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Platelet derived growth factor receptorMetastasesPapillary thyroid cancerTTF1(Nkx2-1) 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/main.PMC5078607.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.007 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/main.PMC5078607.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/main.PMC5078607.pdf
EBioMedicineEBioMedicine 12 (2016) 1 http://dx.doi.org/10.1016/j.ebiom.2016.10.011 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/3d/e6/main.PMC5078611.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/e6/main.PMC5078611.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.003 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC5078613.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC5078613.pdf
759 –788http://dx.doi.org/10.1007/978-3-642-40384-2_34 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC5078613.pdf
"Furthermore, the authors observed mark- edly less accumulation of collagen and extracellular matrix (ECM) pro- teins than in other mouse models for aortic aneurysms.EBioMedicine 12 (2016) 26 –27 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.006 .",OADS,/arxiv_data1/oa_pdf/d4/b5/main.PMC5078614.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.033 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/d4/b5/main.PMC5078614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/b5/main.PMC5078614.pdf
"Taking advantage of the sampling strategy of the Västerbotten Intervention and Mammography screening programs innorthern Sweden ( http://epi.grants.cancer.gov/Consortia/members/ northsweden.html ) at the Umeå Biobank, this study intended to disen- tangle the effects of freezer storage time and individual age in a relative- ly homogenous cohort of subjects.",Non-OADS,/arxiv_data1/oa_pdf/4a/12/main.PMC5078615.pdf
"In fact, the chronological age at sample collection after adjustment for storage-time affected 70 proteins and explained1.1–33.5% of the variance, very similar to the effect of storage time, while the seasonal variation in specimens collected in a region with aEBioMedicine 12 (2016) 32 –33 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.038 .",OADS,/arxiv_data1/oa_pdf/4a/12/main.PMC5078615.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.0052352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/4a/12/main.PMC5078615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/12/main.PMC5078615.pdf
The authors' data suggest thatEBioMedicine 12 (2016) 12 –13 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.003 .,OADS,/arxiv_data1/oa_pdf/04/4d/main.PMC5078616.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.0322352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/4d/main.PMC5078616.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/4d/main.PMC5078616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Zika virusLineagesNeural stem cellsAstrocytes 1.,Non-OADS,/arxiv_data1/oa_pdf/71/94/main.PMC5078617.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.020 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/94/main.PMC5078617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/94/main.PMC5078617.pdf
"The resulting sequences (ZIKV AF and ZIKV AS) and a set of sequences from both Asian and African ZIKV isolates (Accession numbers: KF268950, HQ234500, KF383116, LC002520, KF383119, KF383115, KF383118, KF383117, KF993678, HQ234499, JN860885, KF258813, EU545988, KJ776791, KU955595) were submitted to the French phylogeny website (http://www.phylogeny.fr ) using the “one click version ”for analysis.",Non-OADS,/arxiv_data1/oa_pdf/71/94/main.PMC5078617.pdf
"INFORME EPIDEMIOLÓGICO No10–SEMANA EPIDEMIOLÓGICA (SE) 03/ 2016 (17 A 23/01/2016) MONITORAMENTO DOS CASOS DE MICROCEFALIA NO BRA-SIL.COES microcephalia .A v a i l a b l e a t http://www.salud.gob.ec/wp-content/uploads/ 2015/12/COES-Microcefalias-Informe-Epidemiol-gico-10-SE-03-2016-27jan2016- 12h04.pdf Accessed February 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/71/94/main.PMC5078617.pdf
These ﬁnd- ing would potentially contribute to improvement in prediction and early detection of HCC development.EBioMedicine 12 (2016) 4 –5 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.001 .,Non-OADS,/arxiv_data1/oa_pdf/a9/70/main.PMC5078618.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/70/main.PMC5078618.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/70/main.PMC5078618.pdf
"Whilst the building evidence suggests miRNAs including miR-137 have a role in the development of schizophrenia and may have some ca- pacity as biomarkers, clearly further collaborative efforts will determine how useful they are in understanding what causes schizophrenia, whether they can assist with its diagnosis and importantly, whether they provide insights on how to improve the current treatment options for the disorder.EBioMedicine 12 (2016) 10 –11 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.012 .",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/main.PMC5078619.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.004 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/e4/f3/main.PMC5078619.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/f3/main.PMC5078619.pdf
"There is al- ready evidence that APA-based microencapsulated porcine islets induce an in ﬂammatory response, upregulating in ﬂammatoryEBioMedicine 12 (2016) 22 –23 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.034 .",Non-OADS,/arxiv_data1/oa_pdf/1e/3c/main.PMC5078620.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.023 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/3c/main.PMC5078620.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/3c/main.PMC5078620.pdf
Transplantation http://dx.doi.org/10.1097/TP.0000000000001371 (In press).,Non-OADS,/arxiv_data1/oa_pdf/1e/3c/main.PMC5078620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: microRNANon-coding RNA Cancer TherapeuticsClinical trials Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/ec/07/main.PMC5078622.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.017 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/07/main.PMC5078622.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/07/main.PMC5078622.pdf
"Financial Support This work was supported by Instituto de Salud Carlos III (FIS PI14/ 00844) co- ﬁnanced by the European Regional Development Funds, “AEBioMedicine 12 (2016) 18 –19 DOIs of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.043 ,http:// dx.doi.org/10.1016/j.ebiom.2016.08.037 .",Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5078624.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.021 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5078624.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5078624.pdf
"Keywords: Bioengineering, BiotechnologyReceived: 3 August 2016 Revised: 22 September 2016 Accepted: 11 October 2016 Heliyon 2 (2016) e00179 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"Since detection does not rely upon fluorescence, there is no need Article No~e00179 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Such a system will Article No~e00179 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Probe ID Number Nucleotide sequence (5 ′→3′) Universal Probes Complementary Reporter Probes 1 /5AmMC6/ TGCGACCTCAGCATCG CGATGCTGAGGTCGCA 2 /5AmMC6/ CAGCACCTGACCATCG CGATGGTCAGGTGCTG 3 /5AmMC6/ GACCACCTTGCGATCG CGATCGCAAGGTGGTC 4 /5AmMC6/ TGCGGGTACAGCACCT AGGTGCTGTACCCGCA 5 /5AmMC6/ CAGCGGTAGACCACCT AGGTGGTCTACCGCTG 6 /5AmMC6/ GACCGGTATGCGACCT AGGTCGCATACCGGTC 7 /5AmMC6/ TGCGATCGCAGCGGTA TACCGCTGCGATCGCA 8 /5AmMC6/ CAGCATCGGACCGGTA TACCGGTCCGATGCTG 9 /5AmMC6/ GACCATCGTGCGGGTA TACCCGCACGATGGTC 10 /5AmMC6/ AGCCCTTGCACGTCTG CAGACGTGCAAGGGCT 11 /5AmMC6/ CACGCTTGGTGCTCTG CAGAGCACCAAGCGTG 12 /5AmMC6/ GTGCCTTGAGCCTCTG CAGAGGCTCAAGGCAC 13 /5AmMC6/ AGCCGATGCACGCTTG CAAGCGTGCATCGGCT 14 /5AmMC6/ CACGGATGGTGCCTTG CAAGGCACCATCCGTG 15 /5AmMC6/ GTGCGATGAGCCCTTG CAAGGGCTCATCGCAC 16 /5AmMC6/ AGCCTCTGCACGGATG CATCCGTGCAGAGGCT 17 /5AmMC6/ CACGTCTGGTGCGATG CATCGCACCAGACGTG 18 /5AmMC6/ TCCCCTGTGGACTGTC GACAGTCCACAGGGGA 19 /5AmMC6/ ACGGCTGTTCCCTGTC GACAGGGAACAGCCGT 20 /5AmMC6/ GGACTGTCACGGAGTG CACTCCGTGACAGTCC Article No~e00179 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Since the amplification of the CYP2C9 and VKORC1 targets required different master Article No~e00179 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"Two-step hybridization The integrated universal DNA microarray filters were first washed with 100 μlo f hybridization buffer (150 mM NaCl, 10 mM NaH 2PO4, 1 mM EDTA and 0.1% SDS) at 40 °C for 2 min after which the buffer was pumped out to the cartridge's Article No~e00179 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"After both hybridizations were completed, the microarray chambers were washed with 100 μl of Buffer B (75 mM NaCl, 5 mM NaH 2PO4, 0.5 mM EDTA and 0.1% SDS) at 50 °C for 5 min, followed by a second Article No~e00179 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Probe ID Number Target SNP Reporter Probe Sequence (5 ′→3′) 1 CYP2C9*2_ WT TGAGGA+C+C+GTGTTCA CGATGCTGAGGTCGCA 2 CYP2C9*2_ Mut T+GA+AC+AC+AG+TC+CT+CA CGATGGTCAGGTGCTG 3 CYP2C9*3_ WT A+GG+TC+AA+TG+TA+TC+TC CGATCGCAAGGTGGTC 4 CYP2C9*3_ Mut G+AGA+TA+CCT+TGA+CCTT AGGTGCTGTACCCGCA 7 VKORC-1_WT CATCGA+C+C+CTTGGAC TACCGCTGCGATCGCA 6 VKORC1_ Mut GT+CCA+AGA+GT+CGA+TGA AGGTCGCATACCGGTC Article No~e00179 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"4 A, B), all 20 Article No~e00179 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
The location and concentration Article No~e00179 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"Since those two reporter probes would be expected to hybridize to each other if employed simultaneously, we found that effective detection of SNPs could be achieved by first delivering the wild type reporter probes and allowing the PCR amplicons tohybridize, followed by the delivery of the mutant allele reporter probes and Article No~e00179 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"Alton, S. Hoshika, D. Hutter, N. Sharma, Z. Yang, M.J. Kim, S.A. Benner, High-thoughput Article No~e00179 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
Article No~e00179 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00179 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/2a/main.PMC5078625.pdf
"Thereby, there is considerable evidence that suggests the potential of these circulating MCFAs as biomarkers of mitochondrial dysfunction.EBioMedicine 12 (2016) 8 –9 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.015 .",Non-OADS,/arxiv_data1/oa_pdf/75/9c/main.PMC5078626.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.024 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/75/9c/main.PMC5078626.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/9c/main.PMC5078626.pdf
http://dx.doi.org/10.1007/s00216-016- 9743-1 .,Non-OADS,/arxiv_data1/oa_pdf/75/9c/main.PMC5078626.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/6d/main.PMC5078628.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.10.003 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/6d/main.PMC5078628.pdf
Available at: http://apps.who.int/iris/bitstream/10665/44440/1/ 9789241564090_eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/6d/main.PMC5078628.pdf
Available at: http://www.who.int/chagas/home_more/en/ .,Non-OADS,/arxiv_data1/oa_pdf/7a/6d/main.PMC5078628.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Staphylococcus aureusPseudomonas aeruginosappGppCationic peptide DJK-5 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/e2/main.PMC5078632.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.015 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/e2/main.PMC5078632.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/e2/main.PMC5078632.pdf
http://dx.doi.org/10.1128/JB.00017-16 .,Non-OADS,/arxiv_data1/oa_pdf/ed/e2/main.PMC5078632.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bone regeneration In vivo bioreactor In vivo tissue engineering Flap prefabricationBone graft Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/cf/7c/main.PMC5078640.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.09.016 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/cf/7c/main.PMC5078640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/7c/main.PMC5078640.pdf
Med.http://dx.doi.org/10.1002/term.2076 .,Non-OADS,/arxiv_data1/oa_pdf/cf/7c/main.PMC5078640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/main.PMC5078641.pdf
E-mail address: psnyder@lifespan.org http://dx.doi.org/10.1016/j.dadm.2016.09.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/main.PMC5078641.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/main.PMC5078641.pdf
"Inhibition of the stringent response to block abscess formation could prove to be useful, and would compare to theEBioMedicine 12 (2016) 16 –17 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.015 .",Non-OADS,/arxiv_data1/oa_pdf/cb/0e/main.PMC5078668.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.10.017 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/0e/main.PMC5078668.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/0e/main.PMC5078668.pdf
"http://dx.doi.org/10.1016/j.lrr.2016.09.002 Received 28 June 2016; Accepted 30 September 2016⁎Correspondence to: LeukaemiaLeukemia & Blood Cancer Research Unit, Department of Molecular Medicine and Pathologly, The University of Auckland, Auckland, New Zealand.",Non-OADS,/arxiv_data1/oa_pdf/c1/95/main.PMC5078675.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 14 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/c1/95/main.PMC5078675.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.005 2213-0071/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 181 e186,Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
"177 (9) (2013) 1006, http://dx.doi.org/10.1093/aje/kws342 .",Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
"305 (2013)C1080 eC1090, http://dx.doi.org/10.1152/ajpcell.00109 .",Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
[22] http://www.statista.com/statistics/241488/population-of-the-us-by-sex-and- age/.,Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
"(2010) 2010 e2023, http://dx.doi.org/10.4061/2010/458410 .",Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
"236 (4) (2015) 241 e245, http://dx.doi.org/10.1620/tjem.236.241 .",Non-OADS,/arxiv_data1/oa_pdf/dc/a8/main.PMC5078676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/61/main.PMC5078677.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.009 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/26/61/main.PMC5078677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 177 e180,Non-OADS,/arxiv_data1/oa_pdf/26/61/main.PMC5078677.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/96/main.PMC5078678.pdf
"All  histopathologic  reports  of  excised  appendixes, http://dx.doi.org/10.1016/j.ijscr.2016.10.029 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7b/96/main.PMC5078678.pdf
"http://www.who.int/schistosomiasis/en/ ,  2015 (accessed  20.03.15.).",Non-OADS,/arxiv_data1/oa_pdf/7b/96/main.PMC5078678.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/75/main.PMC5078679.pdf
She  was  a http://dx.doi.org/10.1016/j.ijscr.2016.10.026 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/75/main.PMC5078679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/5b/main.PMC5078680.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.10.001 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/5b/main.PMC5078680.pdf
http://purl.oclc.org/estimates (accessed 16.06.16.).,Non-OADS,/arxiv_data1/oa_pdf/11/5b/main.PMC5078680.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/a7/main.PMC5078681.pdf
This condition  did  not  permit  him  to  have  normal  sexual  activities  and http://dx.doi.org/10.1016/j.ijscr.2016.10.031 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/87/a7/main.PMC5078681.pdf
"183 (March  (3))  (2010)  1060–1064,  http://dx.doi.org/10.1016/j.juro.2009.11.",OADS,/arxiv_data1/oa_pdf/87/a7/main.PMC5078681.pdf
"Nrf2: the master regulator of cellular defense The transcription factor Nrf2, (encoded in humans by the NFE2L2 gene) is the master regulator of antioxidant defenses, regulating more http://dx.doi.org/10.1016/j.redox.2016.10.003 Received 17 September 2016; Received in revised form 6 October 2016; Accepted 11 October 2016⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/29/dc/main.PMC5078682.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 14 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/29/dc/main.PMC5078682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/9b/main.PMC5078694.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.013 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/9b/main.PMC5078694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 187 e189,Non-OADS,/arxiv_data1/oa_pdf/2f/9b/main.PMC5078694.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.rmcr.2016.10.013 .,Non-OADS,/arxiv_data1/oa_pdf/2f/9b/main.PMC5078694.pdf
"[6] N. Jamshed, K. Madan, M. Ekka, R. Guleria, Successful ﬂexible bronchoscopic management of a large-sized aspirated partial denture, BMJ Case Rep. 2014 (2014), http://dx.doi.org/10.1136/bcr-2013-202371 pii: bcr2013202371.",Non-OADS,/arxiv_data1/oa_pdf/2f/9b/main.PMC5078694.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/c5/atr-05-03-33405.PMC5078721.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/36/jjm-09-08-30593.PMC5078722.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/5d/atr-05-03-33664.PMC5078761.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/92/main.PMC5078784.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/ uploads/how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/77/92/main.PMC5078784.pdf
E-mail address: agross14@jhu.edu http://dx.doi.org/10.1016/j.dadm.2016.08.005 2352-8729/ /C2112016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/77/92/main.PMC5078784.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.08.005 .,OADS,/arxiv_data1/oa_pdf/77/92/main.PMC5078784.pdf
"1/28 http://ejgo.orgABSTRACT In 2015, fourteen topics were selected as major research advances in gynecologic oncology.",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"2016 Nov;27(6):e53 https://doi.org/10.3802/jgo.2016.27.e53 pISSN 2005-0380·eISSN 2005-0399 Review Article Received:  Oct 17, 2016 Accepted:  Oct 17, 2016 Correspondence to Jae-Weon Kim Department of Obstetrics and Gynecology,  Seoul National University College of Medicine,  103 Daehak-ro, Jongno-gu, Seoul 03080,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"ORCID Dong Hoon Suh http://orcid.org/0000-0002-4312-966X Miseon Kim http://orcid.org/0000-0002-5118-9275 Hak Jae Kim http://orcid.org/ 0000-0003-3602-2263 Kyung-Hun Lee http://orcid.org/0000-0002-2390-3240 Jae-Weon Kim http://orcid.org/0000-0003-1835-9436 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Dong Hoon Suh,1 Miseon Kim,1 Hak Jae Kim,2 Kyung-Hun Lee,3 Jae-Weon Kim4 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea 2Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea 3Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 4Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaMajor clinical research advances in  gynecologic cancer in 2015",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Median follow-up  2/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Because most relevant studies showed that there  3/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
4/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Using the whole-exome sequencing data for the 210 cases in a discovery cohort from the  5/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
The authors reported that there  6/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
7/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"A total of 14,215 women between the ages  of 16 and 26 were randomly assigned to receive a quadrivalent HPV (qHPV) vaccine control,  which covers four HPV types (6, 11, 16, and 18), or investigational 9vHPV vaccine, which  8/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"There  have been huge efforts to develop a non-surgical immune treatment for CIN2/3, but so  9/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"Excess cases of disseminated cancer with power morcellation  compared with abdominal surgery increased with age from 3.75/10,000 women (age 40–49),  10/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
11/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Myelosuppression and transient elevation of transaminases were the  12/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"Among 6,615 relatives of 938 probands, 347 had  13/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
High-risk  endometrial cancer is a heterogeneous group with different stages and histologic types: stage  14/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"In these node-positive patients, those who received  adjuvant therapy had better PFS (3-year PFS 39.6% vs. 25.9%; HR, 0.67; 95% CI, 0.51 to 0.88;  15/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"However, in CPB+ group compared with  16/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Immune and vascular  17/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"However, there was no significant difference of  objective response rates between the two groups (81.4% vs. 75.8%; difference 5.6%; 95% CI  18/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"There was a phase II clinical trial which demonstrated the notable clinical benefit with  tolerable side effects of the combination therapy of letrozole, an aromatase inhibitor, and  everolimus, a mammalian target of rapamycin (mTOR) inhibitor in recurrent endometrial  19/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
"At 5 years, in this  patient population, the rate of invasive disease–free survival was 93.8% (95% CI, 92.4 to 94.9),  20/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer",Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Patients were randomized to have further cavity shave  margins resected (shave group) or not to have further cavity shave margins resected (no-shave  21/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 22/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Available from: https://www.nccn.org/ professionals/physician_gls/pdf/genetics_screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
23/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 24/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 25/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Available from: https://www.nccn.org/professionals/ physician_gls/pdf/genetics_colon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
Available from: https://www.nccn.org/professionals/physician_gls/ pdf/vulvar.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 26/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 27/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
PUBMED  | CROSSREF 28/28 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e53Major clinical research advances in gynecologic cancer,Non-OADS,/arxiv_data1/oa_pdf/ee/12/jgo-27-e53.PMC5078817.pdf
1/9 http://ejgo.orgABSTRACT Objective : The aim of the study was to establish a predictive model of survival period after  bone metastasis from cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
"2016 Nov;27(6):e55 https://doi.org/10.3802/jgo.2016.27.e55 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Mar 7, 2016 Revised:  Apr 6, 2016 Accepted:  May 13, 2016 Correspondence to Yukiharu Todo Division of Gynecologic Oncology, National  Hospital Organization, Hokkaido Cancer  Center, 4-2, Kikusui, Shiroishi-Ku, Sapporo  003-0804, Japan.",Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
"ORCID Hiroko Matsumiya http://orcid.org/0000-0003-1496-214X Yukiharu Todo http://orcid.org/0000-0001-8692-4789 Kazuhira Okamoto http://orcid.org/0000-0003-3678-6669 Sho Takeshita http://orcid.org/0000-0002-5484-7309 Hiroyuki Yamazaki http://orcid.org/0000-0001-8759-9607 Katsushige Yamashiro http://orcid.org/0000-0001-6020-9496 Hidenori Kato http://orcid.org/0000-0002-2153-5843 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Hiroko Matsumiya,1 Yukiharu Todo,1 Kazuhira Okamoto,1 Sho Takeshita,1   Hiroyuki Yamazaki,2 Katsushige Yamashiro,3 Hidenori Kato1 1Division of Gynecologic Oncology, National Hospital Organization, Hokkaido Cancer Center, Sapporo,  Japan 2Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Sapporo, Japan 3Division of Pathology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, JapanA prediction model of survival for  patients with bone metastasis from  uterine cervical cancer",Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
2/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
3/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
4/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer Table 1.,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
"The following five factors were confirmed as independent  prognostic factors in a multivariate analysis: (1) extraskeletal metastasis (HR, 6.1; 95% CI, 2.2  to 16.6); (2) performance status of 3 to 4 (HR, 7.8; 95% CI, 3.3 to 18.2); (3) previous radiation  5/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer Scapula /one.LP./nine.LP% (n=/one.LP) Upper extremities/one.LP./nine.LP % (n=/one.LP) Rib/one.LP/one.LP./one.LP % (n=/six.LP) Pelvis/two.LP/nine.LP./six.LP % (n=/one.LP/six.LP) Lower extremities (Femur)/one.LP/one.LP./one.LP % (n=/six.LP)Cervical spine/one.LP/six.LP./seven.LP% (n=/nine.LP) Thoracic spine /two.LP/seven.LP./eight.LP% (n=/one.LP/five.LP) Lumbar spine/five.LP/one.LP./nine.LP% (n=/two.LP/eight.LP) Sacrum /one.LP/four.LP./eight.LP% (n=/eight.LP) Fig.",Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
6/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer Table 3.,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
These issues were caused by the fact  7/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
PUBMED  | CROSSREF 8/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
PUBMED  | CROSSREF 9/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e55Bone metastasis from uterine cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/15/f1/jgo-27-e55.PMC5078818.pdf
1/10 http://ejgo.orgABSTRACT Objective:  Infection with high-risk genotypes of human papillomavirus (HR-HPV) is the  major cause of invasive cervical cancers.,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"2016 Nov;27(6):e56 https://doi.org/10.3802/jgo.2016.27.e56 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Jan 10, 2016 Revised:  Apr 18, 2016 Accepted:  May 31, 2016 Correspondence to Ahwon Lee Department of Hospital Pathology, College of  Medicine, The Catholic University of Korea, 222  Banpo-daero, Seocho-gu, Seoul 06591, Korea.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"ORCID Yeoun Eun Sung http://orcid.org/0000-0002-9408-0085Yeoun Eun Sung,1 Eun Young Ki,2 Youn Soo Lee,1 Soo Young Hur,2 Ahwon Lee,1   Jong Sup Park2 1Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea 2Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic  University of Korea, Seoul, KoreaCan human papillomavirus (HPV)  genotyping classify non-16/18  high-risk HPV infection by risk  stratification?",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"In this study, we examined the HPV genotype distribution  and odds ratios for histologically confirmed ≥CIN 2 for each HR-HPV genotype using a  commercially available HPV DNA chip test (HPV 9G DNA chip, Biometrix Technology Inc.,  2/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification Eun Young Ki http://orcid.org/0000-0003-1189-3310 Youn Soo Lee http://orcid.org/0000-0002-1653-6315 Soo Young Hur http://orcid.org/0000-0001-6563-2293 Ahwon Lee http://orcid.org/0000-0002-2523-9531 Jong Sup Park http://orcid.org/0000-0003-4086-4885 Conflict of Interest No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"From this specimen, viral nucleic acids were extracted by using a commercial  QIAsymphony DSP Virus/Pathogen Mini Kits (QIAGEN, Venlo, the Netherlands) and were  3/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification Table 1.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
4/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
5/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification Table 2.,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"As a next step, we categorized these  12 groups of non-16/18 HR-HPV genotypes into two groups based on the odds ratios of each  6/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification Table 4.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
"In our study, the cytology test showed a higher sensitivity of 95.9% (95% CI, 91.7 to 97.0)  compared to that of the HPV 9G DNA chip test, which was 86.3% (95% CI, 82.2 to 89.8)  and the HPV 9G DNA chip test showed a higher specificity of 60.0% (95% CI, 58.5 to 61.2)  7/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification Table 6.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
8/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
PUBMED  | CROSSREF 9/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
PUBMED  | CROSSREF 10/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e56Non-16/18 high-risk HPV infection by risk stratification,Non-OADS,/arxiv_data1/oa_pdf/78/e2/jgo-27-e56.PMC5078819.pdf
1/10 http://ejgo.orgABSTRACT Objective:  To identify suitable diagnostic tools and evaluate the efficacy of sentinel lymph  node (SLN) biopsy for inguinal lymph node metastasis in vulvar cancer.,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"2016 Nov;27(6):e57 https://doi.org/10.3802/jgo.2016.27.e57 pISSN 2005-0380·eISSN 2005-0399 Original Article Revised:  May 22, 2016 Accepted:  Jun 16, 2016 Correspondence to Ken Yamaguchi Department of Gynecology and Obstetrics,  Kyoto University, 54 Kawahara-cho, Shogoin,  Sakyo-ku, Kyoto 606-8507, Japan.",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"ORCID Chieko Sakae http://orcid.org/0000-0001-9858-8049 Ken Yamaguchi http://orcid.org/0000-0002-7669-1405 Hidekatsu Nakai http://orcid.org/0000-0002-9994-2131 Yumiko Yoshioka http://orcid.org/0000-0002-4654-0585 Eiji Kondoh http://orcid.org/0000-0001-9399-1015 Junzo Hamanishi http://orcid.org/0000-0002-7750-0623 Kaoru Abiko http://orcid.org/0000-0001-9648-158X Masafumi Koshiyama http://orcid.org/0000-0003-2412-4430 Tsukasa Baba http://orcid.org/0000-0003-0066-3747Chieko Sakae,1 Ken Yamaguchi,1 Noriomi Matsumura,1 Hidekatsu Nakai,2   Yumiko Yoshioka,1 Eiji Kondoh,1 Junzo Hamanishi,1 Kaoru Abiko,1 Masafumi Koshiyama,1  Tsukasa Baba,1 Aki Kido,3 Masaki Mandai,2 Ikuo Konishi1 1Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan 2Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan 3Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University, Kyoto, JapanGroin lymph node detection and  sentinel lymph node biopsy in vulvar  cancer",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"At 18 to 20 hours before the operation, 99mTc-futin acid was  2/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer Aki Kido http://orcid.org/0000-0001-5131-2870 Conflict of Interest No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"The decision tree was generated using Weka, a publically available data mining  software ( http://www.cs.waikato.ac.nz/ml/weka/ ).",OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
3/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"Of these three patients, two died of vulvar cancer and one  4/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer Table 1.",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
5/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer Fig.,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
The seven patients whose groin node had a  6/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer Fig.,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"In 2008, the International Sentinel Lymph Node Society stated that  groin SLN biopsy performed by a skilled multidisciplinary team was feasible for well-selected  patients with SCC of the vulva, whose primary tumors had an invasion depth >1 mm, a tumor  7/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
"A  long axis >10 mm had a favorable sensitivity of 87.5% and NPV of 92.3%, suggesting that  only 7.8% of cases with a long axis of the groin node <10 mm will experience recurrence  8/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer",Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
PUBMED  | CROSSREF 9/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
PUBMED  | CROSSREF 10/10 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e57Groin lymph node detection in vulvar cancer,Non-OADS,/arxiv_data1/oa_pdf/33/ab/jgo-27-e57.PMC5078820.pdf
1/12 http://ejgo.orgABSTRACT Objective:  To investigate the role of radiotherapy (RT) in patients who underwent  hysterectomy for uterine carcinosarcoma (UCS).,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
"2016 Nov;27(6):e58 https://doi.org/10.3802/jgo.2016.27.e58 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Feb 4, 2016 Revised:  Jun 23, 2016 Accepted:  Jun 27, 2016 Correspondence to Yong Bae Kim Department of Radiation Oncology, Yonsei  Cancer Center, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
"ORCID Jihye Cha http://orcid.org/0000-0001-5926-5685 Hak Jae Kim http://orcid.org/0000-0003-3602-2263 Juree Kim http://orcid.org/0000-0002-3724-5293 Won Sup Yoon http://orcid.org/0000-0002-6098-1993 Jun Won Kim http://orcid.org/0000-0003-1358-364X Yong Bae Kim http://orcid.org/0000-0003-4884-2330 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Jihye Cha,1 Young Seok Kim,2 Won Park,3 Hak Jae Kim,4 Joo-Young Kim,5 Jin Hee  Kim,6 Juree Kim,7 Won Sup Yoon,8 Jun Won Kim,9 Yong Bae Kim10 1Department of Radiation Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea 2Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  Korea 3Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea 4Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College  of Medicine, Seoul, Korea 5Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea 6Department of Radiation Oncology, Keimyung University Dongsan Medical Center, Keimyung University  School of Medicine, Daegu, Korea 7Department of Radiation Oncology, Cheil General Hospital & Women's Healthcare Center, Dankook  University College of Medicine, Seoul, Korea 8Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine,  Ansan, Korea 9Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine,  Seoul, Korea 10Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul,  KoreaClinical significance of radiotherapy  in patients with primary uterine  carcinosarcoma: a multicenter  retrospective study (KROG 13-08)",Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
PLND and para-aortic lymph node  sampling or dissection (PALND) were performed in 181 patients (77%) and 131 patients  2/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
3/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
"Locoregional recurrence,  4/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma Table 1.",Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
5/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
6/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
7/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma Table 4.,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
8/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma Month0.6 0.4 0.2 0 84 108 120Recurrence-fee survival0.81.0 96 36 60 72 48 12 24No PLND no RT No  PLND + RT PLND no RT PLND + RT p</zero.LP./zero.LP/zero.LP/one.LPLog rank test Fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
"Furthermore, 36.4% and 22.7% of patients who received  pelvic RT previously underwent PLND and PALND, respectively; these rates were less than  half of the corresponding rates among patients who did not receive pelvic RT previously  9/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma",Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
10/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
PUBMED  | CROSSREF 11/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
PUBMED  | CROSSREF 12/12 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e58Adjuvant radiotherapy for uterine carcinosarcoma,Non-OADS,/arxiv_data1/oa_pdf/a9/87/jgo-27-e58.PMC5078821.pdf
"1/11 http://ejgo.orgABSTRACT Objective:  The aim of this analysis was to examine the management of cervix cancer in  elderly patients referred for radiotherapy and the results of treatment in terms of overall  survival (OS), relapse-free survival (RFS), and treatment-related toxicities.",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"2016 Nov;27(6):e59 https://doi.org/10.3802/jgo.2016.27.e59 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Feb 1, 2016 Revised:  Jun 18, 2016 Accepted:  Jun 27, 2016 Correspondence to Ming Yin Lin Gynae-Oncology Unit, Department of  Radiation Oncology and Cancer Imaging,  Peter MacCallum Cancer Centre, Locked  Bag 1 A’Beckett Street, Melbourne, VIC 8006,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"ORCID Ming Yin Lin http://orcid.org/0000-0003-2416-7326 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Ming Yin Lin,1 Srinivas Kondalsamy-Chennakesavan,1,2 David Bernshaw,1   Pearly Khaw,1 Kailash Narayan1,3 1Gynae-Oncology Unit, Department of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer  Centre, Melbourne, Australia 2Rural Clinical School, The University of Queensland School of Medicine, Toowoomba, Queensland, Australia 3Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, AustraliaCarcinoma of the cervix in elderly  patients treated with radiotherapy:  patterns of care and treatment  outcomes",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"Within the 4b category,  patients were eligible for this analysis provided all known disease was able to be encompassed  2/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
3/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
4/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
5/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
6/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly  Month0.50 0 12 60Relapse-free survival0.751.00 0.25 24 48 36Curative Palliative Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"In general, patient’s  7/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly  Table 5.",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"Similarly the patterns of failure, local, nodal and distant were  8/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly",Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
9/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
Available from: http://www.census.gov/population/projections/  7.,OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
PUBMED  | CROSSREF 10/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
Available from: http://life-span.healthgrove.com/l/83/82  29.,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
PUBMED  | CROSSREF 11/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e59Radiotherapy for Carcinoma of the Cervix in the Elderly,Non-OADS,/arxiv_data1/oa_pdf/04/d2/jgo-27-e59.PMC5078822.pdf
"1/11 http://ejgo.orgABSTRACT Objective:  To create a comprehensive algorithmic approach to reconstruction after vulvar  cancer ablative surgery, which includes both traditional and perforator flaps, evaluating  anatomical subunits and shape of the defect.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"2016 Nov;27(6):e60 https://doi.org/10.3802/jgo.2016.27.e60 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Mar 15, 2016 Revised:  May 13, 2016 Accepted:  Jun 27, 2016 Correspondence to Stefano Gentileschi Department of Plastic and Reconstructive  Surgery, Catholic University Sacred Heart,  Largo Agostino Gemelli 8, Roma 00168, Italy.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"ORCID Stefano Gentileschi http://orcid.org/0000-0001-9682-4706 Maria Servillo http://orcid.org/0000-0002-0228-9114 Giorgia Garganese http://orcid.org/0000-0002-4147-3491 Simona Fragomeni http://orcid.org/0000-0002-9062-8197 Francesca De Bonis http://orcid.org/0000-0002-7109-7482 Giovanni Scambia http://orcid.org/0000-0001-5911-8255 Marzia Salgarello http://orcid.org/0000-0003-2893-8562 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Stefano Gentileschi,1 Maria Servillo,1 Giorgia Garganese,2 Simona Fragomeni,2  Francesca De Bonis,1 Giovanni Scambia,2 Marzia Salgarello1 1Department of Plastic and Reconstructive Surgery, Fondazione Policlinico Gemelli, Rome, Italy 2Department of Gynecology, Fondazione Policlinico Gemelli, Rome, ItalySurgical therapy of vulvar cancer: how  to choose the correct reconstruction?",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"After surgery, all patients were placed  2/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"Another would be in the case of an asymmetrical defect on the contralateral  side which doesn’t necessarily require a contralateral flap, but direct closure would distort  3/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
4/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"If posterior perineal  defect is not wide, and is asymmetric, so that it allows the reconstruction of the smaller side  with a local flap and one of the groins can be repaired by direct closure, we usually perform  5/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm Fig.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
6/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
This increased mobility is at times such that it is possible to  7/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
8/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"In conclusion, when approaching reconstruction after vulvar cancer ablative surgery we  believe that not only the dimension, but mainly the geometry of the defect and the subunits  9/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm Fig.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
PUBMED 10/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
PUBMED  | CROSSREF 11/11 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e60Postoncologic vulvar reconstruction: an algorithm,Non-OADS,/arxiv_data1/oa_pdf/d2/f8/jgo-27-e60.PMC5078823.pdf
"1/2 http://ejgo.orgTo the editor: Currently, in the aspect of drug repositioning, metformin which is the first line drug of  choice for type 2 diabetes mellitus (T2DM) has been considered as a kind of therapeutic drug  for gynecologic cancers based on its antitumor effects [ 1].",Non-OADS,/arxiv_data1/oa_pdf/44/be/jgo-27-e61.PMC5078824.pdf
"2016 Nov;27(6):e61 https://doi.org/10.3802/jgo.2016.27.e61 pISSN 2005-0380·eISSN 2005-0399 Correspondence Received:  Jun 6, 2016 Accepted:  Jul 19, 2016 Correspondence to Jee Young Hwang Department of Obstetrics and Gynecology,  Dongguk University School of Medicine, 123  Dongdae-ro, Gyeongju 38066, Korea.",Non-OADS,/arxiv_data1/oa_pdf/44/be/jgo-27-e61.PMC5078824.pdf
"ORCID Jee Young Hwang http://orcid.org/0000-0003-1491-8413 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Jee Young Hwang  Department of Obstetrics and Gynecology, Dongguk University School of Medicine, Gyeongju, KoreaProtective and therapeutic effects of  metformin on gynecologic cancers",Non-OADS,/arxiv_data1/oa_pdf/44/be/jgo-27-e61.PMC5078824.pdf
PUBMED  | CROSSREF 2/2 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e61Effect of metformin on gynecologic cancers,Non-OADS,/arxiv_data1/oa_pdf/44/be/jgo-27-e61.PMC5078824.pdf
1/9 http://ejgo.orgABSTRACT Objective:  Distal pancreatectomy with splenectomy may be required for optimal  cytoreductive surgery in patients with epithelial ovarian cancer (EOC) metastasized to  splenic hilum.,Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"2016 Nov;27(6):e62 https://doi.org/10.3802/jgo.2016.27.e62 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Mar 24, 2016 Revised:  Jun 23, 2016 Accepted:  Jul 19, 2016 Correspondence to Huijuan Yang Department of Gynecological Oncology,  Fudan University Shanghai Cancer Center and  Department of Oncology, Shanghai Medical  College, Fudan University, Shanghai 200032,  China.",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"ORCID Yunxia Tu http://orcid.org/0000-0001-9672-2267 Tiancong He http://orcid.org/0000-0002-5736-3617Libing Xiang,1,2,* Yunxia Tu,3,* Tiancong He,1,2 Xuxia Shen,2,4 Ziting Li,1,2   Xiaohua Wu,1,2 Huijuan Yang1,2 1 Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Fudan University,  Shanghai, China 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China 3Department of Oncology, Maternal and Child Health Hospital of Jiangxi Province, Nanchang, China 4Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, ChinaDistal pancreatectomy with  splenectomy for the management  of splenic hilum metastasis in  cytoreductive surgery of epithelial  ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
The major pancreatic duct  2/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer Xuxia Shen http://orcid.org/0000-0003-2302-7188 Ziting Li http://orcid.org/0000-0003-2993-7369 Xiaohua Wu http://orcid.org/0000-0002-6889-3541 Huijuan Yang http://orcid.org/0000-0003-4569-6454 Conflict of Interest No potential conflict of interest relevant to this  article was reported.,Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"These patients underwent extensive upper-abdominal, middle-abdominal, lower-abdominal,  3/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
4/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"Pancreatic fistula occurred in four patients (22.2%): three of the patients had  grade A pancreatic fistulas with transient biochemical evidence and no clinical symptoms,  5/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer Table 1.",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"However, optimal cytoreduction rates during upfront surgeries vary among  6/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer Table 3.",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"All the patients  with pancreatic fistula in the current study recovered after conservative treatment; these  treatments included prolonged drainage, late recovery of oral intake and total parenteral  7/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer A Month Month0.6 0.4 0.2 0 12 24 36 48 60 72 0 12 24 36 48 60 72Progression-free survival0.81.0 0.6 0.4 0.20.81.0BOverall survival Fig.",Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
PUBMED  | CROSSREF 8/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
PUBMED  | CROSSREF 9/9 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e62Distal pancreatectomy in advanced ovarian cancer,Non-OADS,/arxiv_data1/oa_pdf/45/2e/jgo-27-e62.PMC5078825.pdf
"1/8 http://ejgo.orgOn June 18, 2016, the 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean  Gynecologic Oncology Group (KGOG) Joint Meeting was held in Zhongshan Hospital, Fudan  University, Shanghai, China.",Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
"2016 Nov;27(6):e64 https://doi.org/10.3802/jgo.2016.27.e64 pISSN 2005-0380·eISSN 2005-0399 Meeting Report Received:  Aug 8, 2016 Accepted:  Aug 8, 2016 Correspondence to Rongyu Zang Department of Obstetrics and Gynecology,  Zhongshan Hospital, Fudan University,  Shanghai 200032, China.",Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
"ORCID Ha Kyun Chang http://orcid.org/0000-0003-3138-1697 Byoung-Gie Kim http://orcid.org/0000-0002-0572-8450 Ting-Yan Shi http://orcid.org/0000-0002-5356-0365 Rongyu Zang http://orcid.org/0000-0002-1334-2398 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Ha Kyun Chang,1 Byoung-Gie Kim,2 Ting-Yan Shi,3 Rongyu Zang3 1 Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic  University of Korea, Seoul, Korea 2 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea 3Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, ChinaThe 5th Shanghai Gynecologic  Oncology Group (SGOG)-Korean  Gynecologic Oncology Group (KGOG)  joint meeting and 2016 Asia-Pacific  Ovarian cancer Laparotomy and  Laparoscopic Operation (APOLLO)  symposium in Shanghai",Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
2/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
"Recently,  two randomized controlled trials, the European Organisation for Research and Treatment  of Cancer (EORTC) 55971 and Chemotherapy or Upfront surgery (CHORUS) studies, have  3/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report Table 2.",Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
4/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
5/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report,Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
"APOLLO means exploration of novel and precise surgical treatment for ovarian cancer, translational  6/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report Fig.",Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
7/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report,Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
8/8 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e642016 Shanghai Meeting report,Non-OADS,/arxiv_data1/oa_pdf/a7/fa/jgo-27-e64.PMC5078826.pdf
"1/4 http://ejgo.orgABSTRACT Between the years of 2010-2012, it was estimated there were a total of 112,392 new cases of  cancers in Thailand, thus, the total age-standardized rate (ASR) per 100,000 is 137.6.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
"2016 Nov;27(6):e65 https://doi.org/10.3802/jgo.2016.27.e65 pISSN 2005-0380·eISSN 2005-0399 Expert Report Received:  Sep 5, 2016 Revised:  Oct 3, 2016 Accepted:  Oct 3, 2016 Correspondence to Sarikapan Wilailak Department of Obstetrics and Gynecology,  Faculty of Medicine, Ramathibodi Hospital,  Mahidol University, 270 Rama VI Road,  Ratchatewi, Bangkok 10400, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
"ORCID Sarikapan Wilailak http://orcid.org/0000-0001-7288-494X   Nuttapong Lertchaipattanakul http://orcid.org/0000-0002-7213-6885 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Sarikapan Wilailak,1 Nuttapong Lertchaipattanakul2 1 Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University,  Bangkok, Thailand 2 Department of Academics and Culture, Faculty of Medicine, Ramathibodi Hospital, Mahidol University,  Bangkok, ThailandThe epidemiologic status of  gynecologic cancer in Thailand",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
"Once after the age of 75, the incidence rate started  2/4 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e65Epidemiology of gynecologic cancer in Thailand A BCancer typeMale Age standardized rates (World)0 510 20 30 35 15 25 40/three.LP/three.LP./nine.LP /two.LP/two.LP./seven.LP /one.LP/four.LP./four.LP /seven.LP./one.LP /six.LP./two.LP /five.LP./two.LP /five.LP./one.LP /four.LP./two.LP /three.LP./nine.LP /three.LP./six.LPLiver and bile duct Trachea, bronchus and lung Colon and rectum Prostate Non-Hodgkin lymphoma Leukemia Oral cavity Bladder Esophagus Stomach Cancer typeFemale Age standardized rates (World)0 510 20 30 35 15 25 40/two.LP/eight.LP./five.LP /one.LP/four.LP./four.LP /one.LP/two.LP./nine.LP /one.LP/one.LP./two.LP /one.LP/zero.LP./one.LP /six.LP /five.LP./one.LP /four.LP./five.LP /four.LP./three.LP /four.LPBreast Cervix uteri Liver and bile duct Colon and rectum Trachea, bronchus and lung Ovary Thyroid Non-Hodgkin lymphoma Corpus uteri Leukemia Fig.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
"Currently, there are some cancer screening program that has been integrated  3/4 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e65Epidemiology of gynecologic cancer in Thailand",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
PUBMED  | CROSSREF 4/4 http://ejgo.org https://doi.org/10.3802/jgo.2016.27.e65Epidemiology of gynecologic cancer in Thailand,Non-OADS,/arxiv_data1/oa_pdf/2c/b9/jgo-27-e65.PMC5078827.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/c0/atr-05-03-33051.PMC5078833.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/2e/atr-05-03-32933.PMC5078834.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 OPEN Genome-wide analysis of over 106 000 individuals identi ﬁes 9 neuroticism-associated loci DJ Smith, V Escott-Price, G Davies, MES Bailey, L Colodro-Conde, J Ward, A Vedernikov, R Marioni, B Cullen, D Lyall, SP Hagenaars, DCM Liewald, M Luciano, CR Gale, SJ Ritchie, C Hayward, B Nicholl, B Bulik-Sullivan, M Adams, B Couvy-Duchesne, N Graham, D Mackay, J Evans, BH Smith, DJ Porteous, SE Medland, NG Martin, P Holmans, AM McIntosh, JP Pell, IJ Deary and MC O'Donovan Molecular Psychiatry (2016) 21,1643 –1644; doi:10.1038/mp.2016.177; published online 13 September 2016 Table 2A.",Non-OADS,/arxiv_data1/oa_pdf/ca/3f/41380_2016_Article_BFmp2016128.PMC5078851.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Metformin for antipsychotic-induced dyslipidemia R-R Wu et al 1544 Molecular Psychiatry (2016), 1537 –1544",Non-OADS,/arxiv_data1/oa_pdf/76/3c/mp2015221a.PMC5078852.pdf
"(1) Expert hippocampal manual tracing was performed using our previous published protocol;63,64 (2) Functional MRI of the brain (FMRIB) ’s Integrated Registration and Segmentation Tool (FIRST v5.0.0 http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FIRST) inFMRIB ’s Software Library (FSL, v5.0, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) was used to measure hippocampal volume and morphometry; (3) thelongitudinal pipeline in FreeSurfer (v5.1.0, http://freesurfer.net) was applied to measure the longitudinal training effect on cortical thickness on a vertex basis.",Non-OADS,/arxiv_data1/oa_pdf/3d/82/mp201619a.PMC5078857.pdf
"Glm_ ﬂex, a postprocessing package based on SPM (http://nmr.mgh.harvard.edu/harvardagingbrain/People/AaronSchultz/Aarons_Scripts.html), was used to perform this model.Whole-brain cluster-level false discovery rate (FDR) correction issued with an initial threshold at P uncorrected o0.001 and cluster size k4100.",OADS,/arxiv_data1/oa_pdf/3d/82/mp201619a.PMC5078857.pdf
2008; http://health.gov/paguidelines/guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/3d/82/mp201619a.PMC5078857.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Physical and cognitive training-induced brain mechanisms C Suo et al 1642 Molecular Psychiatry (2016), 1633 –1642",Non-OADS,/arxiv_data1/oa_pdf/3d/82/mp201619a.PMC5078857.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Misassembly of full-length DISC1 SV Trossbach et al 1572 Molecular Psychiatry (2016), 1561 –1572",Non-OADS,/arxiv_data1/oa_pdf/51/18/mp2015194a.PMC5078859.pdf
"The array results are listed on the website http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc = GSE76280, and the gene expression omnibus acces-sion number is GSE76280.",OADS,/arxiv_data1/oa_pdf/96/d3/onc201690a.PMC5078861.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Downregulated miR-506 expression promotes PDAC JL iet al 5514 Oncogene (2016) 5501 –5514 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/96/d3/onc201690a.PMC5078861.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/b9/atr-05-03-32985.PMC5078874.pdf
doi: http://dx.doi.org/10.1016/S1008-1275(08)60002-4.,OADS,/arxiv_data1/oa_pdf/c0/b9/atr-05-03-32985.PMC5078874.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/ 6/e003191.full J Am Heart Assoc.,Non-OADS,/arxiv_data1/oa_pdf/55/c4/JAH3-5-e002102.PMC5078999.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/6/ e002839.full J Am Heart Assoc.,Non-OADS,/arxiv_data1/oa_pdf/47/3a/JAH3-5-e002114.PMC5079000.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/6/e002 846.full J Am Heart Assoc.,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/JAH3-5-e002120.PMC5079001.pdf
"Accompanying Tables S1 through S6 and Figures S1 through S20 are available at http://jaha.ahajournals.org/content/5/9/e002495/DC1/embed/ inline-supplementary-material-1.pdf Correspondence to: Peter Scarborough, BSc, PhD, The BHF Center on Population Health, Old Road Campus, Roosevelt Drive, Headington, Oxford OX3 7LF, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/75/cb/JAH3-5-e002495.PMC5079002.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/75/cb/JAH3-5-e002495.PMC5079002.pdf
Available at: http://scienceblog.cancerresearchuk.org/ 2012/08/15/is-being-inactive-really-as-bad-as-smoking/.,Non-OADS,/arxiv_data1/oa_pdf/75/cb/JAH3-5-e002495.PMC5079002.pdf
"Accompanying Datas S1 through S4 are available at http://jaha.ahajournals.org/ content/5/9/e003058/ DC1/embed/inline-supplementary-materi al-1.pdf Correspondence to: Ashkan Afshin, MD, MPH, MSc, ScD, 2301 5th Avenue, Suite 600, Seattle, WA 98121.",Non-OADS,/arxiv_data1/oa_pdf/dd/5c/JAH3-5-e003058.PMC5079005.pdf
"Accompanying Tables S1 and S2 and Figures S1 through S3 are available at http://jaha.ahajournals.org/content/5/9/e003262/DC1/embed/inline- supplementary-material-1.pdf Correspondence to: Amanda L. Thompson, PhD, MPH, 137 East Franklin St., CB#8120, Chapel Hill, NC 27515.",Non-OADS,/arxiv_data1/oa_pdf/48/64/JAH3-5-e003262.PMC5079008.pdf
Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/a2/87/JAH3-5-e003289.PMC5079009.pdf
"Accompanying Tables S1, S2 and Figures S1 through S4 are available at http://jaha.ahajournals.org/content/5/9/e003375/DC1/embed/inline-supplementary-material-1.pdf *Dr Cheng, Dr Lin, and Dr Ji contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/d5/ff/JAH3-5-e003375.PMC5079012.pdf
Conclusions- —Alirocumab 150 mg Q4W can be considered in patients not on statin with inadequately controlled hypercholes- terolemia as a convenient option for lowering LDL-C. Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/5a/05/JAH3-5-e003421.PMC5079013.pdf
"*An accompanying Appendix S1 which contains complete list of the ODYSSEY CHOICE II investigators, Tables S1 through S6 and Figures S1 through S4 are available at http://jaha.ahajournals.org/content/5/9/e003421/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Erik Stroes, MD, PhD, Department of Vascular Medicine, F4.211, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/5a/05/JAH3-5-e003421.PMC5079013.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/98/cd/JAH3-5-e003493.PMC5079016.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/9/e003503/DC1/embed/inline-supplementary-material- 1.pdf Correspondence to: Timothy W. Hegeman, DO, MS, Vanderbilt University Medical Center, 383 Preston Research Building, 2220 Pierce Ave, Nashville,TN 37232.",Non-OADS,/arxiv_data1/oa_pdf/39/55/JAH3-5-e003503.PMC5079017.pdf
Available at: http://www.medpac.gov/docs/default-source/reports/jun13_ entirereport.pdf?sfvrsn=0.,OADS,/arxiv_data1/oa_pdf/39/55/JAH3-5-e003503.PMC5079017.pdf
Available at: https://www.hcup-us.ahrq.gov/toolssoft- ware/ccs/CCSUsersGuide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/14/JAH3-5-e003544.PMC5079019.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/5e/8a/JAH3-5-e003557.PMC5079020.pdf
"An accompanying Figure S1 is available at http://jaha.ahajournals.org/content/5/9/e003570/DC1/embed/inline-supplementary-material-1.pd f Correspondence to: Tomas G. Neilan, MD, MPH, Division of Cardiology, Department of Medicine, Cardiac MR PET CT Program, Department of Radiology, Massachusetts General Hospital, 165 Cambridge St, Boston, MA 02114.",Non-OADS,/arxiv_data1/oa_pdf/54/c1/JAH3-5-e003570.PMC5079022.pdf
Available at: http://meps.ahrq.gov/ mepsweb/about_meps/survey_back.jsp.,OADS,/arxiv_data1/oa_pdf/f2/12/JAH3-5-e003614.PMC5079024.pdf
Available at: http://www.hhs.gov/ohrp/regulations-and- policy/decision-trees/#c2.,Non-OADS,/arxiv_data1/oa_pdf/f2/12/JAH3-5-e003614.PMC5079024.pdf
Available at: https://meps.ahrq.gov/survey_comp/ hc_ques_glossary.shtml.,OADS,/arxiv_data1/oa_pdf/f2/12/JAH3-5-e003614.PMC5079024.pdf
"Accompanying Tables S1 through S5 are available at http://jaha.ahajour- nals.org/content/5/9/e003680/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Isuru Ranasinghe, MBChB, MMed, PhD, Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, 28 Woodville Road, Woodville South, Adelaide, South Australia 5011, Australia.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/JAH3-5-e003680.PMC5079029.pdf
Available at: http://www.aha- dataviewer.com/about/hospital-database/.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/JAH3-5-e003680.PMC5079029.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/9/e003698/DC1/embed/inline-supplementary-mate-rial-1.pdf Correspondence to: Philip Wenzel, MD, Center for Cardiology and CTH Professorship “Vascular In ﬂammation ”, University Medical Center Mainz, Langenbeckstr 1, 55131 Mainz, Germany.",Non-OADS,/arxiv_data1/oa_pdf/51/ee/JAH3-5-e003698.PMC5079031.pdf
"Accompanying Datas S1, S2 and Figures S1 through S6 are available at http://jaha.ahajournals.org/content/5/9/e003733/DC1/embed/inline- supplementary-material-1.pdf This article was handled by Christopher M. Kramer, MD, as a guest editor.",Non-OADS,/arxiv_data1/oa_pdf/22/18/JAH3-5-e003733.PMC5079032.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajournals.org/content/5/9/e003738/DC1/embed/inline-supplementary-mater ial-1.pdf *A complete list of the SESSA Research Group members can be found in the Appendix at the end of the article.Correspondence to: Takashi Hisamatsu, MD, PhD, Department of Environmental Medicine and Public Health, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan.",Non-OADS,/arxiv_data1/oa_pdf/74/9e/JAH3-5-e003738.PMC5079033.pdf
"”This global rating re ﬂects subjective and objective perceptions of mental and physical disease burden25and is shaped by individual and social characteristics.26,27We chose this item because of its importance in population health surveillance28(http://www.cdc.gov/hrqol/overview.htm) and because it complements other assessments, such as the medical history and laboratory tests.2This single-item assessment has comparable predictive validity for mortality irrespective of wording and when compared to more-complex multi-item assessments.6,29We did not evaluate change in health status over the last year or subjective health questionsthat were not assessed across both survey cycles.",Non-OADS,/arxiv_data1/oa_pdf/d1/d5/JAH3-5-e003741.PMC5079034.pdf
"Accompanying Tables S1, S2 and Figures S1 through S3 are available at http://jaha.ahajournals.org/content/5/9/e003755/DC1/embed/inline-supp lementary- material-1.pdf Correspondence to: Miguel A.",Non-OADS,/arxiv_data1/oa_pdf/40/47/JAH3-5-e003755.PMC5079035.pdf
"Accompanying Data S1, Table S1, and Figures S1 through S7 are available at http://jaha.ahajournals.org/content/5/9/e003774/DC1/embed/inline-supplementary-material-1.pdf *Dr Hurt, Dr Lu and Dr Stary contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/e8/82/JAH3-5-e003774.PMC5079036.pdf
Accompanying ﬁgures S1 to S3 are available at http://jaha.ahajour- nals.org/content/5/9/e003820/DC1/embed/inline-supplementary-mate- rial-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/45/JAH3-5-e003820.PMC5079037.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/d0/4e/JAH3-5-e003891.PMC5079040.pdf
"This kit covers endogenous metabolites playing pleiotropic roles in bioenergetics metabolism, cell signaling, and cell structures and previously involved in numerous diseases including cardiovascular ones.22,23 This kit was used in combination with a QTRAP 5500 (AB SCIEX, Toronto, Canada) mass spectrometer, enabling the quanti ﬁcation of up to 188 different endogenous molecules, including acylcarnitines, amino acids, biogenic amines, glyc- erophospholipids, sphingolipids, and sugars (http://www.biocrates.com/products/research-products/absolute- idq-p180-kit).",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/JAH3-5-e003891.PMC5079040.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/content/5/9/e003946/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Amit N. Vora, MD, MPH, 2400 Pratt St, Durham, NC 27705.",Non-OADS,/arxiv_data1/oa_pdf/f0/40/JAH3-5-e003946.PMC5079042.pdf
"In-hospital data collection used standardized de ﬁni- tions created by the National Cardiovascular Data Registry, acollection of quality-improvement registries involving over 2000 hospitals in the United States (http://cvquality.acc.org/ NCDR-Home.aspx).",OADS,/arxiv_data1/oa_pdf/f0/40/JAH3-5-e003946.PMC5079042.pdf
26We de ﬁned studies with a NOS score ≥6 stars as moderate to high quality and studies with a NOS score <6 stars as low quality.Statistical Analyses All statistical analyses were performed using Review Manager (RevMan) version 5.30 software (Nordic Cochrane Center; http://ims.cochrane.org/revman).,OADS,/arxiv_data1/oa_pdf/fb/ff/JAH3-5-e004006.PMC5079045.pdf
Available at: http://www.ohri.ca/pro-grams/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/fb/ff/JAH3-5-e004006.PMC5079045.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/con- tent/5/9/e004026/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Lucas Ramirez, MD, 1100 N State St, CT A4E #117, Los Angeles, CA 90033.",Non-OADS,/arxiv_data1/oa_pdf/47/59/JAH3-5-e004026.PMC5079046.pdf
We followed the HCUP guideline for the data analysis (https://www.hcup-us.ahrq.gov/tech_assist/tutorials.jsp).,Non-OADS,/arxiv_data1/oa_pdf/47/59/JAH3-5-e004026.PMC5079046.pdf
"Reprinted from HCUP NIS Description of Data Elements , in Healthcare Cost and Utilization Project (HCUP) ,  Retrieved August 26, 2016 , from  https://www.hcup -us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp.",OADS,/arxiv_data1/oa_pdf/47/59/JAH3-5-e004026.PMC5079046.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/9/e004031/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Dongqi Tang, MD, PhD, Center for Gene Therapy and Immunotherapy, The Second Hospital of Shandong University, 247 BeiyuanStreet, Jinan 250012, China.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/JAH3-5-e004031.PMC5079047.pdf
Clinical Trial Registration- —URL: https://www.chictr.org.,Non-OADS,/arxiv_data1/oa_pdf/ea/d8/JAH3-5-e004132.PMC5079052.pdf
Accompanying Tables S1 through S5 are available at http://jaha.ahajournals.org/content/5/9/e004132/DC1/embed/inline-supplementary-mater ial-1.pdf *Dr Liu and Dr Cui contributed equally to this work and share ﬁrst authorship.,Non-OADS,/arxiv_data1/oa_pdf/ea/d8/JAH3-5-e004132.PMC5079052.pdf
"Accompanying Tables S1 through S5 and Figures S1 through S5 are available at http://jaha.ahajournals.org/content/5/9/e004137/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Kasper Adelborg, MD, Department of Clinical Epidemi- ology, Aarhus University Hospital, Skejby, Olof Palmes All /C19e 43-45, DK-8200 Aarhus N, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/JAH3-5-e004137.PMC5079053.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/2d/atr-05-03-33595.PMC5079064.pdf
Available from: http://www.ilo.org/global/topics/ safety-and-health-at-work/lang--en/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/c7/2d/atr-05-03-33595.PMC5079064.pdf
Available	 from:	 http://www.hhs.gov/ ohrp/compliance-and-reporting/determination-letters/2013.,OADS,/arxiv_data1/oa_pdf/35/76/PCR-7-149.PMC5079085.pdf
Available	 from:	http://www.who.int/ethics/ publications/9789241502948/en/.,Non-OADS,/arxiv_data1/oa_pdf/35/76/PCR-7-149.PMC5079085.pdf
Available	 from:	http://www.hhs.gov/ohrp/ education-and-outreach/index.html#.,Non-OADS,/arxiv_data1/oa_pdf/35/76/PCR-7-149.PMC5079085.pdf
Available	 from:	http://www.rallyformedicalresearch.org/pages/ rally.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/PCR-7-152.PMC5079086.pdf
Available	 from:	http://www.rallyformedicalresearch.org/Pages/ default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/PCR-7-152.PMC5079086.pdf
Available	 from:	http://www.cdsco.nic.in/writereaddata/GSR%20 53(E).pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/PCR-7-152.PMC5079086.pdf
Available	 from:	http://www.fdanews.com/articles/157735-u-s-nih- halts-clinical-trials-in-india	 -cites-uncertainty-over-compensation-rules?v=preview.,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/PCR-7-152.PMC5079086.pdf
Available	 from:	 http://www.cognizant.com/ InsightsWhitepapers/real-world-evidence-a-better-life 	 journey- for-pharmas -payers-and-patients -codex1259.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.healtheconomics.com/white-papers/ real-world-data-sources-and-applications/.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.cprd.com/home.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.thin-uk.com.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	 http://www.healtheconomics.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.archivepharma.financialexpress.com/ sections/management/4307-need-for-heor-in-india-an-overview.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.ec.europa.eu/health/files/committee/ stamp/2016-03_stamp4/4_real_world_evidence_ema_presentation.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	 http://www.quintiles.com/blog/achieving-hta- success-with-real-world-evidence.,Non-OADS,/arxiv_data1/oa_pdf/dd/ed/PCR-7-156.PMC5079087.pdf
Available	 from:	http://www.clinicaltrial.gov.,Non-OADS,/arxiv_data1/oa_pdf/18/7b/PCR-7-161.PMC5079088.pdf
Available	 from:	http://www.cdsco.nic.in/writereaddata/G.S.R%20 72(E)%20dated%2008.02.2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/79/PCR-7-165.PMC5079089.pdf
DDIs  were assessed by Medscape Drug Interaction Checker  software (version ‑ 4.4 available on: http://www.reference.,OADS,/arxiv_data1/oa_pdf/8e/c0/PCR-7-168.PMC5079090.pdf
Available	 from:	http://www.icmr.nic.in/ethical_guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/a1/PCR-7-174.PMC5079091.pdf
Available	 from:	http://www.dbtbiosafety.nic.in/act/ schedule_y.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/a1/PCR-7-174.PMC5079091.pdf
Available	 from:	 http://www.ncbi.nlm.nih.gov/books/NBK50892/.,Non-OADS,/arxiv_data1/oa_pdf/5a/a1/PCR-7-174.PMC5079091.pdf
Available	 from:	http://www.apps.who.int/ medicinedocs/en/d/Jh2992e/6.html.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/PCR-7-181.PMC5079092.pdf
Available	 from:	 http://www.WHO-UMC.org/ graphics/4409.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/PCR-7-181.PMC5079092.pdf
"This is, however,  often not true, and hence the popular statistical adage:  “Correlation does not imply causation.” You may wish  to visit https://en.wikipedia.org/wiki/Correlation_does_not_imply_causation for some interesting insights  into how correlation can arise without any causative  link.",Non-OADS,/arxiv_data1/oa_pdf/65/a5/PCR-7-187.PMC5079093.pdf
Available	 from:	 http://www.icmr.nic.in/ethical_guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/69/PCR-7-191.PMC5079094.pdf
"Abbreviations:  MS,  mitral  stenosis;  BMV,  balloon  mitral  valvotomy;  LV,  left  ventricle;  EF,  ejection  fraction;  MAPSE,  mitral  annular  plane systolic  excursion;  MASV,  mitral  annular  systolic  velocity;  E0,  early  diastolic  mitral  annular  velocity;  MPI,  myocardial  performance  index; TDE,  tissue  Doppler  echocardiography;  RHD,  rheumatic  heart  disease;  AF,  atrial  ﬁbrillation;  ROC,  receiver –operating  characteristics;  IVCT, isovolumic  contraction  time;  IVRT,  isovolumic  relaxation  time.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0300019-4832/ # 2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/b9/22/main.PMC5079113.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/22/main.PMC5079113.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/22/main.PMC5079113.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/f4/main.PMC5079114.pdf
E-mail  address:  dradascard@rediffmail.com  (A.  Das).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.2990019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/cd/f4/main.PMC5079114.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/f4/main.PMC5079114.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/d2/atr-05-03-30011.PMC5079115.pdf
Available from: http://www.itl.nist.gov/div898/handbook/eda/section3/ boxplot.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/88/HI-11-1-25.PMC5079117.pdf
Available  from: http://www.itl.nist.gov/div898/handbook/eda/section3/ autocopl.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/88/HI-11-1-25.PMC5079117.pdf
Available from: http://www.itl.nist.gov/div898/handbook/pmc/section4/pmc4431.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/88/HI-11-1-25.PMC5079117.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/29/main.PMC5079123.pdf
"1Formerly  fellow  in  Nuclear  Medicine  at  Apollo  Hospital,  Chennai,  India.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.017 0019-4832/ #  2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/83/29/main.PMC5079123.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/29/main.PMC5079123.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC5079124.pdf
Saha).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0130019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC5079124.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC5079124.pdf
2015.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC5079124.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC5079124.pdf
E-mail  address:  n_awasthy@yahoo.com  (N.  Awasthy).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0010019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/11/03/main.PMC5079125.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/03/main.PMC5079125.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/11/03/main.PMC5079125.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/7f/main.PMC5079126.pdf
E-mail  address:  drjohnjose@gmail.com  (J.  Jose).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0060019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/09/7f/main.PMC5079126.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/7f/main.PMC5079126.pdf
Retrieved  from http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WorldPopulationAgeing2013.pdfAccessed August  2015.. 7.,Non-OADS,/arxiv_data1/oa_pdf/09/7f/main.PMC5079126.pdf
Retrieved from  http://www.censusindia.gov.in/vital_statistics/ SRS_Reports_2013.html  Accessed  August  2015.,OADS,/arxiv_data1/oa_pdf/09/7f/main.PMC5079126.pdf
mddionline.com/article/fda-a pproves-medtronic's-evolut- r-tavr-06-24-15 )  and  Sapien  3  valve  systems  (which  uses  an expandable  e-sheaths  http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm451678.htm ).,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
E-mail  address:  guptasa@ohsu.edu  (S.  Gupta).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0240019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
http://clinicaltrials.gov/ct2/show/NCT01314313 .10.,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
2011. http://www.clinicaltrials.gov/ct2/show/NCT01057173?term=NCT01057173&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/main.PMC5079127.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
Jaywant).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0160019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
http://dx.doi.org/10.1093/eurheartj/ ehm583 .,Non-OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
http://dx.doi.org/10.1016/j.jjcc.2009.06.007 .Table  6  –  Summary  of  patients  with  SAE  by  SOC  and  PT.,OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
http://dx.doi.org/ 10.1001/jama.2009.1619 .,Non-OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
http://dx.doi.org/ 10.1016/j.amjcard.2010.05.002 .,OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bf/main.PMC5079128.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/d2/main.PMC5079129.pdf
E-mail  address:  jjdalal@hotmail.com  (J.J.  Dalal).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0220019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/66/d2/main.PMC5079129.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/d2/main.PMC5079129.pdf
http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/66/d2/main.PMC5079129.pdf
http://www.accessdata.fda.gov/ drugsatfda_docs/label/2009/022307s000lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/66/d2/main.PMC5079129.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/75/main.PMC5079130.pdf
E-mail  address:  abhijeet_avian@yahoo.co.in  (A.  V.  Naik).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.0020019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/26/75/main.PMC5079130.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/75/main.PMC5079130.pdf
"This  is  obvious  from  the  differences  between  the percent  prevalence  of  frank  hypercholesterolemia  across  4 different  regions  according  to  WHO  (http://www.who.int/ gho/ncd/risk_factors/cholesterol_text/en/ ),  in  the  upper panel  (A),  and  the  percent  population-attributable  coronary risk  due  to  dyslipidemia  across  4  different  regions  in  the INTERHEART  study  (reference  4),  in  the  lower  panel  (B).",Non-OADS,/arxiv_data1/oa_pdf/6a/da/main.PMC5079131.pdf
Athyros) Available  online  10  March  2016 http://dx.doi.org/10.1016/j.ihj.2016.02.022 0019-4832/ #  2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/6a/da/main.PMC5079131.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  5  9  6  –  5  9  8 598,Non-OADS,/arxiv_data1/oa_pdf/6a/da/main.PMC5079131.pdf
E-mail  address:  calambur@hotmail.com  (C.  Narasimhan).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0110019-4832/ # 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/44/91/main.PMC5079132.pdf
This  is  an  open  access  article  under  the  CC  BY- NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/91/main.PMC5079132.pdf
This  is  an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  6  6  3  –  6  7  0 664,Non-OADS,/arxiv_data1/oa_pdf/44/91/main.PMC5079132.pdf
1996  In:  https://www.pharmacoepi.,Non-OADS,/arxiv_data1/oa_pdf/44/91/main.PMC5079132.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/24/main.PMC5079133.pdf
"Abbreviations:  LVOT,  left  ventricular  outﬂow  tract  obstruction;  ASA,  alcohol  septal  ablation;  RFCA,  radio  frequency  catheter  ablation; HOCM,  hypertrophic  obstructive  cardiomyopathy;  LAD,  left  anterior  descending  artery;  ICE,  intra  cardiac  echocardiography;  LBB,  left bundle  branch;  CHB,  complete  heart  block.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.0070019-4832/ # 2016  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/d0/24/main.PMC5079133.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/24/main.PMC5079133.pdf
"Abbreviations:  BMI,  body  mass  index;  BP,  blood  pressure;  CAD,  coronary  artery  disease;  CVA,  cerebrovascular  accident;  CVD,  cardio- vascular  diseases;  DM,  diabetes  mellitus;  HP,  Himachal  Pradesh;  HTN,  hypertension;  MI,  myocardial  infarction;  NCD,  non  communicable diseases.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0020019-4832/ # 2016  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC5079134.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC5079134.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  6  5  5  –  6  6  2 656,Non-OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC5079134.pdf
Available  from:  http://www.cdc.gov/BRFSS/  [accessed 25.07.08].,OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC5079134.pdf
Available  from:  http://www.who.int/ncd_surveillance/steps/ riskfactor/en/index.html  [accessed  25.11.14].,OADS,/arxiv_data1/oa_pdf/aa/cf/main.PMC5079134.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/ff/main.PMC5079135.pdf
E-mail  address:  drharikrishnan@outlook.com  (S.  Harikrishnan).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0100019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/b3/ff/main.PMC5079135.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/ff/main.PMC5079135.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/db/main.PMC5079136.pdf
"E-mail  addresses:  yogdiab@gmail.com ,  info@mittalhospital.com  (T.  Saxena).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.005 0019-4832/ #  2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/94/db/main.PMC5079136.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/db/main.PMC5079136.pdf
Available  from:  https://en.wikipedia.org/wiki/Newton% 27s_laws_of_motion  [accessed  15.09.15].,Non-OADS,/arxiv_data1/oa_pdf/94/db/main.PMC5079136.pdf
http://dx.doi.org/10.1001/ jama.2013.284427 .,Non-OADS,/arxiv_data1/oa_pdf/94/db/main.PMC5079136.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/24/main.PMC5079137.pdf
E-mail  address:  a51hauzkhas@gmail.com  (J.C.  Mohan).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0140019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/00/24/main.PMC5079137.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/24/main.PMC5079137.pdf
This  is  an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/60/main.PMC5079138.pdf
Vilvanathan).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.0130019-4832/ # 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/b3/60/main.PMC5079138.pdf
This  is  an  open  access  article  under  the  CC  BY- NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/60/main.PMC5079138.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/ee/main.PMC5079139.pdf
Al-Daydamony).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.0070019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/f6/ee/main.PMC5079139.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/ee/main.PMC5079139.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.012 0019-4832/ /C223  2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/8c/dd/main.PMC5079188.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/dd/main.PMC5079188.pdf
http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/8c/dd/main.PMC5079188.pdf
2012;S5:004.  http://dx.doi.org/10.4172/2161-0665.S5-004 .,Non-OADS,/arxiv_data1/oa_pdf/eb/3d/main.PMC5079189.pdf
2016.  http://dx.doi.org/10.1016/j.ihj.2016.,OADS,/arxiv_data1/oa_pdf/eb/3d/main.PMC5079189.pdf
"P.  Syamasundar  Rao  MD,  DCH,  FAAP,  FACC,  FSCAI Professor  of  Pediatrics  and  Medicine,  Emeritus  Chief  of  Pediatric Cardiology,  UT  Health  McGovern  Medical  School,  Children's Memorial  Hermann  Hospital,  Houston,  TX,  United  States E-mail  address:  P.Syamasundar.Rao@uth.tmc.edu Available  online  4  April  2016 http://dx.doi.org/10.1016/j.ihj.2016.03.018 0019-4832/ #  2016  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/eb/3d/main.PMC5079189.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  8  (  2  0  1  6  )  5  9  2  –  5  9  5  595,Non-OADS,/arxiv_data1/oa_pdf/eb/3d/main.PMC5079189.pdf
"Osong Public Health Res Perspect 2016 7(5), 313 e319 http://dx.doi.org/10.1016/j.phrp.2016.08.005pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/65/2c/main.PMC5079190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/2c/main.PMC5079190.pdf
Available from: http://www.komci.org/GSResult.,Non-OADS,/arxiv_data1/oa_pdf/65/2c/main.PMC5079190.pdf
"Osong Public Health Res Perspect 2016 7(5), 301 e306 http://dx.doi.org/10.1016/j.phrp.2016.08.006pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/main.PMC5079191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/4a/main.PMC5079191.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/54/main.PMC5079192.pdf
E-mail  address:  kumarpre@hotmail.com  (R.K.  Jain).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.09.0070019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/31/54/main.PMC5079192.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/54/main.PMC5079192.pdf
Transesophageal  echocardiographic  mid  esophageal  long  axis  view  showing atrial  septal  defect  closure  device  protruding  in  left  ventricle.Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.0080019-4832/ /C223 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/39/fc/main.PMC5079193.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/fc/main.PMC5079193.pdf
"Osong Public Health Res Perspect 2016 7(5), 296 e300 http://dx.doi.org/10.1016/j.phrp.2016.08.004pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/b7/09/main.PMC5079194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/09/main.PMC5079194.pdf
This  is  an  open  access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/f2/main.PMC5079195.pdf
E-mail  address:  dr_dash2003@yahoo.com.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.009 0019-4832/ #  2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/e7/f2/main.PMC5079195.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/f2/main.PMC5079195.pdf
"The Osong Public Health Res Perspect 2016 7(5), 279 e280 http://dx.doi.org/10.1016/j.phrp.2016.09.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/3b/1f/main.PMC5079197.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/1f/main.PMC5079197.pdf
"Osong Public Health Res Perspect 2016 7(5), 327 e333 http://dx.doi.org/10.1016/j.phrp.2016.09.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
Available from: http://www.fao.org/hivaids/publications/ hivaids.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
Available from: http://www.fao.org/newsroom/common/ecg/ 1000544/en/hivﬁshingEN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
Availablefrom: http://www.ceeindia.org/cee/pdf_ﬁles/kutch_coast_study.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
Available at: http://www.fao.org/ 3/a-y5922e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5079198.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Correspondance  /  Indian  Heart  Journal  68  (2016)  747–750  749,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
Retrieved  from: http://www.ijme.in/index.php/ijme/article/view/1320/2927 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
In:  https://www.osha.gov/SLTC/workplaceviolence/ 8.,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
2010;376(9742):657.  http://dx.doi.org/ 10.1016/S0140-6736(10)61315-3 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
http://dx.doi.org/10.1371/journal.pone.0128394 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
http://dx.doi.org/ 10.1136/bmjopen-2014-006431 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
http://dx.doi.org/10.1136/ bmjopen-2014-006719 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
2011.  http://dx.doi.org/10.1016/j.jemermed.,OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
2012;12:469.  http://dx.doi.org/10.1186/1472-6963-12-469 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
2016;12(January–March  (1)):26– 34.  http://dx.doi.org/10.1097/JFN.0000000000000100 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
http://dx.doi.org/ 10.1080/10803548.2015.1073008 .,Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
"Paurush  Ambesh Department  of  Internal  Medicine,  Maimonides  Medical  Center, New  York  City  11219,  USA E-mail  address:  paurush17@gmail.com Received  21  July  2016 Available  online  2  August  2016 http://dx.doi.org/10.1016/j.ihj.2016.07.023Correspondance  /  Indian  Heart  Journal  68  (2016)  747–750 750",Non-OADS,/arxiv_data1/oa_pdf/ab/2e/main.PMC5079199.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/df/main.PMC5079200.pdf
Angiographic  image  of  RCA  showing  non-signiﬁcant  proximal  lesion  (A).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.001 0019-4832/ /C223  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/7a/df/main.PMC5079200.pdf
http://dx.doi.org/10.1016/ j.jacc.2013.05.071 .,OADS,/arxiv_data1/oa_pdf/7a/df/main.PMC5079200.pdf
http://dx.doi.org/10.1007/s10554-014-0543-4 .3.,Non-OADS,/arxiv_data1/oa_pdf/7a/df/main.PMC5079200.pdf
"Osong Public Health Res Perspect 2016 7(5), 307 e312 http://dx.doi.org/10.1016/j.phrp.2016.08.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/eb/f9/main.PMC5079201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/f9/main.PMC5079201.pdf
"26.  http://healthimpactnews.com/2014/the-cancer-industry-is-too-prosperous-to- allow-a-cure/#sthash.tKuXW1yM.dpuf Vitull  K.  Guptaa,b* aKishori  Ram  Hospital  and  Diabetes  Care  Centre,  India bAIMSR,  India Praneet  Wander Department  of  Medicine,  Mount  Sinai  St  Lukes  Roosevelt  Hospital, New  York,  United  States Meghna  Gupta Adesh  Institute  of  Medical  Sciences  and  Research,  Bathinda,  Punjab, India *Corresponding  author  at:  AIMSR,  India E-mail  address:  vitullgupta2000@yahoo.com  (V.K.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC5079202.pdf
Received  27  May  2016 Available  online  11  June  2016 http://dx.doi.org/10.1016/j.ihj.2016.05.015Correspondance  /  Indian  Heart  Journal  68  (2016)  747–750 748,Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC5079202.pdf
"Osong Public Health Res Perspect 2016 7(5), 320 e326 http://dx.doi.org/10.1016/j.phrp.2016.08.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
Available from: http://tbzero.cdc.,Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
Available from: http://kostat.go.kr/portal/english/index.action .,Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
Available from: http://www.who.int/tb/ publications/global_report/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
Availablefrom: http://www.who.int/gho/countries/kor.pdf?ua Z1http:// www.who.int/countries/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b6/7f/main.PMC5079203.pdf
"Osong Public Health Res Perspect 2016 7(5), 334 e338 http://dx.doi.org/10.1016/j.phrp.2016.07.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/31/1a/main.PMC5079204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/1a/main.PMC5079204.pdf
"Osong Public Health Res Perspect 2016 7(5), 281 e288 http://dx.doi.org/10.1016/j.phrp.2016.09.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/24/20/main.PMC5079205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/20/main.PMC5079205.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents  lists  available  at  ScienceDirect Indian  Heart  Journal jo  u  rn  al  h  om  epag  e:  ww  w.els  evier.c  o  m/lo  cat  e/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.013 0019-4832/ /C223  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/14/e0/main.PMC5079206.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/9d/atr-05-03-33335.PMC5079207.pdf
Available from: http://www.awmf.org/ uploads/tx_szleitlinien/012-001l_S2e_Schenkelhalsfraktur_des_ Erwachsenen.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/atr-05-03-33335.PMC5079207.pdf
Available from: http://www.egms.de/static/de/meetings/dkou2010/ 10dkou476.shtml .,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/atr-05-03-33335.PMC5079207.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/37/atr-05-03-37005.PMC5079208.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/f6/atr-05-03-36952.PMC5079209.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/9e/atr-05-03-36570.PMC5079210.pdf
Available from: https://www.amar.org.,Non-OADS,/arxiv_data1/oa_pdf/d6/9e/atr-05-03-36570.PMC5079210.pdf
Model trauma system policy Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d6/9e/atr-05-03-36570.PMC5079210.pdf
"Osong Public Health Res Perspect 2016 7(5), 289 e295 http://dx.doi.org/10.1016/j.phrp.2016.08.007pISSN 2210-9099 eISSN 2233-6052 Copyright ª2016 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/66/e7/main.PMC5079212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/e7/main.PMC5079212.pdf
"Temperature 2016; 3:444-54; http://dx.doi.org/10.1080/23328940.2016.1179382 From a broader context, this above-mentioned paper1focuses on strategies to maximize post-exercise recovery in hot and humid environmental conditions; a topic that has received growing attention in thesports science literature.",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"3, 366 –368 http://dx.doi.org/10.1080/23328940.2016.1214335",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"Temperature 2016; 3:444-54; http://dx.doi.org/10.1080/ 23328940.2016.1179382 [2] Duf ﬁeld R, King M, Skein M. Recovery of voluntary and evoked muscle performance following intermittent-sprint exercise in the heat.",OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"http://www.inmet.gov.br/portal/index.php?R Dbdmep/bdmep [4] Gant N, Stinear CM, Byblow WD.",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"Brain Res 2010; 1350:151- 8; PMID:20388497; http://dx.doi.org/10.1016/j.brainres.2010.04.004 [5] Nassif C, Ferreira AP, Gomes AR, Silva Lde M, Garcia ES, Marino FE.",OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"J Sci Med Sport 2008; 11:72-9; PMID:18023253; http://dx.doi.org/10.1016/j.jsams.2007.08.015 Samuel Penna Wanner Exercise Physiology Laboratory, School of Physical Education Physiotherapy and Occupation Therapy Universidade Federal de Minas Gerais Belo Horizonte (MG), 31270-901, Brazil samuelwanner@eeffto.ufmg.br Carolina Franco Wilke Exercise Physiology Laboratory, School of Physical Education Physiotherapy and Occupation Therapy, Universidade Federal de Minas Gerais Belo Horizonte (MG), Brazil; Sports Sciences Integration Department Minas T ^enis Clube, Belo Horizonte (MG), Brazil Rob Duf ﬁeld Sport and Exercise Discipline Group, Faculty of Health University of Technology Sydney, Moore Park (NSW), Australia368 S. P. WANNER ET AL.",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/ktmp-03-03-1214335.PMC5079213.pdf
"Temperature 2016; 3:220-31; http://dx.doi.org/10.1080/23328940.2016.1174794 Farrell recently published an interesting review paper on imaging human brain responses during heating and cooling.1Here, he discussed our work on imaging such responses during menopausal hot ﬂashes (HFs).2 Hotﬂashes are triggered by small elevations in core body temperature acting within a greatly reduced inter- threshold zone in symptomatic menopausal women.3This reduction is due to estrogen withdrawal and increased sympathetic activation among other factors.4There is an a2-adrenergic component in this mechanism, as dem- onstrated by the fact that HFs can be provoked by yohimbine, an a2-adrenergic antagonist and inhibited by clon- dine, an a2-adrenergic agonist.5 We have demonstrated, in this temporal sequence, activation of speci ﬁc areas of the brainstem, insula, and prefrontal cortex during HFs using fMRI.2The rise in brainstem activity occurred before HF onset, as detected by sternal skin conductance level, an electrical measure of sweating.",Non-OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
Temperature 2016; 3:220-31; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
"Cereb Cortex 2014; 24:3006-13; PMID:23787950; http://dx.doi.org/10.1093/cercor/bht155 [3] Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot ﬂashes.",OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
Am J Obstet Gynecol 1999; 181:66-70; PMID:10411797; http://dx.doi.org/10.1016/S0002-9378(99)70437-0 [4] Freedman RR.,Non-OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
"J Steroid Biochem Mol Biol 2014; 142:115-20. Review; PMID:24012626; http://dx.doi.org/10.1016/j.jsbmb.2013.08.010 [5] Freedman RR, Woodward S, Sabharwal SC.",OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
"3, 361http://dx.doi.org/10.1080/23328940.2016.1208318",Non-OADS,/arxiv_data1/oa_pdf/d3/fd/ktmp-03-03-1208318.PMC5079214.pdf
"3, 455 –464 http://dx.doi.org/10.1080/23328940.2016.1182669",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Int J Biometeorol 1984; 28:137-46; PMID:6735516; http://dx.doi.org/10.1007/BF02191726 [4] Nielsen B, Strange S, Christensen NJ, Warberg J, Saltin B.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"P ﬂugers Arch 1997; 434:49-56; PMID:9094255; http://dx.doi.org/10.1007/s004240050361 [5] Candas V, Libert JP, Vogt, JJ.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
Eur J Appl Physiol 1985; 54:480-7;PMID:4085475; http://dx.doi.org/10.1007/BF00422956 [8] Gonzalez-Alonso J Human thermoregulation and the car- diovascular system.,Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Exp Physiol 2012; 97:340-6;PMID:22227198; http://dx.doi.org/10.1113/expphysiol.2011.058701 [9] Sawka MN, Cheuvront SN, Kene ﬁck RW.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"High skin tem- perature and hypohydration impair aerobic performance.Exp Physiol 2012; 97:327-32; PMID:22143882; http://dx.doi.org/10.1113/expphysiol.2011.061002 [10] Helou NE, Taf ﬂet M, Berthelot G, Tolaini J, Marc A, Guillaume M, Hausswirth C, Toussaint J.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"PloS One 2012; 7:1-9; PMID:22649525; http://dx.doi.org/10.1371/journal.pone.0037407 [11] Gagge A.P, Gonzalez, R.R.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"First published in print 1996 [12] Moyen NE, Ellis CLV, Ciccone, AB, Thurston, TS, Cochrane, K C ,B r o w n ,L E ,C o b u r n ,J W ,J u d e l s o n ,D A .I n c r e a s i n gr e l a -tive humidity impacts low-intensity exercise in the heat.Aviat Space Environ Med 2014; 85:112-9; PMID:24597154;http://dx.doi.org/10 .3357/ASEM.3787.2014 [13] Maughan RJ, Otani H, Watson P. In ﬂuence of relative humidity on prolonged exercise capacity in a warm envi- ronment.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Eur J Appl Physiol 2012; 112:2313-21; PMID:22012542; http://dx.doi.org/10.1007/s00421-011-2206-7 [14] Adams WC, Mack GW, Langhans GW, Nadel ER.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Acta Physiol Scand 2005; 183:241-55;PMID:15743384; http://dx.doi.org/10.1111/j.1365-201X.2004.01400.x [16] DuBois D, DuBois EF.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
ArchInt Med 1916; 17:863-71; PMID:2520314; http://dx.doi.org/10.1001/archinte.1916.00080130010002 [17] Siri WE.,OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
J Therm Biol 2014; 43:7-12; PMID:24956952; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"2000;29:329-59; PMID:10840867; http://dx.doi.org/10.2165/00007256-200029050-00004 [30] Nielsen B, Hales J, Strange S, Christensen N, Warberg J, Saltin B.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"J Physiol 1993; 460:467-85; PMID:8487204; http://dx.doi.org/10.1113/jphysiol.1993.sp019482 [31] Gonzalez-Alonso J, Teller C, Andersen S, Jensen F, Hyldig T, Nielsen, B.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Eur JAppl 1993; 67:174-9; PMID:8223525; http://dx.doi.org/10.1007/BF00376663 [33] Cheuvront SN, Kene ﬁck RW, Montain SJ, Sawka MN.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
J Appl Physiol 2010; 109:1989-95; PMID:20689090; http://dx.doi.org/10.1152/ japplphysiol.00367.2010[34] Kerslake DM.,Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Acta Physiol Scand Suppl 1969; 323:1-74;PMID:5345560; http://dx.doi.org/10.1111/j.1748-1716.1969.tb04445.x [36] Rowell LB, Brengelmann GL, Murray JA, Kraning II, KK, Kusumi F. Human metabolic responses to hyperthermia during mild to maximal exercise.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Scand Arch Physiol 1938; 79:193-230;http://dx.doi.org/10.1111/j.1748-1716.1938.tb01246.x [38] Nadel ER, Bullard RW, Stolwijk JA.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Appl Human Sci 1996; 15:249-58; PMID:9008978; http://dx.doi.org/10.2114/jpa .15.249 [41] Filingeri D, Havenith G. Human skin wetness perception: psychological and neurophysiological bases.",Non-OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Temp 2015;2:86-104; http://dx.doi.org/10.1080/23328940.2015.1008878 [42] Sawka MN, Latzka WA, Montain SJ, Cadarette BS, Kolka MA, Kraning KK, Gonzalez RR.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Med Sci Sports Exerc 2001; 33:422-30; PMID:11252069; http://dx.doi.org/10.1097/00005768-200103000-00014 [43] Byrne C, Lee JK, Chew SA, Lim CL, Tan EY.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Med Sci Sports Exerc 2006;38:803-10; PMID:16672830; http://dx.doi.org/10.1249/01.mss.0000218134.74238.6a [44] Ely BR, Ely MR, Cheuvront SN, Kene ﬁck RW, DeGroot DW, Montain SJ.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"J Appl Physiol2009; 107:1519-25; PMID:19713430; http://dx.doi.org/10.1152/japplphysiol.00577.2009 [45] Ely BR, Cheuvront SN, Kene ﬁck RW, Sawka MN.",OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
Med Sci Sports Exerc 2010; 42:135-41; PMID:20010120; http://dx.doi.org/10.1249/ MSS.0b013e3181adb9fb464 A. M. CHE MUHAMED ET AL.,OADS,/arxiv_data1/oa_pdf/9d/08/ktmp-03-03-1182669.PMC5079215.pdf
"Temperature2016; 3:371-83; http://dx.doi.org/10.1080/23328940.2016.1177159 If all you have is a hammer, everything looks like a nail.",Non-OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
"3, 364 –365 http://dx.doi.org/10.1080/23328940.2016.1213349",Non-OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
Temperature 2016; 3:371-83; http://dx.doi.org/10.1080/23328940.2016.1177159 [2] Mandelbrot BB.,OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
"J Physiol 2009; 587:3929-41; PMID:19528254; http://dx.doi.org/10.1113/jphysiol.2009.169219 [5] Plourde B, Sarrazin JF, Nault I, Poirier P. Sudden cardiac death and obesity.",Non-OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
"Expert Rev Cardiovasc Ther 2014; 12:1099-110; PMID:25160995; http://dx.doi.org/10.1586/14779072.2014.952283 Karl J. Kaiyala School of Dentistry, Department of Oral Health Sciences University of Washington, Seattle, WA, USA kkaiyala@uw.eduTEMPERATURE 365",Non-OADS,/arxiv_data1/oa_pdf/97/35/ktmp-03-03-1213349.PMC5079216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cit ed.TEMPERATURE 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"3, 444 –454 http://dx.doi.org/10.1080/23328940.2016.1179382",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Scand Arch Physiol 1939; 81:160-71; http://dx.doi.org/10.1111/j.1748-1716.1939.tb01320.x [2] Cermak NM, van Loon LJ.",OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Sports Med 2013;43:1139-55; PMID:23846824; http://dx.doi.org/10.1007/s40279-013-0079-0 [3] Costill DL, Sherman WM, Fink WJ, Maresh C, Witten M, Miller JM.",OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Curr Sports Med Rep 2008;7:193-201; PMID:18607220; http://dx.doi.org/10.1249/ JSR.0b013e31817fc0fd[5] Ivy JL, Katz AL, Cutler CL, Sherman WM, Coyle EF.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
Med Sci Sports Exerc 2009;41:709-31; PMID:19225360; http://dx.doi.org/10.1249/MSS.0b013e31890eb86 [8] Burke LM.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Comp Biochem Physiol A Mol Integr Physiol 2001; 128:735-48; PMID:11282317; http://dx.doi.org/10.1016/ S1095-6433(01)00279-3 [ 9 ] W e n d tD ,v a nL o o nL J ,L i c h t e n b e l tW D .T h e r m o r e g u - lation during exercise in the heat: strategies for main-taining health and performance.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
Sports Med 2007;37:669-82; PMID:17645370; http://dx.doi.org/10.2165/00007256-200737080-00002 [10] Febbraio MA.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Sports Med 2001; 31:47-59; PMID:11219501; http://dx.doi.org/10.2165/00007256-200131010-00004 [11] Yaspelkis BB, Ivy JL.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"J Appl Physiol 2002; 92:1562-72; PMID:11896023; http://dx.doi.org/10.1152/japplphysiol.00482.2001 [13] Jentjens RL, Underwood K, Achten J, Currell K, Mann CH, Jeukendrup AE.",OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
J Appl Physiol2006; 100:807-16; PMID:16282436; http://dx.doi.org/ 10.1152/japplphysiol.00322.2005 [14] Abd-Aziz S. Sago starch and its utilisation.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"J Biosci Bio- eng 2002; 94:526-9; PMID:16233345; http://dx.doi.org/10.1016/S1389-1723(02)80190-6 [15] Singhal RS, Kennedy JF, Gopalakrishnan SM, Kaczmarek A.",OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Carbohyd Polym 2008;72:1-20; http://dx.doi.org/10.1016/j.carbpol.2007.07.043 [16] Che Jusoh MR, Stannard SR, M €undel T. Physiologic and performance effects of sago supplementation before andduring cycling in a warm-humid environment.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Temperature2016; 3:318-27; http://dx.doi.org/10.1080/23328940.2016.1159772 [17] Ahmad H, Singh R, Ghosh AK.",OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Scand J Med Sci Sports 2015; 25 Suppl 1:296-301; PMID:25943681; http://dx.doi.org/10.1111/sms.12332 [19] Burgomaster KA, Heigenhauser GJ, Gibala MJ.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"J Appl Physiol 2006; 100:2041-7; PMID:1646993 3; http://dx.doi.org/ 10.1152/japplphysiol.01220.2005 [20] Brickley G, Green S, Jenkins DG, McEinery M, Wish- art C, Doust JD, Williams CA.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
Med Sci SportsExerc 1996; 28:266-70; PMID:8775164; http://dx.doi.org/10.1097/00005768-199602000-00017 [23] Ramanathan NL.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Sports Med 2000; 30:1-15; PMID:10907753;http://dx.doi.org/10.2165/00007256-200030010-00001 [26] Wong SH, Williams C, Adams N. Effects of ingesting a large volume of carbohydrate-electrolyte solution onrehydration during recovery and subsequent exercisecapacity.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
1987; 8:99- 104; PMID:3298088; http://dx.doi.org/10.1055/s-2008- 1025649 [30] Frayn KN.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Int J Sports Med 1996; 17:373-8; PMID:8858410; http://dx.doi.org/10.1055/s-2007-972863 [34] Clark VR, Hopkins WG, Hawley JA, Burke LM.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
Med Sci Sports Exerc 2000; 32:1642-7;PMID:10994918; http://dx.doi.org/10.1097/00005768-200009000-00019454 M. R. CHE JUSOH ET AL.,OADS,/arxiv_data1/oa_pdf/a1/59/ktmp-03-03-1179382.PMC5079217.pdf
"Temperature2016; 3:371-83; http://dx.doi.org/10.1080/23328940.2016.1177159 In his landmark Physiological Reviews article of 19291Walter Cannon de ﬁned homeostasis as the coordinated physiological mechanisms that maintain the physical and chemical properties of the internal environment, i.e.the extracellular ﬂuid that surrounds all cells in the body.",Non-OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
"3, 362 –363 http://dx.doi.org/10.1080/23328940.2016.1211503",Non-OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
"Temperature 2016; 3:371-83; http://dx.doi.org/10.1080/23328940.2016.1177159 [3] Ootsuka Y, de Menezes RC, Zaretsky DV, Alimoradian A, Hunt J, Stefanidis A, Old ﬁeld BJ, Blessing WW.",OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
Neurosci 2009;164:849-61; PMID:19679172; http://dx.doi.org/10.1016/j.neuroscience.2009.08.013 [4] Dampney RA.,OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
Am J PhysiolRegul Integr Comp Physiol 2015; 309:R429-43; PMID:26041109; http://dx.doi.org/10.1152/ajpregu.00051.2015 [5] Day TA.,OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
"Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:1195-200; PMID:16213079; http://dx.doi.org/10.1016/j.pnpbp.2005.08.005 Roger A. L. Dampney School of Medical Sciences (Physiology) and Bosch Institute The University of Sydney, NSW 2006, Australia roger.dampney@sydney.edu.auTEMPERATURE 363",Non-OADS,/arxiv_data1/oa_pdf/ea/9b/ktmp-03-03-1211503.PMC5079219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"3, 476 –483 http://dx.doi.org/10.1080/23328940.2016.1214334",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
Naturwissenschaften2014; 101:679-85; PMID:25005222; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Physiol Biochem Zool 2003; 76:868-76; PMID:14988802; http://dx.doi.org/10.1086/378915 [7] Bondarenco, A, K €ortner, G, Geiser, F. Some like it cold: summer torpor by freetail bats in the Australian aridzone.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 2013; 183:1113-22; http://dx.doi.org/10.1007/s00360-013-0779-7 [8] Serventy, V, Raymond, R. Torpidity in desert animals.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 2007; 177:885-92;http://dx.doi.org/10.1007/s00360-007-0186-z [11] Rambaldini, DA, Brigham, RM.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
J Mammal 2008; 89:933-41; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Naturwissenschaften2008; 95:73-8; PMID:17684718; http://dx.doi.org/10.1007/s00114-007-0293-4 [13] K €ortner, G, Geiser, F. The key to winter survival: daily torpor in a small arid-zone marsupial.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Naturwissenschaf- ten 2009; 96:525-30; PMID:19082573; http://dx.doi.org/ 10.1007/s00114-008-0492-7 [14] Munn, AJ, Kern, P, McAllan, BM.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Naturwissenschaften 2010; 97:601-5; PMID:20442980; http://dx.doi.org/10.1007/s00114-010-0670-2 [15] Speakman, JR, Thomas, DW.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Proc R Soc B-Biol Sci 2015; 282:2014-781;http://dx.doi.org/10.1098/rspb.2014.2781 [18] Bradley, WG, Yousef, MK.",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 2012;182:1129-40; http://dx.doi.org/10.1007/s00360-012-0683-6 [21] Turbill, C, Geiser, F. Hibernation by tree-roosting bats.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 2008; 178:597-605; http://dx.doi.org/10.1007/s00360-007-0249-1 [22] Geiser, F, Brigham, RM.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 2000; 170:153-62; http://dx.doi.org/10.1007/s003600050270 [23] Geiser, F. Metabolic rate and body temperature reduction during hibernation and daily torpor.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Annu Rev Physiol2004; 66:239-74; PMID:14977403; http://dx.doi.org/10.1146/annurev.physiol.66.032102.115105 [24] Kunz, T, Fenton, B.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Mammal 2009; 90:752-60; http://dx.doi.org/10.1644/08-MAMM-A-286R.1 [26] Hosken, DJ, Withers, PC.",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B 1997; 167:71-80; http://dx.doi.org/10.1007/s003600050049 [27] Bullen, R, McKenzie, NL.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Aust J Zool 2001; 49:235-61; http://dx.doi.org/10.1071/ZO00037 [28] Lyman, CP, Willis, JS, Malan, A, Wang, LC.",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Comp Physiol B2005; 175:479-86; http://dx.doi.org/10.1007/s00360-005- 0008-0 [31] Tregear, RT.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Funct Ecol 2002; 16:18-26; http://dx.doi.org/10.1046/j.0269-8463.2001.00602.x [34] Turbill, C, Law, BS, Geiser, F. Summer torpor in a free-ranging bat from subtropical Australia.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Therm Biol2003; 28:223-6; http://dx.doi.org/10.1016/S0306- 4565(02)00067-0 [35] Geiser, F, Stawski, C. Hibernation and torpor in tropical and subtropical bats in relation to energetics, extinctions,and the evolution of endothermy.",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Integr Comp Biol2011; 51:337-48; PMID:21700575; http://dx.doi.org/10.1093/icb/icr042 [36] K €ortner, G, Geiser, F. Ecology of natural hibernation in the marsupial mountain pygmy-possum ( Burramys par- vus).",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"Oecologia 1998; 113:170-8; http://dx.doi.org/ 10.1007/s004420050365 [37] Barclay, RM, Kalcounis, MC, Crampton, LH, Stefan, C, Vonhof, MJ, Wilkinson, L, Brigham, RM.",Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"J Mammal 1996; 77:1102-6; http://dx.doi.org/10.2307/1382791 [38] Willis, CK, Brigham, RM.",OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
J Comp Physiol B 2003; 173:379-89; http://dx.doi.org/10.1007/s00360-003-0343-y [39] R development Core Team.,Non-OADS,/arxiv_data1/oa_pdf/b4/0c/ktmp-03-03-1214334.PMC5079220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
"3, 355 –357 http://dx.doi.org/10.1080/23328940.2016.1218991",Non-OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
"Temperature 2016; 3:340-53; http://dx.doi.org/10.1080/23328940.2016.1163452 [2] Cooper CE, Withers PC, Hardie A, Geiser F. Marsupials don ’t adjust their thermal energetics for life in an alpine environment.",Non-OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
"Temperature 2016; 3:484-97; http://dx.doi.org/10.1080/23328940.2016.1171280 [3] Stephens J, Schiemann AH, Roesl C, Miller D, Massey S, Pollock N, Bulger T, Stowell K. Functional analysis of RYR1 variants linked to malignant hyperthermia.",OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
"Temperature 2016; 3:328-39; http://dx.doi.org/10.1080/23328940.2016.1153360 [4] Thomas KN, van Rij AM, Lucas SJE, Gray AR, Cotter JD.",OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
Temperature 2016; 3:286-97; http://dx.doi.org/10.1080/23328940.2016.1156215356 T. M€UNDEL ET AL.,OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
"Temperature 2016; 3:307-17; http://dx.doi.org/10.1080/23328940.2016.1156801 Toby M €undel School of Sport and Exercise, Massey University Private Bag 11-222, Palmerston North, New Zealand t.mundel@massey.ac.nz Eugene Nalivaiko School of Biomedical Sciences and Pharmacy University of Newcastle, Callaghan, NSW, Australia Stephen Kent School of Psychology and Public Health La Trobe University, Bundoora, VIC, Australia Shane K. Maloney School of Anatomy, Physiology and Human Biology The University of Western Australia, Crawley, WA, Australia Irina Vetter Institute for Molecular Biology The University of Queensland, Brisbane, QLD, AustraliaTEMPERATURE 357",Non-OADS,/arxiv_data1/oa_pdf/a1/49/ktmp-03-03-1218991.PMC5079222.pdf
J Am Med Assoc 2015; 313:724-25; http://dx.doi.org/10.1001/jama.2015.153.,Non-OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
"3, 358 –360 http://dx.doi.org/10.1080/23328940.2016.1211073",Non-OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
"J Am Med Assoc 2015; 313:724 –5;http://dx.doi.org/ 10.1001/jama.2015.153 [3] Gupta S, Carmichael C, Simpson C, Clarke MJ, Allen C, Gao Y, Chan EY, Murray V. Electric fans for reducing adverse health impacts in heatwaves.",OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
Cochrane Database Syst Rev 2012; 7:CD009888; PMID:22786530; http://dx.doi.org/10.1002/14651858.CD009888.pub2 [4] WHO.,OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
"Applied Ergonomics 2015; 43:137 –43;http://dx.doi.org/ 10.1016/j.apergo.2014.07.013 Nicholas M. Ravanelli School of Human Kinetics, University of Ottawa, 200 Lees Ave, Ottawa K1N 6N5, Canada Thermal Ergonomics Laboratory, Faculty of Health Sciences, University of Sydney, NSW, Australia Ollie Jay Thermal Ergonomics Laboratory, Faculty of Health Sciences, University of Sydney H110, 75 East St, Lidcombe, NSW 2141, Australia Charles Perkins Center, University of Sydney, NSW, Australia ollie.jay@sydney.edu.au360 N. M. RAVANELLI AND O. JAY",Non-OADS,/arxiv_data1/oa_pdf/dc/18/ktmp-03-03-1211073.PMC5079223.pdf
"3, 371 –383 http://dx.doi.org/10.1080/23328940.2016.1177159",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Ann Rev Physiol 1993; 55:17-54; PMID:8466172; http://dx.doi.org/10.1146/annurev.ph.55.030193.000313 [2] Darwin C. On the Origin of Species by Means of Natural Selection.,Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Exp Brain Res 1985; 12(Supple-ment):321-34; http://dx.doi.org/10.1007/978-3-642-70483-3_21 [8] Stampi C., ed.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Neuroscientist 1998; 4:380-5;http://dx.doi.org/10.1177/107385849800400520 [12] Haldane JS.,Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Philosophy of Science 1943; 10:18-24;http://dx.doi.org/10.1086/286788 [16] Strubbe JH, Woods SC.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Psychol Rev 2004; 111:128-41; PMID:14756590; http://dx.doi.org/ 10.1037/0033-295X.111.1.128 [17] Woods S, Ramsay D. Homeostasis: beyond curt richter.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Appetite 2007; 49:388-98; PMID:17524521; http://dx.doi.org/10.1016/j.appet.2006.09.015 [18] Ramsay DS, Woods SC.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Psychol Rev2014; 121:225-47; PMID:24730599; http://dx.doi.org/10.1037/a0035942 [19] Day TA.,Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Prog Neuropsychophar-macol Biol Psychiatry 2005; 29:1195-200; PMID:16213079;http://dx.doi.org/10.1016/j.pnpbp.2005.08.005 [20] Schweitzer A, Wright S. Effects on the knee jerk of stimu- lation of the central end of the vagus, and of variouschanges in the circulation and respiration.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Front Biosci 2010; 15:564-94; http://dx.doi.org/10.2741/3634 [22] Halberg F. Chronobiology.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Annu Rev Physiol 1969; 31:675-725; PMID:4885778; http://dx.doi.org/10.1146/annurev.ph.31.030169.003331 [23] Halberg F, Cornelissen G, Katinas G, Syutkina EV, Sothern RB, Zaslavskaya R, Halberg F, Watanabe Y, Schwartzkopff O, Otsuka K, et al.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
J Circadian Rhythms 2003; 1:2; PMID:14728726; http://dx.doi.org/10.1186/1740-3391-1-2 [24] Re ﬁnetti R. Relationship between the daily rhythms of locomotor activity and body temperature in eight mam-malian species.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Physiol Behav 2012; 105:966-74; PMID:22115948;http://dx.doi.org/10.1016/j.physbeh.2011.11.009 [28] Blessing W, Mohammed M, Ootsuka Y.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Physiol Behav2013; 121:61-9; PMID:23562865; http://dx.doi.org/10.1016/j.physbeh.2013.03.028 [29] Ootsuka Y, de Menezes RC, Zaretsky DV, Alimoradian A, Hunt J, Stefanidis A, Old ﬁeld BJ, Blessing WW.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Neuroscience 2009; 164:849-61; PMID:19679172;http://dx.doi.org/10.1016/j.neuroscience.2009.08.013 [30] Buzs /C19aki G. Rhythms of the Brain.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Biol Rhythm Res 2007;38:275-325; PMID:23710111; http://dx.doi.org/10.1080/09291010600903692 [32] Piccione G, Caola G, Re ﬁn e t t iR .T e m p o r a lr e l a t i o n - ships of 21 physiological variables in horse and sheep.Comp Biochem Physiol A Mol Integr Physiol 2005;142:389-96; PMID:16290083; http://dx.doi.org/10.1016 /j.cbpa.2005.07.019 [33] Bash KW.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
J Comp Physiol Psychol 1939;28:109-33; http://dx.doi.org/10.1037/h0061206 [34] Baker RA.,Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"J Comp Physiol Psychol 1953; 46:422-6; PMID:13109064;http://dx.doi.org/10.1037/h0062279 [35] Sokolove PG, Bushell WN.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
J Theor Biol 1978; 72:131-60; PMID:566361; http://dx.doi.org/10.1016/0022-5193(78)90022-X [36] Lomb NR.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Astrophysics and Space Science 1976;39:447-62; http://dx.doi.org/10.1007/BF00648343 [37] Press WH, Rybicki GB.",Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Astrophys J 1989; 338:277- 80; http://dx.doi.org/10.1086/167197 [38] Grinsted A, Moore JC, Jevrejeva S. Application of the cross wavelet transform and wavelet coherence togeophysical time series.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Nonlinear Proc Geoph 2004; 11:561-6; http://dx.doi.org/10.5194/npg-11-561-2004 [39] Leise TL.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"J Circadian Rhythms 2013; 11:5;PMID:23816159; http://dx.doi.org/10.1186/1740-3391-11-5 [40] Price TS, Baggs JE, Curtis AM, Fitzgerald GA, Hogenesch JB.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Bioinformatics 2008; 24:2794-5; PMID:18931366; http://dx.doi.org/10.1093/bioinformatics/btn521 [41] Leise TL, Indic P, Paul MJ, Schwartz WJ.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"J Biol Rhythms 2013; 28:62-8; PMID:23382592;http://dx.doi.org/10.1177/0748730412468693 [42] Mohammed M, Ootsuka Y, Yanagisawa M, Blessing W. Reduced brown adipose tissue thermogenesis during environmental interactions in transgenic rats with ataxin-3-mediated ablation of hypothalamic orexin neu-rons.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Am J Physiol Regul Integr Comp Physiol 2014; 307:R978-89; PMID:25324552; http://dx.doi.org/10.1152/ajpregu.00260.2014 [43] Higuchi T. Approach to an irregular time series on the basis of the fractal therory.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Physica D 1988; 31:277-83;http://dx.doi.org/10.1016/0167-2789(88)90081-4 [44] Bassingthwaighte JB, Liebovitch LS, West BJ.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Biol Cybern 1997; 77:339-50; PMID:9418215; http://dx.doi.org/10.1007/s004220050394 [46] Klonowski W. From conformons to human brains: an informal overview of nonlinear dynamics and its appli- cations in biomedicine.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Nonlinear Biomed Phys 2007; 1:5; PMID:17908344; http://dx.doi.org/10.1186/1753-4631-1-5 [47] Higuchi T. Fractal analysis of time series (in Japanese).,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
RespirPhysiol Neurobiol 2004; 141:317-29; PMID:15288602; http://dx.doi.org/10.1 016/j.resp.2004.03.014 [49] Buzsaki G. Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning.,OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"Hippo-campus 2015; 25:1073-188; PMID:26135716; http://dx.doi.org/10.1002/hipo.22488 [50] Baker FC, Angara C, Szymusiak R, McGinty D. Persistence of sleep-temperature coupling aftersuprachiasmatic nuclei lesions in rats.",OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
Am J Physiol Regul Integr Comp Physiol 2005; 289: R827-38; PMID:15860650; http://dx.doi.org/10.1152/ajpregu.00093.2005TEMPERATURE 383,Non-OADS,/arxiv_data1/oa_pdf/26/58/ktmp-03-03-1177159.PMC5079224.pdf
"3, 465 –475 http://dx.doi.org/10.1080/23328940.2016.1184366",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Temperature 2015; 2:392-405;http://dx.doi.org/10.1080/23328940.2015.1069437 [2] Nakamura K, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Cell Metab 2014; 19:741-56; PMID:24630813; http://dx.doi.org/10.1016/j.cmet.2014.02.007 [4] Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, KozlowskiGP, Wilson S, et al.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Am J Physiol RegulIntegr Comp Physiol 2014; 307:R978-89; PMID:25324552;http://dx.doi.org/10.1152/ajpregu.00260.2014 [10] Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yana- gisawa M. Orexin peptides prevent cataplexy andimprove wakefulness in an orexin neuron-ablated modelof narcolepsy in mice.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"J Physiol 2013; 591:5623-43;http://dx.doi.org/10.1113/jphysiol.2013.261271 [13] Zhang W, Sunanaga J, Takahashi Y, Mori T, Sakurai T, Kanmura Y, Kuwaki T. Orexin neurons are indispensable for stress-induced thermogenesis in mice.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"J physiol 2010;588:4117-29; PMID:20807795; http://dx.doi.org/10.1113/jphysiol.2010.195099 [14] Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Neuroscience 2009; 164:849-61; PMID:19679172;http://dx.doi.org/10.1016/j.neuroscience.2009.08.013 [16] Mohammed M, Ootsuka Y, Blessing W. Brown adipose tissue thermogenesis contributes to emotional hyperther- mia in a resident rat suddenly confronted with anintruder rat.",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Am J Physiol Regul Integr Comp Physiol2014; 306:R394-400; PMID:24452545; http://dx.doi.org/10.1152/ajpregu.00475.2013 [17] Ootsuka Y, Kulasekara K, de Men ezes RC, Blessing WW.",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Am J Physiol Regul Integr Comp Physiol 2011; 301:R987-94; PMID:21813867;http://dx.doi.org/10.1152/ajpregu.00085.2011 [18] Blessing W, Mohammed M, Ootsuka Y.",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Physiol Behav 2012; 105:966-74; PMID:22115948;http://dx.doi.org/10.1016/j.physbeh.2011.11.009 [19] Rusyniak DE, Ootsuka Y, Blessing WW.",Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Neuroscience 2008; 154:1619-26; PMID:18534763;http://dx.doi.org/10.1016/j.neuroscience.2008.04.041 [20] Ootsuka Y, Heidbreder CA, Hagan JJ, Blessing WW.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
J ApplPhysiol 2010; 109:1053-63; PMID:20705949; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"The role of orexin/hypocre- tin in the central nervous system and peripheral tissues.Vitam Horm 2012; 89:19-33; PMID:22640606; http://dx.doi.org/10.1016/B978-0-12-394623-2.00002-0 [34] Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M. Orex- ins and their receptors: structural aspects and role inperipheral tissues.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
Br J Pharmacol2014; 171:332-50; PMID:24102345; http://dx.doi.org/10.1111/bph.12415 [36] Kukkonen JP.,Non-OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Am J Physiol Cell Physiol2013; 304:C2-32; PMID:23034387; http://dx.doi.org/10.1152/ajpcell.00227.2012 [37] Kirchgessner AL, Liu M. Orexin synthesis and response in the gut.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Sleep 1982; 5:311-7; PMID:6819628; http://dx.doi.org/10.3389/ fnins.2014.00014 [51] Kuroki C, Takahashi Y, Ootsuka Y, Kanmura Y, Kuwaki T. The impact of hypothermia on emergence from iso-ﬂurane anesthesia in orexin neuron-ablated mice.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Anesth Analg 2013; 116:1001-5; PMID:23477964; http://dx.doi.org/10.1213/ANE.0b013e31828842f0 [52] Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"Brain Res2009; 1298:123-30; PMID:19699727; http://dx.doi.org/10.1016/j.brainres.2009.08.042 [54] Garcia JN, Pedersen NP, Nalivaiko E, Blessing WW.",OADS,/arxiv_data1/oa_pdf/21/17/ktmp-03-03-1184366.PMC5079225.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"3, 384 –393 http://dx.doi.org/10.1080/23328940.2016.1211072",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Scand Arch Physiol 1939; 81:160-71; http://dx.doi.org/10.1111/j.1748-1716.1939.tb01320.x [2] Cermak NM, van Loon LJ.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Sports Med 2013;43:1139-55; PMID:23846824; http://dx.doi.org/10.1007/s40279-013-0079-0 [3] Burke LM, Hawley JA.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
Curr Opin Clin Nutr Metab Care 1999; 6:515-20; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Sports Med 2011; 41:773-92; PMID:21846165;http://dx.doi.org/10.2165/11590520-000000000-00000 [5] Rodriguez NR, Di Marco NM, Langley S. American College of Sports Medicine position stand.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
Med Sci Sports Exerc 2009;41:709-31; PMID:19225360; http://dx.doi.org/10.1249/ MSS.0b013e31890eb86 [6] Burke LM.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Comp Biochem Physiol A Mol Integr Physiol 2001;128:735-48; PMID:11282317; http://dx.doi.org/10.1016/S1095-6433(01)00279-3 [ 7 ] W e n d tD ,v a nL o o nL J ,L i c h t e n b e l tW D .T h e r m o r e g u - lation during exercise in the heat: strategies for main- taining health and performance.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Sports Med 2007;37:669-82; PMID:17645370; http://dx.doi.org/10.2165/00007256-200737080-00002 [8] Yaspelkis BB, Ivy JL.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J ApplPhysiol 2002; 92:1562-72; PMID:11896023; http://dx.doi.org/10.1152/japplphysiol.00482.2001 [10] Jentjens RL, Underwood K, Achten J, Currell K, Mann CH, Jeukendrup AE.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Appl Physiol 2006; 100:807-16; PMID:16282436; http://dx.doi.org/ 10.1152/japplphysiol.00322.2005 [11] Pitsiladis YP, Maughan RJ.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"JPhysiol 1999; 517:919-30; PMID:10358130; http://dx.doi.org/10.1111/j.1469-7793.1999.0919s.x [12] Carter J, Jeukendrup AE, Mundel T, Jones DA.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
P ﬂug Arch 2003; 446:211-9; http://dx.doi.org/10.1007/s00424-003-1020-4 [13] Harding S. The tropical agenda.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
J Tropical Psychol 2011; 1:2-5; http://dx.doi.org/10.1375/jtp.1.1.2 [14] Abd-Aziz S. Sago starch and its utilisation.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Biosci Bio- eng 2002; 94:526-9; PMID:16233345; http://dx.doi.org/10.1016/S1389-1723(02)80190-6 [15] Singhal RS, Kennedy JF, Gopalakrishnan SM, Kaczmarek A.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Carbohyd Polym 2008;72:1-20; http://dx.doi.org/10.1016/j.carbpol.2007.07.043 [16] Ahmad H, Singh R, Ghosh AK.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Scand J Med Sci Sports 2015; 25:S296-301; http://dx.doi.org/10.1111/sms.12332 [19] Che Jusoh MR, Stannard SR, M €undel T. Physiologic and performance effects of sago supplementationTEMPERATURE 391",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
Temperature 2016; 3:318-27; http://dx.doi.org/10.1080/23328940.2016.1159772.,OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Temperature 2016; 3:444- 54; http://dx.doi.org/10.1080/23328940.2016.1179382 [21] Fink WJ, Costill DL, Van Handel PJ.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Eur J ApplPhysiol Occup Physiol 1975; 34:183-90; PMID:1181181;http://dx.doi.org/10.1007/BF00999931 [22] Febbraio MA, Snow RJ, Stathis CG, Hargreaves M, Carey MF.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc 1997; 29:1240-9;PMID:9309637; http://dx.doi.org/10.1097/00005768-199709000-00018 [24] Parkin JM, Carey MF, Zhao S, Febbraio MA.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Appl Phys- iol 1999; 86:902-8; PMID:10066703; http://dx.doi.org/10.1063/1.370821 [25] Young AJ, Sawka MN, Levine L, Cadarette BS, Pandolf KB.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc 1995; 27:200-10; PMID:7723643; http://dx.doi.org/10.1249/00005768-199502000-00009 [29] Febbraio MA, Murton P, Selig SE, Clark SA, Lambert DL, Angus DJ, Carey MF.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Athl Train 2008; 43:585-91; PMID:19030136; http://dx.doi.org/10.4085/1062-6050-43.6.585 [31] Abbiss CR, Peiffer JJ, Peake JM, Nosaka K, Suzuki K, Martin DT, Laursen PB.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Appl Physiol 2008;104:1021-8; PMID:18218905; http://dx.doi.org/10.1152/ japplphysiol.00683.2007 [32] Nassif C, Gomes AR, Peixoto GH, Chagas MH, Soares DD, Silami-Garcia E, Drinkwater EJ, Cannon J, MarinoFE.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"PLoS One 2014; 9:e104710; PMID:25110952; http://dx.doi.org/10.1371/journal.pone.0104710 [33] Che Muhamed AM, Mohamed NG, Ismail N, Aziz AR, Singh R. Mouth rinsing improves cycling endurance perfor-mance during Ramadan fasting in a hot humid environment.Appl Physiol Nutr Metab 2014; 39:458-64; PMID:24669987;http://dx.doi.org/10 .1139/apnm-2013-0276 [34] Hargreaves M, Angus D, Howlett K, Conus NM, Feb- braio M. Effect of heat stress on glucose kinetics during exercise.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci SportsExerc 1996; 28:266-70; PMID:8775164; http://dx.doi.org/ 10.1097/00005768-199602000-00017 [37] Davis JM, Burgess WA, Slentz CA, Bartoli WP, Pate RR.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Effects of ingesting 6% and 12% glucose/electrolyte bev-erages during prolonged intermittent cycling in the heat.Eur J Appl Physiol Occup Physiol 1988; 57:563-9;PMID:3396573; http://dx.doi.org/10.1007/BF00418463 [38] Fern /C19andez-El /C19ıas VE, Ortega JF, Nelson RK, Mora- Rodriguez R. Relationship between muscle water and glycogen recovery after prolonged exercise in the heat in humans.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
Eur J Appl Physiol 2015; 115:1919-26; http://dx.doi.org/10.1007/s00421-015-3175-z [39] Burke LM.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Int J Sports Med 1996; 17:366-372; PMID:8858409; http://dx.doi.org/ 10.1055/s-2007-972862 [41] Jozsi AC, Trappe TA, Starling RD, Goodpaster B, Trappe SW, Fink WJ, Costill DL.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Nutri-tion 2011; 27:659-65; PMID:20951003; http://dx.doi.org/10.1016/j.nut.2010.07.008 [43] Stephens FB, Roig M, Armstrong G, Greenhaff PL.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Sports Sci 2011; 26:149-54; http://dx.doi.org/10.1080/ 02640410701361548 [44] Singh J, Dartois A, Kaur L. Starch digestibility in food matrix: a review.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Trends Food Sci Technol 2010; 21:168-80; http://dx.doi.org/10.1016/j.tifs.2009.12.001 [45] Thomas DE, Brotherhood JR, Brand JC.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Int J Sport Med 1991; 12:180-6; http://dx.doi.org/10.1055/s- 2007-1024664 [46] Wong SH, Chen YJ, Fung WM, Morris JG.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Effect of glycemic index meals on recovery and subsequent endurance capacity.Int J Sports Med 2009; 30:898-905; PMID:20013559; http://dx.doi.org/10.1055/s-0029-1237710 [47] Brown LJ, Midgley AW, Vince RV, Madden LA, McNaugh- ton LR.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"J Sci MedSport 2013; 16:450-4; PMID:23154155; http://dx.doi.org/10.1016/j.jsams.2012.10.006 [48] Pei-Lang AT, Mohamed AMD, Karim AA.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Carbohydr Polym 2005; 63:283-6; http://dx.doi.org/10.1016/j.carbpol.2005.08.061 [49] Tek-Ann C, Md.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Starch from the sago palm - Properties, prospects and challengesas a new industrial source for food and other uses.Compr Rev Food Sci Food Saf 2008; 7:215-28; http://dx.doi.org/10.1111/j.1541-4337.2008.00042.x [51] Flores DM.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Am J Agric Biol Sci 2008; 3:639-46;http://dx.doi.org/10.3844/ajabssp.2008.639.646 [53] Thorne MJ, Thompson LU, Jenkins DJ.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Int J Food Sci Nutr 2010; 61:512-8; PMID:20141487;http://dx.doi.org/10.3109/09637480903517796 [55] Saris WH, Antoine JM, Brouns F, Fogelholm M, Glee- son M, Hespel P, Jeukendrup AE, Maughan RJ, Panne- mans D, Stich V. PASSCLAIM - Physical performanceand ﬁtness.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med SciSports Exerc 1999; 31:472-85; PMID:10188754; http://dx.doi.org/10.1097/00005768-199903000-00018 [58] O ’Brien WJ, Stannard SR, Clarke JA, Rowlands DS.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc2013; 45:1814-24; PMID:23949097; http://dx.doi.org/10.1249/MSS.0b013e31828e12d4 [59] Hopkins WG, Marshall SW, Batterham AM, Hanin J.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc 2009;41:3-13; PMID:19092709; http://dx.doi.org/10.1249/ MSS.0b013e31818cb278 [60] Hopkins WG, Batterham AM.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc 2007; 39:377-90; PMID:17277604; http://dx.doi.org/10.1249/01.mss.0000272779.34140.3b [64] Clark VR, Hopkins WG, Hawley JA, Burke LM.",Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"Med Sci Sports Exerc 2000; 32:1642-7;PMID:10994918; http://dx.doi.org/10.1097/00005768-200009000-00019 [65] Febbraio MA, Snow RJ, Hargreaves M, Stathis CG, Martin IK, Carey MF.",OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
Med Sci Sports Exerc1993; 25:1211-24; PMID:8289607; http://dx.doi.org/ 10.1249/00005768-199311000-00003 [67] Febbraio MA.,Non-OADS,/arxiv_data1/oa_pdf/f9/70/ktmp-03-03-1211072.PMC5079226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"3, 394 –411 http://dx.doi.org/10.1080/23328940.2016.1216256",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Occupational Environmental Med 2015; 72:580-6;PMID:26081622; http://dx.doi.org/10.1136/oemed-2014-102706 [5] Patterson MJ, Roberts WS, Lau WM, Prigg SK.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Int J Occupational EnvironmentalHealth 2015; 21:285-93; http://dx.doi.org/10.1179/2049396715Y.0000000006 [7] Webb P. Dissociation of heat production, and heat loss in working men.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J Sci Med Sport 2008; 11:6-19; PMID:17997136;http://dx.doi.org/10.1016/j.jsams.2007.08.017 [13] Havenith G. Heat balance when wearing protective cloth- ing.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Ann Occup Hyg 1999; 43:289-96; PMID:10481628; http://dx.doi.org/10.1093/annhyg/43.5.289 [14] Gun RT.,OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Med 2013; 28:139-44; PMID:23340114; http://dx.doi.org/ 10.1017/S1049023X12001847 [16] Hunt AP, Parker AW, Stewart IB.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J Occupa-tional Environmental med / Am College OccupationalEnvironmental Med 2014; 56:409-14; http://dx.doi.org/10.1097/JOM.0000000000000114 [17] Gun RT.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Med Biol Eng Comput 1981;19:356-8; PMID:7300475; http://dx.doi.org/10.1007/BF02442557 [21] Amos D, Hansen R, Lau WM, Michalski JT.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Int J Wildland Fire 1997; 7:105-18; http://dx.doi.org/10.1071/WF9970105 [23] Budd GM, Brotherhood JR, Hendrie AL, Jeffrey SE, Beas- ley FA, Costin BP, Zhien W, Baker MM, Cheney NP,Dawson MP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Int J Wildland Fire 1997; 7:119-31; http://dx.doi.org/10.1071/WF9970119 [24] Budd GM, Brotherhood JR, Hendrie AL, Jeffrey SE, Beas- ley FA, Costin BP, Zhien W, Baker MM, Cheney NP, Dawson MP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Int J Wildland Fire 1997; 7:133-44; http://dx.doi.org/10.1071/WF9970133 [25] Hendrie AL, Brotherhood JR, Budd GM, Jeffrey SE, Beas- ley FA, Costin BP, Zhien W, Baker MM, Cheney NP,Dawson MP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Int J Wildland Fire 1997; 7:145-58; http://dx.doi.org/10.1071/WF9970145 [26] Gun RT.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"PloS One 2013; 8: e83148; PMID:24349447; http://dx.doi.org/10.1371/journal.pone.0083148 [28] Kenney WL, Munce TA.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"J Appl Physiol 2003;95:2598-603; PMID:14600165; http://dx.doi.org/10.1152/japplphysiol.00202.2003 [29] Snellen JW, Mitchell D, Wyndham CH.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Int J Wildland Fire 1997; 7:167-80; http://dx.doi.org/10.1071/WF9970167 [33] Havenith G, Coenen JM, Kistemaker L, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Eur J Appl Physiol Occup Physiol 1998; 77:231-41;PMID:9535584; http://dx.doi.org/10.1007/s004210050327 [34] Havenith G, Luttikholt VG, Vrijkotte TG.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Eur J Appl Physiol Occup Physiol 1995; 70:270- 9; PMID:7607204; http://dx.doi.org/10.1007/BF00238575 [35] Cramer MN, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"JApplied Physiol 2014; 116:1123-32; PMID:NOT_FOUND;http://dx.doi.org/10.1152/japplphysiol.01312.2013 [36] Cramer MN, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"J Applied Physiol 2015; 119:982-9; http://dx.doi.org/10.1152/japplphysiol.00281.2015 [37] Gagnon D, Jay O, Kenny GP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J Physiol 2013; 591:2925-35; PMID:23459754;http://dx.doi.org/10.1113/jphysiol.2012.248823 [38] Webb P. The physiology of heat regulation.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Skandinavian Arch Physiol 1938; 79:193-230; http://dx.doi.org/10.1111/j.1748-1716.1938.tb01246.x [40] Candas V, Libert JP, Vogt JJ.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J ApplPhysiol 2013; 114:778-85; PMID:23329814; http://dx.doi.org/10.1152/japplphysiol.01271.2012 [42] Wenger CB.,OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Jama 1984; 252:1165-9; PMID:6471340;http://dx.doi.org/10.1001/jama.1984.03350090041020 [46] Godek SF, Bartolozzi AR, Burkholder R, Sugarman E, Peduzzi C. Sweat rates and ﬂuid turnover in professional football players: a comparison of National FootballLeague linemen and backs.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J Athl Train 2008; 43:184-9;PMID:18345344; http://dx.doi.org/10.4085/1062-6050- 43.2.184 [47] Greenleaf JE.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Med Sci Sports Exerc 1992;24:645-56; PMID:1602937; http://dx.doi.org/10.1249/00005768-199206000-00007 [48] Brake DJ, Bates GP.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Occupational Environmental Med 2003; 60:90-6; http://dx.doi.org/10.1136/oem.60.2.90 [49] Morris NB, Coombs G, Jay O.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"MedSci Sports Exerc 2016; 48:114-22; PMID:26258857;http://dx.doi.org/10.1249/MSS.0000000000000746 [50] Bain AR, Lesperance NC, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Acta Physiol (Oxf) 2012; 206:98-108; PMID:22574769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Med Sci SportsExerc 2015; 47:1272-80; PMID:25259541; http://dx.doi.org/10.1249/MSS.0000000000000533 [52] Morris NB, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Temperature 2016; 3:191 –4; http://dx.doi.org/10.1080/23328940.2016.1185206 [53] Munoz CX, Carney KR, Schick MK, Coburn JW, Becker AJ, Judelson DA.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Scand J Med Sci Sports 2012; 22:e115-24; PMID:22862563; http://dx.doi.org/10.1111/j.1600-0838.2012.01510.x [54] Kenny GP, Jay O. Thermometry, calorimetry, and mean body temperature during heat stress.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
ComprehensivePhysiol 2013; 3:1689-719; http://dx.doi.org/10.1002/cphy.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"J Physiol1964; 171:384-96; PMID:14193928; http://dx.doi.org/10.1113/jphysiol.1964.sp007384 [56] Cheuvront SN, Kene ﬁck RW, Montain SJ, Sawka MN.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J Applied Physiol 2010;109:1989-95; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"00367.2010 [57] Schlader ZJ, Simmons SE, Stannard SR, Mundel T. The independent roles of temperature and thermal perceptionin the control of human thermoregulatory behavior.Physiol Behavior 2011; 103:217-24; http://dx.doi.org/ 10.1016/j.physbeh.2011.02.002 [58] Schlader ZJ, Simmons SE, Stannard SR, Mundel T. Skin temperature as a thermal controller of exercise intensity.Eur J Appl Physiol 2011; 111:1631-9; PMID:21197543;http://dx.doi.org/10.1007/s00421-010-1791-1 [59] Simmons SE, Saxby BK, McGlone FP, Jones DA.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Eur J Appl Physiol 2008; 104(2):271-80; PMID:18214520; http://dx.doi.org/10.1007/s00421-008-0677-y [60] Mackworth NH.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Occupational Environmental Med 2000; 57:165-74; http://dx.doi.org/ 10.1136/oem.57.3.165 [65] Budd GM.,OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"J Sci Med Sport 2008;11:20-32; PMID:17765661; http://dx.doi.org/10.1016/j.jsams.2007.07.003 [66] Hunt AP, Billing DC, Patterson MJ, Caldwell JN.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Temperature 2016; 3:307 –17; http://dx.doi.org/10.1080/ 23328940.2016.1156801 [67] Brearley MB, Norton I, Rush D, Hutton M, Smith S, Ward L, Fuentes H. In ﬂuence of chronic heat acclimati- sation on occupational thermal strain in tropical ﬁeld conditions.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"J Occupational Environ- mental Hygiene 2015; 12:156-62; http://dx.doi.org/ 10.1080/15459624.2014.957831 [72] Budd GM, Brotherhood JR, Hendrie AL, Jeffrey SE, Beas- ley FA, Costin BP, Zhien W, Baker MM, Cheney NP,Dawson MP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
Int J Wildland Fire 1997; 7:69-76; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Ergonomics 1995; 38:1368-84; PMID:7635127; http://dx.doi.org/10.1080/00140139508925195 [75] Taylor NA, Caldwell JN, Dyer R. The physiological demands of horseback mustering when wearing an equestrian helmet.Eur J Appl Physiol 2008; 104:289-96; PMID:18176814;http://dx.doi.org/10.1007/s00421-007-0659-5 [76] Miller VS, Bates GP.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Ann Occup Hyg 2007; 51:553-61; PMID:17878259; http://dx.doi.org/10.1093/annhyg/mem035 [77] Miller VS, Bates GP.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Appl Physiol Nutr Metab 2016; 41:117-24;PMID:26771198; http://dx.doi.org/10.1139/apnm-2015-0386 [82] Raines J, Snow R, Nichols D, Aisbett B. Fluid intake, hydration, work physiology of wild ﬁreﬁghters working in the heat over consecutive days.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Ann Occup Hyg 2015; 59:554-65; PMID:25667157; http://dx.doi.org/10.1093/ annhyg/meu113 [83] Wade H, Sinclair J, Brownsburger C. Wearing long p a n t sw h i l ew o r k i n go u t o o r si nt h et r o p i c sd o e sn o tyield higher body temperatures.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Aust NZ J PublicHealth 2013; 37:70-5; http://dx.doi.org/10.1111/1753-6405.12013 [84] Peiffer JJ, Abbiss CR.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"Ann Occup Hyg 2013; 57:519-27; PMID:23184257; http://dx.doi.org/10.1093/annhyg/mes084 [85] Brake DJ, Bates GP.",OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
J OccupationalEnvironmental Med / Am College Occupational Envi-ronmental Med 2002; 44:125-35; http://dx.doi.org/10.1097/00043764-200202000-00007TEMPERATURE 411,Non-OADS,/arxiv_data1/oa_pdf/0c/7e/ktmp-03-03-1216256.PMC5079227.pdf
"3, 484 –498 http://dx.doi.org/10.1080/23328940.2016.1171280",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Zool 1986; 208:595-614; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"BiolRev 2012; 87:128-62; PMID:21682837; http://dx.doi.org/10.1111/j.1469-185X.2011.00188.x [8] Withers PC, Cooper CE, Maloney SK, Bozinovic F, Cruz- Neto AP.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Comp BiochemPhysiol A 1997; 117:399-405; PMID:9172391; http://dx.doi.org/10.1016/S0300-9629(96)00357-X [10] McNab BK.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Comp Physiol B 1978; 125:115-28; http://dx.doi.org/10.1007/BF00686747 [11] Schmidt S, Withers PC, Cooper CE.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Comp Physiol Bio- chem A 2009; 154:92-7; PMID:19447187; http://dx.doi.org/10.1016/j.cbpa.2009.05.002 [12] Cooper CE, Withers, PC, Cruz-Neto AP.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Physiol Biochem Zool 2009; 82:153- 62; PMID:19199558; http://dx.doi.org/10.1086/595967 [13] Cooper CE, Withers PC.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Comp Physiol B 2010; 180:857-68; PMID:20217094; http://dx.doi.org/10.1007/s00360-010-0452-3 [14] McNab BK.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Ecogra 2005; 28:731-44;http://dx.doi.org/10.1111/j.2005.0906-7590.04173.x [16] Jansa SA, Barker FK, Voss RS.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Evol 2014: 68: 684-95; http://dx.doi.org/10.1111/evo.12290 [17] Martin GM, Gonz /C19alez-Ch /C19avez B. Observations on the behavior of Caenolestes fuliginosus (Tomes, 1863) (Mar- supialia, Paucituberculata, Caenolestidae) in captivity.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Comp Physiol B 2004; 174:293- 7; PMID:14760502; http://dx.doi.org/10.1007/s00360-004-0414-8 [20] Pearson OP.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Comp Physiol B 2010;180:767-73; PMID:20165853; http://dx.doi.org/10.1007/s00360-010-0449-y [22] Martin GM, Sauthier DEU.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Mammalia 2011; 75:281-6; http://dx.doi.org/10.1515/mamm.2011.032 [23] Withers PC, Cooper CE, Nespolo RF.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Exp Biol 2012; 215:2806-13; PMID:22837452; http://dx.doi.org/10.1242/jeb.070433[24] Geiser F, Martin GM.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Naturwissenschaften 2013;100:975-81; PMID:24045765; http://dx.doi.org/10.1007/s00114-013-1098-2 [25] Broome LS, Geiser F. Hibernation in free-living moun- tain pygmy-possums, Burramys parvus (Marsupialia: Burramyidae).",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Aust J Zool 1995; 43:373-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Oecologia 1998; 113:170-8; http://dx.doi.org/ 10.1007/s004420050365 [27] New South Wales National Parks and Wildlife Service.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Physiol Zool 1997; 70:53-60;PMID:9231376; http://dx.doi.org/10.1086/639541 [30] Cooper CE, Geiser F. The “minimal boundary curve for endothermy ”as a predictor of heterothermy in mammals and birds: a review.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Comp Physiol B 2008; 178:1-8;PMID:17674009; http://dx.doi.org/10.1007/s00360-007-0193-0 [31] Wallis RL.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Comp Biochem Physiol A 1976; 53:319-22;PMID:3311; http://dx.doi.org/10.1016/S0300-9629(76)80147-8 [32] Geiser F. Daily torpor and thermoregulation in Antechi- nus(Marsupialia): in ﬂuence of body mass, season, devel- opment, reproduction, and sex.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Oecologia 1988; 77:395-9; http://dx.doi.org/10.1007/BF00378050 [33] Rojas AD, K €ortner G, Geiser F. Torpor in free ranging antechinus: does it increase ﬁtness?",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Naturwissenschaften 2014; 101:105-14; PMID:24441710; http://dx.doi.org/10.1007/s00114-013-1136-0 [34] Stawski C, K €ortner G, Nowack J, Geiser F. The impor- tance of mammalian torpor for survival in a post- ﬁre landscape.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Biol Let 2015; 11:20150134; PMID:26063748;http://dx.doi.org/10.1098/rsbl.2015.0134 [35] Withers PC.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Aust J Zool 2001; 49:445-61; http://dx.doi.org/10.1071/ZO00057 [36] Withers PC.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
2011; 84:514-21; PMID:21897088; http://dx.doi.org/ 10.1086/661637 [38] Crawley MJ.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
2014. http://CRAN.R-project.org/package Dlme4.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
R package ver-sion 2.0-6. http://CRAN.R-project.org/package DlmerTest.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
URL http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Zool J Linn Soc2016; 176:686-701; http://dx.doi.org/10.1111/zoj.12323.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Comp Physiol Biochem A 2010; 157:73-8; PMID:20451650; http://dx.doi.org/10.1016/j.cbpa.2010.04.018 [44] Pusey H, Cooper CE, Withers PC.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Comp PhysiolB 2006; 176:623-629; PMID:16639599; http://dx.doi.org/ 10.1007/s00360-006-0085-8 [46] Tomlinson S, Withers, PC, Maloney SK.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Aust J Zool 2012; 60:54-63; http://dx.doi.org/10.1071/ZO12034 [47] Cheverud JM, Dow MM.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Am J Phys Anth 1985; 67:113-21; http://dx.doi.org/10.1002/ajpa.1330670206 [48] Rohlf FJ.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Evol 2001;55:2143-60; PMID:11794776; http://dx.doi.org/10.1111/j.0014-3820.2001.tb00731.x [49] Bininda-Emonds ORP, Cardillo M, Jones KE, MacPhee RDE, Beck RMD, Grenyer R, Price SA, Vos RA, Gittle- man, JL, Purvis, A.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Nature 2007; 446:507-12; http://dx.doi.org/10.1038/nature05634 [50] Strahan R. The Mammals of Australia Sydney: Reed New Holland, 2002.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Mol Ecol 2003; 12:475-84; PMID:12535097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Anim Ecol 2001; 70:633- 40; http://dx.doi.org/10.1046/j.1365-2656.2001.00518.x [54] Speakman JR, Kr /C19ol E, Johnson MS.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"The functional signif- icance of individual variation in basal metabolic rate.Physiol Biochem Zool 2004; 77:900-15; PMID:15674765;http://dx.doi.org/10.1086/427059 [55] Withers PC, Cooper CE.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Comp Bio- chem Physiol A 2009b; 153:317-23; http://dx.doi.org/ 10.1016/j.cbpa.2009.03.006 [56] Biro, PA, Stamps, JA.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Phys-iol Biochem Zool 2012; 85:543-71; PMID:23099454;http://dx.doi.org/10.1086/666970 [58] McNab BK.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Ecol 1971; 52:845-54; PMID:NOT_FOUND; http://dx.doi.org/10.2307/1936032 [59] Atkinson D, Sibly RM.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Divers Dist 1999; 5:165-74; http://dx.doi.org/10.1046/j.1472-4642.1999.00046.x [61] Meiri S. Bergmann ’s Rule –what ’s in a name?,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Global Ecol Biogeog 2011; 20:203-7; http://dx.doi.org/10.1111/j.1466-8238.2010.00577.x [62] Sullivan RM, Best TL.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Mamm 1997; 78:798-810; http://dx.doi.org/10.2307/1382937 [63] McNab BK.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Physiol Biochem Zool 1999; 72:642-4;PMID:10521332; http://dx.doi.org/10.1086/316701 [64] Chappell MA, Dawson TJ.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Physiol Zool 1994; 67:418-37; http://dx.doi.org/10.1086/ physzool.67.2.30163856 [65] Hinds DS, MacMillen RE.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Physiol Zool 1986; 59:1-9; http://dx.doi.org/10.1086/physzool.59.1.30156083 [66] Cooper CE, Withers PC.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Physiol Biochem Zool 2009; 82:438-446; PMID:19653857; http://dx.doi.org/10.1086/603654TEMPERATURE 497,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Comp Bio-chem Physiol A 2014; 178:24-9; PMID:25108134; http://dx.doi.org/10.1016/j.cbpa.2014.07.026 [68] Dickman CR, Parnaby HE, Crowther MS, King DH.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Aust J Zool 1998; 46:1-26; http://dx.doi.org/10.1071/ZO97036 [69] Scholander PF, Hock R, Walters V, Johnson F, Irving L. Heat regulation in some Arctic and tropical mammals.Biol Bull 1950; 99:237-58; PMID:14791422; http://dx.doi.org/10.2307/1538741 [70] Withers PC, Cooper CE.",OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Mamm 2009a; 90:752-60;http://dx.doi.org/10.1644/08-MAMM-A-286R.1 [71] Munn AJ, Kern P, McAllan BM.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
Naturwissenschaften 2010; 97:601-5; PMID:20442980; http://dx.doi.org/10.1007/s00114-010-0670-2 [72] Green K. Al titudinal and seasonal differences in the diets of Antechinus swainsonii and Antechinus stuar- tii(Marsupialia: Dasyuridae) in relation to the avail- ability of prey in the Snowy Mountains.,Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Aust Wild Res 1989; 16:581-92; http://dx.doi.org/10.1071/ WR9890581 [73] Cooper CE, McAllen BM, Geiser F. Effect of torpor on the water economy of an arid-zone marsupial, the stripe-faced dunnart ( Sminthopsis macroura ).",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"J Comp Physiol B 2005; 175:323-8; PMID:15864500; http://dx.doi.org/10.1007/s00360-005-0488-y [73] MacMillen RE, Hinds DS.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
"Ecol 1983; 64:152-64; http://dx.doi.org/10.2307/1937337 [75] Cooper CE, Withers PC.",Non-OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
J Comp Physiol B 2002; 172:669-75; PMID:12444465; http://dx.doi.org/10.1007/s00360-002-0294-8498 C. E. COOPER ET AL.,OADS,/arxiv_data1/oa_pdf/46/6a/ktmp-03-03-1171280.PMC5079228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/45/main.PMC5079233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/45/main.PMC5079233.pdf
http://dx.doi.org/10.1016/j.eucr.2016.09.008Urology Case Reports 10 (2017) 6 e8,Non-OADS,/arxiv_data1/oa_pdf/a8/45/main.PMC5079233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/6c/main.PMC5079234.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/6c/main.PMC5079234.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.011Urology Case Reports 10 (2017) 4 e5,Non-OADS,/arxiv_data1/oa_pdf/c7/6c/main.PMC5079234.pdf
http://dx.doi.org/10.1016/j.clinimag.2012.01.034 .,OADS,/arxiv_data1/oa_pdf/c7/6c/main.PMC5079234.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Multiple sclerosis CD4+Tc e l l s GlycolysisOXPHOSOxidative stress 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/main.PMC5079236.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.10.004 2214-6474/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/main.PMC5079236.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/main.PMC5079236.pdf
"(2011), http://dx.doi.org/10.1155/2011/167156 .",Non-OADS,/arxiv_data1/oa_pdf/9e/c4/main.PMC5079236.pdf
"Psychia- try 44 (1981) 1129 –1135, http://dx.doi.org/10.1136/jnnp.44.12.1129 .",Non-OADS,/arxiv_data1/oa_pdf/9e/c4/main.PMC5079236.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/2b/main.PMC5079237.pdf
"Abdominal computed  tomography  (CT)  revealed  wall  thicken- ing  at  the  fundus  of  the  gallbladder,  which  was  well  contrasted http://dx.doi.org/10.1016/j.ijscr.2016.10.042 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/46/2b/main.PMC5079237.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/39/main.PMC5079238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/39/main.PMC5079238.pdf
http://dx.doi.org/10.1016/j.eucr.2016.09.006Urology Case Reports 10 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/09/39/main.PMC5079238.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/fd/main.PMC5079240.pdf
Abdominopelvic  CT http://dx.doi.org/10.1016/j.ijscr.2016.10.014 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e1/fd/main.PMC5079240.pdf
"3, 437 –443 http://dx.doi.org/10.1080/23328940.2016.1184367",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Eur J Applied Physiol 2012; 112:1827-37;http://dx.doi.org/10.1007/s00421-011-2153-3 [2] Armstrong LE, Maresh CM.",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Sports Med 1991; 12:302-12; PMID:1763248; http://dx.doi.org/10.2165/00007256-199112050-00003 [3] P /C19eriard JD, Cramer MN, Chapman PG, Caillaud C, Thompson MW.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Exp Physiol2011; 96:134-44; http://dx.doi.org/10.1113/expphysiol.2010.054213 [4] Chalmers S, Esterman A, Eston R, Bowering KJ, Norton K. Short-term heat acclimation training improves physi-cal performance: a systematic review, and exploration ofphysiological adaptations and application for teamsports.",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Sports Med 2014; 44:971-88; PMID:24817609;http://dx.doi.org/10.1007/s40279-014-0178-6 [5] P /C19eriard JD, Racinais S, Sawka MN.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Scandinavian J Med Sci Sports 2015; 25:20-38; http://dx.doi.org/10.1111/sms.12408 [6] Pyne DB, Mujika I, Reilly T. Peaking for optimal perfor- mance: Research limitations and future directions.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"JSports Sci 2009; 27:195-202; PMID:19153861; http://dx.doi.org/10.1080/02640410802509136 [7] Mujika I, Padilla S. Scienti ﬁc bases for precompetition tapering strategies.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Med Sci Sports Exercise 2003; 35:1182- 7; http://dx.doi.org/10.1249/ 01.MSS.0000074448.73931.11[8] Crowcroft S, Duf ﬁeld R, McCleave E, Slattery K, Wallace LK, Coutts AJ.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Scandinavian J Med Sci Sports 2015; 25:287-95;http://dx.doi.org/10.1111/sms.12364 [9] Weller AS, Linnane DM, Jonkman AG, Daanen HAM.",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Eur J Applied Physiol2007; 102:57-66; http://dx.do i.org/10.1007/s00421-007- 0563-z [10] Wyndham CH, Jacobs GE.",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
Ergo- nomics 1977; 20:399-408; PMID:908323; http://dx.doi.org/10.1080/00140137708931642 [12] Moseley PL.,Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Med Sci Sports Exercise 2009; 41:3;http://dx.doi.org/10.124 9/MSS.0b013e31818cb278 [15] Garrett AT, Goosens NG, Rehrer NG, Patterson MJ, Cot- ter JD.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
Eur J Appl Physiol 2009; 107:659-70; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"JSports Sci 2013; 31:779-86; PMID:23215944; http://dx.doi.org/10.1080/02640414.2012.750006 [18] Chen TI, Tsai PH, Lin JH, Lee NY, Liang MT.",OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
Eur J Appl Physiol 1997; 76:181-6; http://dx.doi.org/10.1007/s004210050232 [21] Horowitz M. Heat acclimation: phenotypic plasticity and cues to the underlying molecular mechanisms.,OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
J ThermalBiol 2001; 26:357-63; http://dx.doi.org/10.1016/S0306-4565(01)00044-4442 J. R. CASADIO ET AL.,OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Sports Med 2014; 44:1323-31;PMID:24943043; http://dx.doi.org/10.1007/s40279-014-0212-8[23] Fry RW, Morton AR, Keast D. Periodisation of training stress: a review.",Non-OADS,/arxiv_data1/oa_pdf/68/36/ktmp-03-03-1184367.PMC5079264.pdf
"Please see Appendix 1, SDC (http://links.lww.com/TP/B351) for more c o m p l e t ed e t a i l so nt h e2m o d e l s .",Non-OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
"We therefore calculatedthe LYFT that would be expected if each kidney allograft used in SLK was used in Ki or SPK instead, as the age- and diabetes status-weighted average of LYFTs of the donor-matched kidney ( Appendix 5, SDC , http://links.lww.com/ TP/B351, for details).",Non-OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
"Multiple imputation for missing var- iables did not materially alter our results ( Appendix 4, SDC , http://links.lww.com/TP/B351).",Non-OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
2014; https://optn.transplant.hrsa.gov/ContentDocuments/Guide_to_Calculating_Interpreting_KDPI.pdf.,OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
2016; https://www.transplantpro.org/wp-content/uploads/sites/3/KAS_12month_analysis.pdf.,OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
2015 ; http://optn.transplant.hrsa.,Non-OADS,/arxiv_data1/oa_pdf/89/e2/tp-101-1111.PMC5079265.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/30/dkw264.PMC5079295.pdf
Medicine (2016) 95:42(e4410)Received: 6 November 2015 / Received in ﬁnal form: 30 June 2016 / Accepted: 4 July 2016 http://dx.doi.org/10.1097/MD.0000000000004410Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/53/c7/medi-95-e4410.PMC5079309.pdf
Medicine (2016) 95:42(e4937)Received: 22 March 2016 / Received in ﬁnal form: 25 July 2016 / Accepted: 30 August 2016 http://dx.doi.org/10.1097/MD.0000000000004937Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/92/04/medi-95-e4937.PMC5079310.pdf
Modi ﬁcation of “Hospital emergency medical capability assessment grading operating procedures ”; Available at: http://www.lawbank.com.tw/fnews/pnews.php?nid=804 44.00.,Non-OADS,/arxiv_data1/oa_pdf/92/04/medi-95-e4937.PMC5079310.pdf
"Available at: http://health99.hpa.gov.tw/Hot_News/h_NewsDetailN.aspx?TopIcNo=7001.Accessed December 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/92/04/medi-95-e4937.PMC5079310.pdf
Available at: http://www.mohw.gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474.,Non-OADS,/arxiv_data1/oa_pdf/92/04/medi-95-e4937.PMC5079310.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/92/04/medi-95-e4937.PMC5079310.pdf
Medicine (2016) 95:42(e5002)Received: 16 May 2016 / Received in ﬁnal form: 5 September 2016 / Accepted: 6 September 2016 http://dx.doi.org/10.1097/MD.0000000000005002Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e4/ca/medi-95-e5002.PMC5079313.pdf
Medicine (2016) 95:42(e5016)Received: 16 June 2016 / Received in ﬁnal form: 16 August 2016 / Accepted: 26 August 2016 http://dx.doi.org/10.1097/MD.0000000000005016Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/49/35/medi-95-e5016.PMC5079314.pdf
[11]The various HIRA datasets are in the public domain and available upon request to researchers for health-related studies (http://www.hira.or.kr; http://opendata.hira.or.kr).,OADS,/arxiv_data1/oa_pdf/49/35/medi-95-e5016.PMC5079314.pdf
"A patient wasclassi ﬁed as a patient with each comorbidity if he or she had 2 or more healthcare institution visits with corresponding diagnosis codes (see Table, Supplemental Content, which illustrates code lists of each comorbidity, http://links.lww.com/MD/B353) duringthe study period.",Non-OADS,/arxiv_data1/oa_pdf/49/35/medi-95-e5016.PMC5079314.pdf
http://www.hira.or.kr/eng/ebook/00_Page_img/extra/00.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/35/medi-95-e5016.PMC5079314.pdf
"http://dx.doi.org/10.1111/dme.13014 [26] Prince M, Bryce R, Albanese E, et al.",OADS,/arxiv_data1/oa_pdf/49/35/medi-95-e5016.PMC5079314.pdf
Medicine (2016) 95:42(e5056)Received: 11 June 2016 / Received in ﬁnal form: 10 September 2016 / Accepted: 13 September 2016 http://dx.doi.org/10.1097/MD.0000000000005056Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/25/9d/medi-95-e5056.PMC5079317.pdf
Medicine (2016) 95:42(e5062)Received: 12 May 2016 / Received in ﬁnal form: 9 September 2016 / Accepted: 12 September 2016 http://dx.doi.org/10.1097/MD.0000000000005062Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/1f/medi-95-e5062.PMC5079318.pdf
Medicine (2016) 95:42(e5082)Received: 2 June 2016 / Received in ﬁnal form: 2 July 2016 / Accepted: 15 September 2016 http://dx.doi.org/10.1097/MD.0000000000005082Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/26/70/medi-95-e5082.PMC5079320.pdf
Medicine (2016) 95:42(e5094)Received: 7 March 2016 / Received in ﬁnal form: 23 August 2016 / Accepted: 15 September 2016 http://dx.doi.org/10.1097/MD.0000000000005094Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/47/fa/medi-95-e5094.PMC5079322.pdf
"The applied model simpli ﬁed the observation pattern, ignoring interval censored data and assumed regular follow-up times, although in the SHCS data there is notable variation for the time between 2 follow-up visits (see Supplementary Material, http://links.lww.com/MD/B352).",Non-OADS,/arxiv_data1/oa_pdf/47/fa/medi-95-e5094.PMC5079322.pdf
"The SHCS data are gathered by the Five Swiss University Hospitals, 2 Cantonal Hospitals,15 af ﬁliated hospitals and 36 private physicians (listed inhttp://www.shcs.ch/180-health-care-providers).",OADS,/arxiv_data1/oa_pdf/47/fa/medi-95-e5094.PMC5079322.pdf
"Each review consist of the following assessments: (1) Clin ical symptoms: cough frequency, daily sputum volume, and hemoptysis (Supplemental Table 1, http://links.lww.com/MD/B338); (2) HRQL, based on their dy spnea rating under the mMRC dyspnea scale and SGRQ score; (3) A lung function test was performed, and FEV1, FEV1% predicted, FVC, FVC% predicted and FEV1/FVC ratiowere measured according to standardized guideline, with the highest of three satisfactory measurements recorded; (4) For each patient, the amount o f the SABA used in each week was recorded.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
Medicine (2016) 95:42(e5116)Received: 4 June 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 18 September 2016 http://dx.doi.org/10.1097/MD.0000000000005116Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
"Each review consists of thefollowing assessments: clinical symptoms (cough frequency, dailysputum volume, and hemoptysis) (see Table, Supplemental Content 1, http://links.lww.com/MD/B338); HRQL, based on their dyspnea rating under the modi ﬁed british medical research council (mMRC dyspnea scale) [19]and their score on St. Geroge ’s Respiratory Questionnaire (SGRQ), self-administered quality of life measure validated for use in bronchiectasis patients, with ahigher score indicating a poorer HRQL [20]; a lung function test was performed, and FEV 1, FEV 1% predicted, FVC, FVC% predicted, and FEV1/FVC ratio were measured according tostandardized guideline, with the highest of 3 satisfactorymeasurements recorded [21]; for each patient, the amount of the SABA used in each week was recorded.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
"The mean changes in FEV 1from baseline to the end of treatment were similar for both groups (0.03 vs. /C00.02, P=0.41) (Seeﬁgure, Supplemental Content 2, http://links.lww.com/MD/ B338).",OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
"4B), and that overall exacerbation frequency was more in the Pa e r u g i n o s a subgroup than the other 2 subgroups (See Table, Supplemental Content 4, http://links.lww.com/MD/B338).",Non-OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
http://www.ginasthma.com.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/medi-95-e5116.PMC5079324.pdf
Medicine (2016) 95:42(e5124)Received: 11 March 2016 / Received in ﬁnal form: 28 August 2016 / Accepted: 22 September 2016 http://dx.doi.org/10.1097/MD.0000000000005124Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ed/ec/medi-95-e5124.PMC5079325.pdf
Medicine (2016) 95:42(e5143)Received: 17 March 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005143Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
"The research was completed on October 25, 2014 (refer to Supplementary materials SM1, http://links.lww.com/MD/B355).",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
"Supplementary materials provide the distribution of the cases by uniform cohort in each of the 9 studies (refer to Supplementary materials SM2, http://links.lww.com/MD/B355).",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
"2.0 package ( ©EpiGear International Pty Ltd ABN 51 134 897 411 Brisbane, Australia, 2011-2014)[26](refer to Supplementary materials SM3, http://links.lww.com/MD/B355).",Non-OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
"BMC Infect Dis 2014;14 (suppl 5):S2http://www.biomedcentral.com/1471 –2334/14/S5/S2[32] D ’Ambrosio R, Aghemo A, De Francesco R, et al.",OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
(https://www.agenziafarmaco.gov.it/piattaformaAlgoritmi/ index.php/survey/index).Mancusi et al.,OADS,/arxiv_data1/oa_pdf/0f/8b/medi-95-e5143.PMC5079327.pdf
Medicine (2016) 95:42(e5144)Received: 9 September 2016 / Received in ﬁnal form: 22 September 2016 / Accepted: 26 September 2016 http://dx.doi.org/10.1097/MD.0000000000005144Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/95/78/medi-95-e5144.PMC5079328.pdf
Medicine (2016) 95:42(e5147)Received: 21 April 2016 / Received in ﬁnal form: 6 September 2016 / Accepted: 26 September 2016 http://dx.doi.org/10.1097/MD.0000000000005147Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1b/46/medi-95-e5147.PMC5079329.pdf
Medicine (2016) 95:42(e5167)Received: 9 June 2016 / Received in ﬁnal form: 27 September 2016 / Accepted: 28 September 2016 http://dx.doi.org/10.1097/MD.0000000000005167Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/fb/medi-95-e5167.PMC5079333.pdf
Medicine (2016) 95:42(e5175)Received: 5 December 2015 / Received in ﬁnal form: 26 May 2016 / Accepted: 28 September 2016 http://dx.doi.org/10.1097/MD.0000000000005175Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0c/76/medi-95-e5175.PMC5079335.pdf
Medicine (2016) 95:42(e5176)Received: 21 March 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 28 September 2016 http://dx.doi.org/10.1097/MD.0000000000005176Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e0/cc/medi-95-e5176.PMC5079336.pdf
Medicine (2016) 95:42(e5178)Received: 4 September 2015 / Received in ﬁnal form: 24 September 2016 / Accepted: 28 September 2016 http://dx.doi.org/10.1097/MD.0000000000005178Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/86/91/medi-95-e5178.PMC5079337.pdf
Medicine (2016) 95:42(e5196)Received: 6 August 2016 / Received in ﬁnal form: 29 September 2016 / Accepted: 30 September 2016 http://dx.doi.org/10.1097/MD.0000000000005196Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/46/02/medi-95-e5196.PMC5079340.pdf
Medicine (2016) 95:42(e5204)Received: 27 April 2016 / Received in ﬁnal form: 30 September 2016 / Accepted: 3 October 2016 http://dx.doi.org/10.1097/MD.0000000000005204Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/35/2d/medi-95-e5204.PMC5079341.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gene expressionHippocampus Caudate putamen Alcohol exposure Speci ﬁcations Organism/cell line/tissueMus musculus , C57BL/6J strain, hippocampus and caudate putamen at postnatal day (P)21 and/or P87 Sex Male and femaleSequencer or array typeIllumina MouseWG-6 v2.0 Expression BeadChip Data format Raw and analyzed Experimental factorsPrenatal ethanol exposure Experimental featuresPregnant females were given free access to either 10% (v/v) ethanol or water from 0.5 days post coitum (fertilization) to8.5 days post coitum.",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87736 2.,OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
http://dx.doi.org/10.1016/j.gdata.2016.10.007 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
"PLoS One 7 (8) (2012), e43024, http://dx.doi.org/10.1371/journal.pone.0043024PONE-D-12-11269 (pii).",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
"(2016), http://dx.doi.org/10.1007/s10198-016-0811-4 .",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
"6 (1) (2010), e1000811, http://dx.doi.org/10.1371/ journal.pgen.1000811 .",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
"Nature 445 (7124) (2007) 168–176, http://dx.doi.org/10.1038/nature05453 .",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
"Epigenetics Chromatin 8 (40) (2015), http://dx.doi.org/10.1186/s13072-015-0032-6 .108 C.R.",Non-OADS,/arxiv_data1/oa_pdf/87/41/main.PMC5079349.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Segmentation GliomaMulti-parametric MRIUnsupervised classi ﬁcation Non-negative matrix factorizationClustering 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/2c/main.PMC5079350.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.0212213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/2c/main.PMC5079350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/2c/main.PMC5079350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.012 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 193 e195,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
http://investors.vrtx.com/releasedetail.cfm?ReleaseID ¼889027 .,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
http://www.psy.miami.edu/cfq_QLab/ scoring.html .,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
http://investors.vrtx.com/releasedetail.cfm?,Non-OADS,/arxiv_data1/oa_pdf/24/11/main.PMC5079351.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
Further- more  direct  physical  interaction  between  cancer  cells  and  normal http://dx.doi.org/10.1016/j.ijscr.2016.10.020 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"34  (292)  (2016)  e1–e8,  http://dx.doi.org/10.1016/j.urolonc.",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"21  (2015)  155–160,  http://dx.doi.org/ 10.1111/tbj.12388 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"101  (2009)  1813–1816,  http://dx.doi.org/10.1038/sj.bjc.",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"JEADV  25  (2011)  340–344,  http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"1)  (2013)  S59–62,  http://dx.doi.org/10.1016/S0049- 3848(13)70024-0 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"1)  (2015)  S8–S11,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"Kehoe,  The  hypercoagulable  state  of malignancy:  pathogenesis and current  debate,  Neoplasia  4  (2002)  465–473, http://dx.doi.org/10.1038/sj.neo.7900263 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"(2016), http://dx.doi.org/10.1016/j.ijsu.",OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"338 (1998) 1169–1173, http://dx.doi.org/10.1056/ NEJM199804233381701 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"JTH  14  (2016)  495–503,  http://dx.doi.org/10.1111/ jth.13251 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"JTH  2  (2004)  884–889,  http://dx.doi.org/10.1111/j.1538- 7836.2004.00720.x .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
"[13]  M.  Chauchard,  K.  Benali,  T.  Papo,  K.  Sacre,  Positron  emission  tomography combined with computed  tomography  as  a screening tool  for  occult malignancy in  patients  with  unprovoked  venous  thromboembolism:  an observational  study,  Medicine (Baltimore) 93  (2014)  e110, http://dx.doi.org/ 10.1097/MD.0000000000000110 .",Non-OADS,/arxiv_data1/oa_pdf/6b/5f/main.PMC5079352.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.10.002 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5079353.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5079353.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5079353.pdf
Geneva http://www.who.int/dietphysicalactivity/factsheet_recommendations/en/ index.html .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5079353.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/90/main.PMC5079354.pdf
"An  inﬂammatory  mass  was  found  in  the  lesser sac,  arising  from  body  and  tail  of  pancreas,  which  was  discharg- http://dx.doi.org/10.1016/j.ijscr.2016.10.016 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a1/90/main.PMC5079354.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d8/main.PMC5079355.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.007 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/d8/main.PMC5079355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 190 e192,Non-OADS,/arxiv_data1/oa_pdf/c9/d8/main.PMC5079355.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ConfabulationAmnesia Medio-dorsal thalamic region 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
http://dx.doi.org/10.1016/j.nicl.2016.10.0112213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
MR data analysis MR data were processed by using Functional MRI of the Brain (FMRIB) Software Library (FSL version 4.1 ( http://www.fmrib.ox.ac.,OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
"uk/fsl; (Smith et al., 2004 ) and TrackVis ( http://trackvis.org ).",OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
TrackVis ( http://trackvis.org ) was used for visualization purpose and to perform tractography.,OADS,/arxiv_data1/oa_pdf/e3/cd/main.PMC5079356.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/main.PMC5079357.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.028 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/main.PMC5079357.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Depression AcupunctureResting-state functional connectivityAmygdalaLimbic systemFluoxetineCombination effect 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/7c/main.PMC5079358.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.011 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/7c/main.PMC5079358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/7c/main.PMC5079358.pdf
"Finally, data were then submitted to motion correction using the artifact detection toolbox(http://www.nitrc.org/projects/artifact_detect/ ).",OADS,/arxiv_data1/oa_pdf/e0/7c/main.PMC5079358.pdf
"Resting-state functional connectivity analysis was conducted using the CONN toolbox v15.g ( Whitﬁeld-Gabrieli & Nieto-Castanon, 2012 ) (http://www.nitrc.org/projects/conn ).",OADS,/arxiv_data1/oa_pdf/e0/7c/main.PMC5079358.pdf
This is an openaccess article underthe CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/main.PMC5079359.pdf
"Being considered an intermediate phase between normal aging and dementia (often AD), MCI is characterized by a deﬁcit in at least http://dx.doi.org/10.1016/j.nicl.2016.10.004 2213-1582/©2016 TheAuthors.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/main.PMC5079359.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/),Non-OADS,/arxiv_data1/oa_pdf/8a/ad/main.PMC5079359.pdf
"In our application, we used the “pls” (Mevik and Wehrens, 2007 ) R-package (http://cran.r-project.org).",OADS,/arxiv_data1/oa_pdf/8a/ad/main.PMC5079359.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 947–959 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.10.001 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/b7/8e/main.PMC5079360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/8e/main.PMC5079360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/8e/main.PMC5079360.pdf
Appl Water Sci 2016. http://dx.doi.org/10.1007/ s13201-016-0392-5 .,OADS,/arxiv_data1/oa_pdf/b7/8e/main.PMC5079360.pdf
"They analyzed data from the UK Collab- orative HIV Cohort (CHIC) Study (avail- able at: http://www.ukchic.org.uk )a n d included 8746 patients who had initiated ART containing TDF, plus lamivudine or emtricitabine and either a nonnucleosidereverse transcriptas e inhibitor (NNRTI; efavirenz or nevirapine) or a ritonavir- boosted protease inhibitor (lopinavir, ata-zanavir, or darunavir), and were followedfor a median of 3.3 years.",Non-OADS,/arxiv_data1/oa_pdf/bc/18/jiw214.PMC5079362.pdf
"This is an OpenAccess article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/18/jiw214.PMC5079362.pdf
Available at: http://www.who.int/hiv/p ub/guidelines/arv2013/ download/en/ .,Non-OADS,/arxiv_data1/oa_pdf/bc/18/jiw214.PMC5079362.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/85/jiw371.PMC5079367.pdf
"The polyfunctionality index (PI) algorithm was obtained from FunkyCells ToolBox, version0.1.0 beta (available at: http://www.FunkyCells.com )[15].",OADS,/arxiv_data1/oa_pdf/87/85/jiw371.PMC5079367.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/de/main.PMC5079381.pdf
Patient  was  discussed  in  a  multidisciplinary team  suggesting  a  palliative  chemotherapy  consisting  of  doxoru- http://dx.doi.org/10.1016/j.ijscr.2016.10.025 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/de/main.PMC5079381.pdf
"10, 1070 –1078 http://dx.doi.org/10.1080/15384047.2016.1219818",Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Br J Cancer 2000; 83:354-9; PMID:10917551; http://dx.doi.org/10.1054/bjoc.2000.1266 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Clin Cancer Res 2007; 13:5501s-8s; PMID:17875782; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Mol Cell Biol 1997; 17:5588-97; PMID:9271434; http://dx.doi.org/10.1128/MCB.17.9.5588 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Int J Radiat Biol 2008; 84:151-64; PMID:18246483; http://dx.doi.org/10.1080/09553000701797021 7.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Int J Radiat Biol2008; 84:253-64; PMID:18386191; http://dx.doi.org/10.1080/ 09553000801953342 8.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
J Radiat Res 2003; 44:329- 33; PMID:15031559; http://dx.doi.org/10.1269/jrr.44.329 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
J Biol Chem 2007; 282:21206-12; PMID:17513297; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Mol Cancer Ther 2008; 7:1772-81;PMID:18644989; http://dx.doi.org/10.1158/1535-7163.MCT-07-2200 12.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Cell Death Dis 2012; 3:e251; PMID:22237208; http://dx.doi.org/10.1038/ cddis.2011.120 14.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Mol Syndromol 2014; 5:293-8; PMID:25565929; http://dx.doi.org/10.1159/000366252 16.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Mol Cell 2009; 35:228-39; PMID:19647519; http://dx.doi.org/10.1016/j.molcel.2009.06.021 17.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Yale J Biol Med 2007; 80:141-2; http://dx.doi.org/10.1002/bmb.90 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
PLoS One 2011; 6:e22879; PMID:21829545; http://dx.doi.org/10.1371/journal.pone.0022879 19.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Nature 1995; 376:313-20; PMID:7630397;http://dx.doi.org/10.1038/376313a0 21.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Cell 1993; 75:805-16; PMID:8242751; http://dx.doi.org/ 10.1016/0092-8674(93)90499-G 23.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Cell 1994; 78:59-66; PMID:8033212; http://dx.doi.org/10.1016/0092-8674(94)90572-XCANCER BIOLOGY & THERAPY 1077,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Nat Cell Biol 2002; 4:9-11; PMID:11780126; http://dx.doi.org/10.1038/ncb714 25.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Mol Cell Bio 2009; 29:2828-40; PMID:19273588; http://dx.doi.org/10.1128/MCB.01830-08 26.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Science 1998; 280:1089-91;PMID:9582124; http://dx.doi.org/10.1126/science.280.5366.1089 27.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Oncogene 2000; 19:649-60; PMID:10698510; http://dx.doi.org/10.1038/sj.onc.1203366 28.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Oncogene 2001; 20:4601-12; PMID:11498783; http://dx.doi.org/10.1038/sj.onc.1204484 29.,Non-OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
Cancer Res 2004; 64:7114-9; PMID:15466212; http://dx.doi.org/10.1158/0008-5472.CAN-04-14331078 Y.-F. CHEN ET AL.,OADS,/arxiv_data1/oa_pdf/5b/6b/kcbt-17-10-1219818.PMC5079390.pdf
"0, e1240055 (7 pages)http://dx.doi.org/10.1080/23262133.2016.1240055",Non-OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Brain Stimul 2008; 1:206-23; PMID:20633386; http://dx.doi.org/10.1016/j.brs.2008.06.004 [ 3 ] K u oM - F ,P a u l u sW ,N i t s c h eM A .T h e r a p e u t i ce f f e c t s of non-invasive brain stimulation with direct currents(tDCS) in neuropsychiatric diseases.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Neuroimage2014; 85 Pt 3:948-60; http://dx.doi.org/10.1016/j.neuroimage.2013.05.117 [4] Radman T, Ramos RL, Brumberg JC, Bikson M. Role of cortical cell type and morphology in subthreshold and suprathreshold uniform electric ﬁeld stimulation in vitro.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Brain Stimul 2009; 2:215-228.e3; PMID:20161507; http://dx.doi.org/10.1016/j.brs.2009.03.007 [5] Purpura DP, McMurtry JG.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"J Physiol 1964;172:369-82; PMID:14199369; http://dx.doi.org/10.1113/jphysiol.1964.sp007425 [8] Reis J, Schambra HM, Cohen LG, Buch ER, Fritsch B, Zarahn E, Celnik PA, Krakauer JW.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Brain 2002; 125:2238-47;PMID:12244081; http://dx.doi.org/10.1093/brain/awf238 [10] Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebe- tanz D, Lang N, Henning S, Tergau F, Paulus W. Phar-macological modulation of cortical excitability shiftsinduced by transcranial direct current stimulation inhumans.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Neuron 2010; 66:198-204; PMID:20434997;http://dx.doi.org/10.1016/j.neuron.2010.03.035[12] Podda MV, Cocco S, Mastrodonato A, Fusco S, Leone L, Barbati SA, Colussi C, Ripoli C, Grassi C. Anodal trans-cranial direct current stimulation boosts synaptic plastic-ity and memory in mice via epigenetic regulation of Bdnfexpression.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Sci Rep 2016; 6:22180; http://dx.doi.org/10.1038/srep22180 [13] Monai H, Ohkura M, Tanaka M, Oe Y, Konno A, Hirai H, Mikoshiba K, Itohara S, Nakai J, Iwai Y, et al.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Calcium imaging reveals glial involvement in transcranial directcurrent stimulation-induced plasticity in mouse brain.Nat Commun 2016; 7:11100; http://dx.doi.org/10.1038/ncomms11100 [14] Ohkura M, Sasaki T, Sadakari J, Gengyo-Ando K, Kagawa-Nagamura Y, Kobayashi C, Ikegaya Y, Nakai J.Genetically encoded green ﬂuorescent Ca 2Cindicators with improved detectability for neuronal Ca2Csignals.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"PLoS One 2012; 7:e51286; PMID:23240011; http://dx.doi.org/10.1371/journal.pone.0051286 [15] Takata N, Mishima T, Hisatsune C, Nagai T, Ebisui E, Mikoshiba K, Hirase H. Astrocyte calcium signalingtransforms cholinergic modulation to cortical plasticityin vivo.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"J Neurosci 2011; 31:18155-65; PMID:22159127;http://dx.doi.org/10.1523/JNEUROSCI.5289-11.2011 [16] Bekar LK, He W, Nedergaard M. Locus coeruleus a-adrenergic-mediated activation of cortical astrocytes in vivo.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Cereb Cortex 2008; 18:2789-95; PMID:18372288;http://dx.doi.org/10.1093/cercor/bhn040 [17] Paukert M, Agarwal A, Cha J, Doze VA, Kang JU, Bergles DE.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Neuron 2014; 82:1263-70; PMID:24945771;http://dx.doi.org/10.1016 /j.neuron.2014.04.038 [18] Ding F, O ’Donnell J, Thrane AS, Zeppenfeld D, Kang H, Xie L, Wang F, Nedergaard M. a1-Adrenergic receptors mediate coordinated Ca(2+) signaling of cortical astro-cytes in awake, behaving mice.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Cell Calcium 2013;54:387-94; PMID:24138901; http://dx.doi.org/10.1016/j.ceca.2013.09.001 [19] Petravicz J, Fiacco TA, McCarthy KD.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"J Neurosci 2008; 28:4967-73; PMID:18463250;http://dx.doi.org/10.1523/JNEUROSCI.5572-07.2008 [20] Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D, Tiret P, Volterra A.",Non-OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Nat Neurosci 2011; 14:1276-84; PMID:21909085;http://dx.doi.org/10.1038/nn.2929 [21] Kanemaru K, Sekiya H, Xu M, Satoh K, Kitajima N, Yoshida K, Okubo Y, Sasaki T, Moritoh S, Hasuwa H,et al.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Cell Rep 2014; 8:311-8; PMID:24981861; http://dx.doi.org/10.1016/j.celrep.2014.05.056 [22] Srinivasan R, Huang BS, Venugopal S, Johnston AD, Chai H, Zeng H, Golshani P, Khakh BS.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"18:708-17; PMID:25894291; http://dx.doi.org/10.1038/ nn.4001 [23] Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Min- ton SK, Taves SR, Casper KB, Fiacco TA, McCarthy KD.What is the role of astrocyte calcium in neurophysiology?Neuron 2008; 59:932-46; PMID:18817732; http://dx.doi.org/10.1016/j.neuron.2008.09.004 [24] Araque A, Carmignoto G, Haydon PG, Oliet SHR, Robi- taille R, Volterra A. Gliotransmitters travel in time andspace.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Neuron 2014; 81:728-39; PMID:24559669; http://dx.doi.org/10.1016/j.neuron.2014.02.007 [25] Volterra A, Liaudet N, Savtchouk I. Astrocyte Ca 2Csig- nalling: an unexpected complexity.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Phil Trans R Soc B 2014; 369:20130604; PMID:25225097; http://dx.doi.org/10.1098/rstb.2013.0604 [27] Daw NW, Fox K, Sato H, Czepita D. Critical period for monocular deprivation in the cat visual cortex.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"NatRev Neurosci 2005; 6:626-40; PMID:16025096; http://dx.doi.org/10.1038/nrn1722 [30] Yang Y, Ge W, Chen Y, Zhang Z, Shen W, Wu C, Poo M, Duan S. Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Nature 2010; 463:232-6; PMID:20075918; http://dx.doi.org/10.1038/nature08673 [32] Wang F, Smith NA, Xu Q, Fujita T, Baba A, Matsuda T, Takano T, Bekar L, Nedergaard M. Astrocytes modulate neural network activity by Ca 2C-dependent uptake of extracellular K+.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"Mol Brain 2013; 6:6; PMID:23356992;http://dx.doi.org/10.1186/1756-6606-6-6 [34] Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, et al.",OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
"A paravascular pathway facilitates CSF ﬂow through the brain parenchyma and the clearance of interstitialsolutes, including amyloid b. Sci Transl Med 2012; 4:147ra111; PMID:22896675; http://dx.doi.org/10.1126/scitranslmed.3003748 [35] Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O’Donnell J, Christensen DJ, Nicholson C, Iliff JJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/65/kngs-03-01-1240055.PMC5079391.pdf
